Alberto Briganti
#103,053
Most Influential Person Now
Alberto Briganti's AcademicInfluence.com Rankings
Alberto Brigantiengineering Degrees
Engineering
#2736
World Rank
#3710
Historical Rank
Biomedical Engineering
#85
World Rank
#86
Historical Rank
Alberto Briganticomputer-science Degrees
Computer Science
#3707
World Rank
#3896
Historical Rank
Computer Graphics
#78
World Rank
#81
Historical Rank
Database
#1006
World Rank
#1059
Historical Rank
Download Badge
Engineering Computer Science
Alberto Briganti's Degrees
- PhD Biomedical Engineering University of Milan
- Masters Biomedical Engineering University of Milan
- Bachelors Biomedical Engineering University of Milan
Why Is Alberto Briganti Influential?
(Suggest an Edit or Addition)Alberto Briganti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis (2018) (1661)
- Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. (2015) (705)
- Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. (2012) (592)
- Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. (2003) (565)
- Multi-institutional validation of a new renal cancer-specific survival nomogram. (2007) (466)
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. (2012) (464)
- Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. (2018) (389)
- Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. (2006) (373)
- Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. (2006) (358)
- A systematic review of the association between erectile dysfunction and cardiovascular disease. (2014) (350)
- Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. (2006) (349)
- Pelvic lymph node dissection in prostate cancer. (2009) (344)
- Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. (2004) (328)
- Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. (2014) (316)
- Distribution of metastatic sites in patients with prostate cancer: A population‐based analysis (2014) (312)
- Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. (2015) (300)
- Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. (2004) (277)
- The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. (2005) (269)
- Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic (2020) (263)
- European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era☆ (2020) (261)
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. (2020) (260)
- 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. (2008) (248)
- Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. (2014) (237)
- Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. (2006) (236)
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. (2013) (230)
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer (2018) (228)
- Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer. (2015) (225)
- The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH) (2013) (224)
- Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. (2011) (223)
- Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. (2015) (223)
- Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. (2006) (221)
- Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women (2005) (214)
- The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. (2011) (210)
- Radiotherapy for renal-cell carcinoma. (2014) (207)
- Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. (2015) (207)
- New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. (2016) (202)
- Defining a standard set of patient-centered outcomes for men with localized prostate cancer. (2014) (195)
- Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. (2009) (193)
- Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. (2017) (185)
- Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study. (2015) (185)
- More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. (2015) (184)
- Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. (2011) (182)
- Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. (2011) (182)
- Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies. (2019) (182)
- Early salvage radiotherapy following radical prostatectomy. (2014) (181)
- Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. (2012) (180)
- Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer (2006) (178)
- A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. (2011) (174)
- Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. (2007) (166)
- Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. (2014) (165)
- Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. (2006) (160)
- When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool. (2010) (159)
- A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. (2002) (159)
- Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy. (2005) (156)
- A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. (2019) (148)
- A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation. (2016) (148)
- High-risk prostate cancer: from definition to contemporary management. (2012) (146)
- Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. (2008) (144)
- The Microbiome of the Prostate Tumor Microenvironment. (2017) (142)
- Women's sexual dysfunction: a pathophysiological review (2004) (142)
- Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study. (2015) (142)
- Are infertile men less healthy than fertile men? Results of a prospective case-control survey. (2009) (138)
- Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer (2008) (138)
- Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. (2017) (137)
- Benign Prostatic Hyperplasia and Its Aetiologies (2009) (134)
- Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. (2013) (133)
- Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. (2010) (132)
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. (2020) (129)
- Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. (2012) (129)
- Sexual function and endocrine profile in fertile women with type 1 diabetes. (2006) (129)
- A non-cancer-related survival benefit is associated with partial nephrectomy. (2012) (129)
- Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. (2015) (127)
- Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. (2012) (127)
- One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice. (2013) (125)
- Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation (2006) (124)
- PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy (2010) (124)
- Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. (2014) (123)
- A critical appraisal of logistic regression‐based nomograms, artificial neural networks, classification and regression‐tree models, look‐up tables and risk‐group stratification models for prostate cancer (2007) (122)
- Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. (2012) (122)
- Erectile function rehabilitation in the radical prostatectomy patient. (2010) (122)
- EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). (2019) (121)
- Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. (2009) (119)
- Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial (2011) (110)
- Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. (2013) (110)
- The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin (2016) (110)
- Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification. (2010) (110)
- Development and external validation of an extended 10-core biopsy nomogram. (2007) (110)
- The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. (2014) (109)
- EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. (2019) (108)
- Local Therapy Improves Survival in Metastatic Prostate Cancer. (2017) (106)
- Peyronie's disease: a review (2003) (105)
- Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. (2016) (104)
- Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018. (2018) (104)
- Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis. (2013) (104)
- Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. (2004) (103)
- Common grounds for erectile dysfunction and coronary artery disease (2004) (103)
- Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain. (2012) (102)
- Natural history of surgically treated high-risk prostate cancer. (2015) (102)
- Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population‐based analysis (2012) (100)
- Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? (2011) (99)
- Effect of minimally invasive surgery on the risk for surgical site infections: results from the National Surgical Quality Improvement Program (NSQIP) Database. (2014) (99)
- Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer. (2020) (99)
- Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. (2007) (95)
- Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review. (2019) (95)
- Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis. (2019) (93)
- Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. (2014) (93)
- Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. (2008) (92)
- Predicting survival of patients with node-positive prostate cancer following multimodal treatment. (2014) (91)
- Prostate cancer nomograms: an update. (2006) (91)
- Prostate volume and adverse prostate cancer features: fact not artifact. (2007) (90)
- Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. (2017) (90)
- Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. (2014) (90)
- Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. (2007) (89)
- Nerve‐sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery (2013) (89)
- 11C-Choline PET/CT Predicts Prostate Cancer–Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy (2014) (88)
- Development and external validation of an extended repeat biopsy nomogram. (2007) (88)
- Contemporary incidence and mortality rates of kidney cancer in the United States. (2014) (87)
- Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres (2020) (86)
- Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. (2017) (86)
- Survivorship and improving quality of life in men with prostate cancer. (2015) (86)
- Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy. (2015) (86)
- Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer. (2010) (84)
- Systematic review of methods for reporting combined outcomes after radical prostatectomy and proposal of a novel system: the survival, continence, and potency (SCP) classification. (2012) (82)
- Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary localized prostate cancer (2019) (82)
- Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. (2017) (81)
- Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature. (2015) (80)
- Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. (2017) (80)
- Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series. (2014) (80)
- Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients. (2012) (80)
- [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. (2010) (80)
- Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. (2007) (79)
- Development and internal validation of a side‐specific, multiparametric magnetic resonance imaging‐based nomogram for the prediction of extracapsular extension of prostate cancer (2018) (79)
- Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis (2021) (78)
- Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients. (2015) (78)
- Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients. (2015) (77)
- PD-L1 Expression and CD8+ T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer. (2017) (76)
- Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. (2006) (75)
- Prediction of functional outcomes after nerve-sparing radical prostatectomy: results of conditional survival analyses. (2012) (75)
- Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. (2011) (75)
- Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up? (2006) (75)
- Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. (2007) (74)
- TWO POSITIVE NODES REPRESENT A SIGNIFICANT CUT-OFF VALUE FOR CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER. A NEW PROPOSAL BASED ON A TWO INSTITUTION EXPERIENCE ON 784 CONSECUTIVE N+ PATIENTS (2008) (74)
- The impact of androgen‐deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non‐metastatic prostate cancer: a population‐based study (2014) (73)
- The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder (2016) (73)
- Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model. (2017) (72)
- A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. (2015) (72)
- Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019. (2019) (71)
- Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer (2014) (70)
- Consensus on molecular imaging and theranostics in prostate cancer. (2018) (70)
- Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. (2013) (69)
- Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy. (2007) (69)
- Comparing long‐term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy (2016) (69)
- Lymphatic spread of nodal metastases in high‐risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum (2012) (68)
- The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. (2014) (67)
- Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy (2012) (67)
- Tumor size improves the accuracy of TNM predictions in patients with renal cancer. (2006) (66)
- Extent of lymph node dissection at nephrectomy affects cancer‐specific survival and metastatic progression in specific sub‐categories of patients with renal cell carcinoma (RCC) (2014) (66)
- Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. (2008) (65)
- Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer. (2017) (64)
- Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. (2017) (64)
- Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. (2019) (63)
- Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. (2008) (63)
- Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. (2020) (62)
- The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. (2020) (62)
- A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. (2007) (60)
- Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation. (2016) (60)
- Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. (2004) (59)
- Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer. (2016) (58)
- Preoperative hypogonadism is not an independent predictor of high‐risk disease in patients undergoing radical prostatectomy (2011) (56)
- Metabolic Syndrome and Benign Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology, and Prevention (2011) (56)
- Predicting the risk of bone metastasis in prostate cancer. (2014) (56)
- External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection (2013) (56)
- Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. (2017) (55)
- Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer (2017) (55)
- Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy. (2012) (54)
- Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. (2016) (53)
- Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction (2005) (53)
- Management of erectile dysfunction after radical prostatectomy in 2007 (2007) (53)
- Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: A systematic review (2015) (53)
- Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. (2020) (52)
- Testing the most stringent criteria for selection of candidates for active surveillance in patients with low‐risk prostate cancer (2010) (52)
- The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study. (2019) (52)
- How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications (2011) (52)
- Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology–Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration (2017) (52)
- Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment. (2017) (52)
- Which Patients with Upper Tract Urothelial Carcinoma Can be Safely Treated with Flexible Ureteroscopy with Holmium:YAG Laser Photoablation? Long‐Term Results from a High Volume Institution (2017) (52)
- The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients. (2016) (51)
- Impact of peri‐operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder (2014) (51)
- The role of prostatic inflammation in the development and progression of benign and malignant diseases (2017) (51)
- Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men (2007) (50)
- Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection. (2018) (50)
- Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions. (2014) (50)
- Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer (2012) (50)
- Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival. (2015) (50)
- Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy (2012) (49)
- EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. (2019) (49)
- Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis (2017) (48)
- Imaging biomarkers in prostate cancer: role of PET/CT and MRI (2015) (48)
- Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases. (2018) (48)
- The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period. (2014) (48)
- Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials. (2020) (48)
- Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. (2015) (48)
- Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study. (2012) (47)
- Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration (2019) (47)
- Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? (2017) (47)
- Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression. (2018) (47)
- The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy. (2006) (47)
- Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer. (2017) (47)
- 123 Five year follow-up of plaque incision and vein grafting for Peyronie's disease (2004) (47)
- Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer (2019) (46)
- [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen. (2013) (46)
- Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. (2016) (46)
- Role of multiparametric magnetic resonance imaging in early detection of prostate cancer (2016) (45)
- Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome (2009) (45)
- Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial. (2020) (45)
- Postprostatectomy Erectile Dysfunction: A Review (2016) (45)
- Prediction of sexual function after radical prostatectomy (2009) (45)
- The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy. (2018) (45)
- Factors predicting continence recovery 1 month after radical prostatectomy: Results of a multicenter survey (2011) (45)
- Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. (2018) (45)
- Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. (2012) (45)
- Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD). (2020) (45)
- Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study. (2020) (45)
- Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. (2005) (44)
- Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial. (2008) (43)
- When to perform lymph node dissection in patients with renal cell carcinoma: a novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow‐up (2013) (43)
- Preoperative erectile function represents a significant predictor of postoperative urinary continence recovery in patients treated with bilateral nerve sparing radical prostatectomy. (2012) (43)
- Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. (2007) (43)
- Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi‐Institutional Analysis (2017) (43)
- Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 (2020) (42)
- Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy. (2020) (42)
- Circulating estradiol, but not testosterone, is a significant predictor of high‐grade prostate cancer in patients undergoing radical prostatectomy (2011) (42)
- What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy? (2011) (42)
- Remembered International Index of Erectile Function domain scores are not accurate in assessing preoperative potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. (2008) (42)
- Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatments. (2014) (42)
- Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement. (2008) (41)
- Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound‐guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy (2012) (41)
- Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer. (2019) (41)
- Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? (2011) (41)
- Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics. (2012) (40)
- Choosing the best candidates for penile rehabilitation after bilateral nerve-sparing radical prostatectomy. (2012) (40)
- Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study (2017) (40)
- High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy. (2012) (40)
- What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series. (2015) (39)
- External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy. (2014) (39)
- Lymphocyte‐to‐monocyte ratio and neutrophil‐to‐lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy (2017) (39)
- Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? (2018) (39)
- Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection. (2012) (39)
- Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection (2018) (39)
- The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis. (2016) (39)
- External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. (2019) (38)
- Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy (2017) (38)
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. (2020) (38)
- Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies. (2005) (38)
- Orgasmic Dysfunction After Robot-assisted Versus Open Radical Prostatectomy. (2016) (38)
- Diagnostic Accuracy of 64Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience. (2017) (38)
- Assessment and follow-up of patency after lymphovenous microsurgery for treatment of secondary lymphedema in external male genital organs. (2011) (38)
- Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion (2018) (37)
- Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification. (2013) (37)
- Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma. (2014) (37)
- Percent free prostate‐specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower (2008) (37)
- External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection. (2020) (37)
- Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer. (2018) (37)
- Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study. (2017) (36)
- Association between erectile dysfunction and coronary artery disease: a case report study. (2005) (36)
- Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection (2015) (36)
- Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study. (2015) (36)
- Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre (2013) (36)
- Assessing the Impact of Surgeon Experience on Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy: Results of Four High-Volume Surgeons. (2017) (36)
- Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. (2022) (35)
- Vardenafil for the treatment of erectile dysfunction: a critical review of the literature based on personal clinical experience. (2005) (35)
- Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study (2017) (35)
- CURRENTLY USED CRITERIA FOR ACTIVE SURVEILLANCE IN MEN WITH LOW RISK PROSTATE CANCER. AN ANALYSIS OF PATHOLOGICAL FEATURES (2008) (35)
- Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy (2016) (35)
- [11C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy (2014) (35)
- Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. (2018) (35)
- Erectile dysfunction as a cardiovascular risk factor in patients with diabetes (2013) (34)
- A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer. (2019) (34)
- Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors. (2011) (34)
- Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single‐arm, non‐placebo controlled clinical study (2018) (34)
- In-hospital length of stay after major surgical oncological procedures. (2018) (34)
- Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer. (2021) (34)
- Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. (2014) (34)
- There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies. (2020) (33)
- Predictive models before and after radical prostatectomy (2010) (33)
- Erectile function outcome after bilateral nerve sparing radical prostatectomy: which patients may be left untreated? (2012) (33)
- Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: Value of extranodal extension and size of the largest LN metastasis (2014) (33)
- Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. (2012) (33)
- Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era (2017) (33)
- Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy (2016) (33)
- The impact of lymph node dissection and positive lymph nodes on cancer‐specific mortality in contemporary pT2‐3 non‐metastatic renal cell carcinoma treated with radical nephrectomy (2018) (33)
- Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails. (2020) (33)
- Prevention and management of post prostatectomy erectile dysfunction (2015) (33)
- Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes. (2018) (33)
- The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy (2011) (33)
- Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages (2018) (33)
- Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. (2020) (33)
- Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series. (2012) (32)
- Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer? (2014) (32)
- Women's sexual dysfunction: a review of the "surgical landscape". (2006) (32)
- Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution. (2015) (32)
- Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups. (2016) (32)
- A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy. (2015) (32)
- Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease. (2012) (32)
- Age-stratified distribution of metastatic sites in bladder cancer: A population-based analysis. (2014) (32)
- Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium. (2017) (32)
- Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer? (2012) (32)
- Penile rehabilitation after radical prostatectomy: does it work? (2015) (32)
- Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2014) (31)
- Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin (2007) (31)
- Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time (2013) (31)
- Prognostic Role of Neutrophil‐to‐Lymphocyte Ratio in Primary Non–muscle‐invasive Bladder Cancer (2017) (31)
- Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series. (2017) (31)
- Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis. (2021) (31)
- Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought (2018) (31)
- Random biopsy: when, how many and where to take the cores? (2014) (31)
- Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study. (2012) (31)
- Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. (2014) (31)
- Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey. (2018) (31)
- Penile implants in the era of oral drug treatment for erectile dysfunction (2004) (31)
- Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. (2005) (30)
- Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study. (2009) (30)
- The role of adjuvant chemotherapy for lymph node‐positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study (2015) (30)
- Preferences in the management of high‐risk prostate cancer among urologists in Europe: results of a web‐based survey (2015) (30)
- Impact of stage migration and practice changes on high‐risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades (2016) (30)
- Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. (2015) (30)
- Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model. (2015) (30)
- Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction (2005) (30)
- Can phosphodiesterase type 5 inhibitors cure erectile dysfunction? (2006) (29)
- Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer. (2020) (29)
- A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer (2008) (29)
- Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter. (2008) (29)
- Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy (2013) (29)
- Prostate cancer: from Gleason scoring to prognostic grade grouping (2016) (28)
- Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy (2019) (28)
- Consulting "Dr. Google" for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis. (2020) (28)
- Surgical checklist impact on recurrence‐free survival of patients with non‐muscle‐invasive bladder cancer undergoing transurethral resection of bladder tumour (2018) (28)
- First North American validation and head‐to‐head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy (2018) (28)
- Salvage therapy of small volume prostate cancer nodal failures: a review of the literature. (2014) (28)
- Comparison of perioperative complications and health‐related quality of life between robot‐assisted and open radical cystectomy: A systematic review and meta‐analysis (2019) (28)
- Influence of obesity on tumour volume in patients with prostate cancer (2012) (27)
- A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. (2014) (27)
- Penile rehabilitation after radical prostatectomy (2006) (27)
- Simplifying patient positioning and port placement during robotic-assisted laparoscopic prostatectomy. (2010) (27)
- Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool. (2014) (27)
- Predicting survival of men with recurrent prostate cancer after radical prostatectomy. (2016) (27)
- Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia. (2018) (27)
- HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC) (2017) (27)
- Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer. (2017) (27)
- Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy (2018) (27)
- Age‐adjusted validation of the most stringent criteria for active surveillance in low‐risk prostate cancer patients (2012) (27)
- Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer (2007) (27)
- Pelvic Lymph Node Dissection in Prostate Cancer: Indications, Extent and Tailored Approaches (2017) (26)
- The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two‐Center Validation Study (2017) (26)
- Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis (2014) (26)
- Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy. (2007) (26)
- Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: Development and external validation of a nomogram of clinical use. (2016) (26)
- Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma. (2020) (26)
- Intraoperative assessment of an implantable electrode array for cavernous nerve stimulation. (2008) (26)
- Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients (2006) (26)
- Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy. (2009) (26)
- Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models (2020) (26)
- Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients. (2020) (25)
- Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates (2013) (25)
- A critical assessment of the value of lymph node dissection at radical prostatectomy: A population‐based study (2011) (25)
- MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma (2016) (25)
- The Triad of Endothelial Dysfunction, Cardiovascular Disease, and Erectile Dysfunction: Clinical Implications (2009) (25)
- Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment (2014) (25)
- Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer. (2018) (25)
- Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology. (2020) (25)
- Results of surgery for high-risk prostate cancer (2013) (25)
- Modelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapy. (2014) (25)
- Radical prostatectomy represents an effective treatment in patients with specimen‐confined high pathological Gleason score prostate cancer (2013) (25)
- Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients (2017) (24)
- Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in D'Amico Intermediate- and High- Risk Radical Prostatectomy Patients: A Multi-Institutional Study. (2019) (24)
- Naftopidil for the treatment of benign prostate hyperplasia: a systematic review (2014) (24)
- Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing‐risks analysis (2014) (24)
- Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. (2016) (24)
- How can we expand active surveillance criteria in patients with low‐ and intermediate‐risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator (2018) (24)
- Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection. (2009) (24)
- Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis. (2014) (24)
- Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. (2007) (24)
- The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. (2019) (24)
- The ageing male and erectile dysfunction (2002) (24)
- The Extent of Lymphadenectomy does Affect Cancer Specific Survival in Pathologically Confirmed T4 Renal Cell Carcinoma (2012) (24)
- Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy. (2007) (23)
- Nomograms in urologic oncology, advantages and disadvantages (2019) (23)
- The diagnosis of benign prostatic obstruction: Development of a clinical nomogram (2016) (23)
- Unilateral prostate cancer cannot be accurately predicted in low-risk patients. (2010) (23)
- The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer (2017) (23)
- Hematologic Toxicity in Patients Treated With Postprostatectomy Whole-Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study. (2016) (23)
- Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study (2014) (23)
- Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell (2014) (23)
- Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study. (2016) (23)
- Early radiotherapy after radical prostatectomy improves cancer‐specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria (2015) (23)
- Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis (2019) (23)
- Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. (2016) (23)
- Postoperative orgasmic function increases over time in patients undergoing nerve-sparing radical prostatectomy. (2010) (23)
- EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (2019) (23)
- Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy. (2012) (23)
- Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases (2019) (23)
- Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer‐Specific Mortality (2018) (23)
- Percentage of high‐grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score (2014) (22)
- How to optimize patient selection for robot-assisted radical prostatectomy: functional outcome analyses from a tertiary referral center. (2014) (22)
- Chocolate and women's sexual health: An intriguing correlation. (2006) (22)
- Pelvic lymph node dissection for prostate cancer: Adherence and accuracy of the recent guidelines (2013) (22)
- Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy. (2016) (22)
- Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: Implications for multimodal therapy (2013) (22)
- Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years. (2018) (22)
- Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? (2020) (22)
- Peyronie's disease and autoimmunity—a real-life clinical study and comprehensive review. (2015) (22)
- Adjuvant cisplatin‐based combined chemotherapy for lymph node (LN)‐positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients (2015) (22)
- A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. (2020) (22)
- National Comprehensive Cancer Network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer. (2012) (22)
- The role of the urologist in the management of female sexual dysfunctions (2004) (22)
- Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study (2016) (22)
- When should we expect no residual tumor (pT0) once we submit incidental T1a‐b prostate cancers to radical prostatectomy? (2011) (22)
- Sperm banking is of key importance in patients with prostate cancer. (2013) (22)
- The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted (2009) (21)
- Identification of pathologically favorable disease in intermediate‐risk prostate cancer patients: Implications for active surveillance candidates selection (2015) (21)
- High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges. (2006) (21)
- Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations (2018) (21)
- Population‐Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients (2017) (21)
- Functional outcomes of clinically high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a multi-institutional analysis (2017) (21)
- Preoperative pembrolizumab (pembro) before radical cystectomy (RC) for muscle-invasive urothelial bladder carcinoma (MIUC): Interim clinical and biomarker findings from the phase 2 PURE-01 study. (2018) (21)
- Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients (2014) (21)
- Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1–2 N0 M0 renal cell carcinoma (2017) (21)
- Obesity and prostate cancer (2017) (21)
- Depressive Symptoms and Low Sexual Desire after Radical Prostatectomy: Early and Long‐Term Outcomes in a Real‐Life Setting (2018) (21)
- Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (2021) (21)
- Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. (2020) (21)
- Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now? (2019) (21)
- Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study. (2016) (20)
- Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies. (2013) (20)
- Health‐insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer (2007) (20)
- Prostate-Specific Membrane Antigen–Guided Surgery (2019) (20)
- North American Population‐Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer (2017) (20)
- Laser Lithotripsy: The Importance of Peak Power and Pulse Modulation. (2021) (20)
- Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. (2017) (20)
- Topical prilocaine–lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: Results from a prospective randomized trial (2008) (20)
- Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer. (2016) (20)
- Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve‐sparing radical prostatectomy (2013) (20)
- Treatment of lymph node-positive prostate cancer: teaching old dogmas new tricks. (2014) (20)
- Outcomes research: a methodologic review. (2006) (20)
- Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis (2020) (20)
- Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study. (2016) (19)
- Efficacy of Preoperative Chemotherapy in High-Risk Upper Tract Urothelial Carcinoma (UTUC). (2020) (19)
- Delay in seeking medical help in patients with new-onset erectile dysfunction remained high over and despite the PDE5 era--an ecological study. (2012) (19)
- Survival after nephroureterectomy for upper tract urothelial carcinoma: A population‐based competing‐risks analysis (2014) (19)
- Effect on postoperative survival of the status of distal ureteral margin: The necessity to achieve negative margins at the time of radical cystectomy. (2016) (19)
- Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study. (2017) (19)
- Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma. (2019) (19)
- Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups. (2021) (19)
- Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups (2021) (19)
- Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma. (2022) (19)
- Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy. (2016) (19)
- Effectiveness of a Combination of Cranberries, Lactobacillus rhamnosus, and Vitamin C for the Management of Recurrent Urinary Tract Infections in Women: Results of a Pilot Study. (2016) (19)
- There is no way to identify patients who will harbor small volume, unilateral prostate cancer at final pathology. Implications for focal therapies (2012) (19)
- Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis. (2021) (19)
- Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68 Ga-PSMA and 11 C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections (2020) (19)
- Diagnostic and Therapeutic Implications of Erectile Dysfunction in Patients with Cardiovascular Disease. (2016) (19)
- 68Ga-PSMA-11 PET Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study. (2019) (18)
- Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy (2020) (18)
- Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis (2017) (18)
- Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis (2021) (18)
- Development and internal validation of preoperative transition zone prostate cancer nomogram. (2006) (18)
- Long-term recovery of normal sexual function in testicular cancer survivors (2015) (18)
- Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction? (2016) (18)
- Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. (2017) (18)
- Assessing the most accurate formula to predict the risk of lymph node metastases from prostate cancer in contemporary patients treated with radical prostatectomy and extended pelvic lymph node dissection. (2013) (18)
- Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion (2016) (18)
- Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study. (2017) (18)
- Identifying candidates for super‐extended staging pelvic lymph node dissection among patients with high‐risk prostate cancer (2018) (18)
- The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer. (2015) (18)
- Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature (2016) (18)
- Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis (2013) (18)
- Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy (2017) (18)
- Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade grouping. (2017) (18)
- Salvage lymphadenectomy in postprostatectomy patients with prostate-specific antigen recurrence (2011) (18)
- Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy (2015) (18)
- Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review. (2015) (18)
- The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status. (2016) (18)
- Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients. (2018) (17)
- Metabolic syndrome, obesity, and radical cystectomy complications: a clavien classification system-based analysis. (2014) (17)
- Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study. (2016) (17)
- Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL. (2007) (17)
- Diagnostic Value, Oncologic Outcomes, and Safety Profile of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy for Prostate Cancer (2021) (17)
- Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma (2016) (17)
- The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis. (2017) (17)
- Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi‐institutional study (2017) (17)
- The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer. (2016) (17)
- A novel tool to assess the risk of urinary incontinence after nerve‐sparing radical prostatectomy (2013) (17)
- Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer. (2016) (17)
- Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2014) (17)
- Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection (2016) (17)
- How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? (2020) (17)
- Detrusor Muscle in TUR-Derived Bladder Tumor Specimens: Can We Actually Improve the Surgical Quality? (2016) (17)
- Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study. (2019) (17)
- Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. (2020) (17)
- Pelvic lymph node dissection in prostate cancer: the mystery is taking shape. (2013) (17)
- Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia (2016) (17)
- Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer (2018) (17)
- Pretreatment tables predicting pathologic stage of locally advanced prostate cancer. (2015) (17)
- Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and Therapies. (2016) (17)
- Elective nodal radiotherapy in prostate cancer. (2021) (17)
- Kidney-Pancreas Transplantation Is Associated With Near-Normal Sexual Function in Uremic Type 1 Diabetic Patients (2011) (17)
- Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? (2021) (17)
- Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy. (2011) (17)
- The oncologic role of local treatment in primary metastatic prostate cancer (2015) (17)
- Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy. (2018) (17)
- Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard. (2021) (17)
- What evidence do we need to support the use of extended pelvic lymph node dissection in prostate cancer? (2015) (16)
- Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer (2017) (16)
- Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis. (2020) (16)
- The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. (2017) (16)
- Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review (2021) (16)
- Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy (2007) (16)
- Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis. (2019) (16)
- Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model. (2016) (16)
- Effects of silodosin on sexual function – realistic picture from the everyday clinical practice (2015) (16)
- The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer. (2013) (16)
- Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis (2020) (16)
- External validation of Chun, PCPT, ERSPC, Kawakami, and Karakiewicz nomograms in the prediction of prostate cancer: A single center cohort-study. (2018) (16)
- Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study. (2020) (16)
- Pathophysiology of erectile dysfunction. (2003) (16)
- Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma. (2020) (16)
- Is sperm banking of interest to patients with nongerm cell urological cancer before potentially fertility damaging treatments? (2009) (16)
- Importance of prostate volume in the stratification of patients with intermediate‐risk prostate cancer (2015) (16)
- The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis. (2014) (16)
- Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis (2019) (16)
- Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy. (2017) (16)
- Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy (2018) (16)
- Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. (2017) (16)
- Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis. (2022) (16)
- The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers. (2016) (16)
- 11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml (2019) (16)
- Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study. (2020) (16)
- Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy (2013) (16)
- DETECTION OF LYMPH-NODE METASTASES WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL RETROPUBIC PROSTATECTOMY: VALIDATION BY OPEN PELVIC-RETROPERITONEAL LYMPHADENECTOMY (2009) (16)
- Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy (2017) (16)
- Patients' desire to preserve sexual activity and final decision for a nerve-sparing approach: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study. (2011) (16)
- Preoperative frailty predicts adverse short‐term postoperative outcomes in patients treated with radical nephroureterectomy (2020) (16)
- 18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study (2019) (15)
- More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis. (2018) (15)
- Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis. (2020) (15)
- Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study. (2016) (15)
- Population‐based assessment of cancer‐specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis (2016) (15)
- Metabolic syndrome correlates with peri‐urethral fibrosis secondary to chronic prostate inflammation: Evidence of a link in a cohort of patients undergoing radical prostatectomy (2014) (15)
- Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy (2016) (15)
- Introducing PIONEER: a project to harness big data in prostate cancer research (2020) (15)
- Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors. (2019) (15)
- Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis? (2019) (15)
- Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma. (2020) (15)
- Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes. (2019) (15)
- Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database. (2018) (15)
- Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification. (2013) (15)
- Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy (2011) (15)
- Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates. (2014) (15)
- Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis (2019) (15)
- Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients. (2020) (15)
- The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients. (2018) (15)
- Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma. (2019) (14)
- Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer. (2017) (14)
- Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines. (2020) (14)
- The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis. (2019) (14)
- Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis. (2018) (14)
- Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study (2018) (14)
- Long-term sexual outcomes after holmium laser enucleation of the prostate: which patients could benefit the most? (2016) (14)
- Predictors of Cancer‐specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence (2018) (14)
- Silodosin: An Update on Efficacy, Safety and Clinical Indications in Urology (2018) (14)
- Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma. (2019) (14)
- Prostate specific‐antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer (2006) (14)
- Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis (2020) (14)
- Long‐term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large‐scale population‐based analysis (2019) (14)
- More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder (2019) (14)
- Neoadjuvant and adjuvant treatment in high-risk prostate cancer (2018) (14)
- Impact of obesity on perioperative outcomes at robotic-assisted and open radical prostatectomy: results from the National Inpatient Sample. (2019) (14)
- The ageing male and erectile dysfunction (2003) (14)
- Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis. (2020) (14)
- The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis. (2018) (14)
- Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy (2018) (14)
- Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool (2012) (14)
- Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients. (2020) (14)
- Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study. (2012) (14)
- Imaging modalities in synchronous oligometastatic prostate cancer (2018) (14)
- A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy (2016) (14)
- Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis. (2016) (14)
- Prognostic value of Caveolin‐1 in patients treated with radical prostatectomy: a multicentric validation study (2016) (14)
- Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients (2019) (14)
- Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer. (2018) (14)
- Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer. (2019) (14)
- Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy (2016) (14)
- Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials. (2019) (13)
- Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting (2021) (13)
- Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States. (2019) (13)
- Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer. (2021) (13)
- Non-muscle-invasive bladder cancer: An overview of potential new treatment options. (2021) (13)
- Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy. (2020) (13)
- A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02. (2021) (13)
- How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications. (2012) (13)
- Increasing rates of NCCN high and very high‐risk prostate cancer versus number of prostate biopsy cores (2021) (13)
- Unsuccessful investigation of preoperative sexual health issues in the prostate cancer "couple": results of a real-life psychometric survey at a major tertiary academic center. (2009) (13)
- Incidence and Predictors of 30‐Day Readmission After Robot‐Assisted Radical Prostatectomy (2017) (13)
- Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer. (2018) (13)
- How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder. (2019) (13)
- Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma. (2018) (13)
- Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy (2020) (13)
- Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy (2016) (13)
- Editorial comment on: Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram. (2009) (13)
- Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA (2017) (13)
- Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node‐positive penile squamous cell carcinoma (2020) (13)
- Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect. (2019) (13)
- The use of phosphodiesterase type 5 inhibitors for erectile dysfunction. (2004) (13)
- Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study. (2021) (13)
- Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration (2021) (13)
- Optimizing postoperative sexual function after radical prostatectomy (2012) (13)
- Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database. (2015) (13)
- The impact of moderate wine consumption on the risk of developing prostate cancer (2018) (13)
- When to perform preoperative chest computed tomography for renal cancer staging (2017) (12)
- The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series. (2020) (12)
- Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling. (2015) (12)
- Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients (2017) (12)
- Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally-advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase 2 PEANUT study. (2020) (12)
- Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study. (2022) (12)
- Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. (2019) (12)
- Contemporary conditional cancer‐specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract (2020) (12)
- Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy. (2019) (12)
- Adherence to the European Association of Urology Guidelines: A National Survey among Italian Urologists (2018) (12)
- A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma. (2018) (12)
- Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution. (2020) (12)
- Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness (2021) (12)
- Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases. (2017) (12)
- Novel nomogram for the prediction of seminal vesicle invasion including multiparametric magnetic resonance imaging (2019) (12)
- Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer? (2018) (12)
- Anatomical radical retropubic prostatectomy in patients with a preexisting three-piece inflatable prosthesis: a series of case reports. (2009) (12)
- Penile rehabilitation with phosphodiesterase type 5 inhibitors after nerve-sparing radical prostatectomy: are we targeting the right patients? (2014) (12)
- Rate and Extent of Pelvic Lymph Node Dissection in the US Prostate Cancer Patients Treated With Radical Prostatectomy (2017) (12)
- A risk calculator predicting recurrence in lymph node metastatic penile cancer (2020) (12)
- Adjuvant Therapies in Nonmetastatic Renal‐Cell Carcinoma: A Review of the Literature (2018) (12)
- Urothelial cancer of the upper urinary tract: emerging biomarkers and integrative models for risk stratification. (2016) (12)
- Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical Prostatectomy (2017) (12)
- Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab. (2021) (12)
- Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up. (2019) (11)
- Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize? (2014) (11)
- PD38-12 [11C]CHOLINE PET/CT PREDICTS SURVIVAL IN HORMONE NAÏVE PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY (2015) (11)
- Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation. (2021) (11)
- 11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS (2008) (11)
- Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer (2019) (11)
- Sex hormone‐binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy (2011) (11)
- Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population‐based analysis (2019) (11)
- Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience. (2016) (11)
- Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer (2011) (11)
- The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy (2016) (11)
- Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer. (2021) (11)
- Prognostic Role of N‐cadherin Expression in Patients With Invasive Bladder Cancer (2017) (11)
- The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC). (2020) (11)
- Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy. (2021) (11)
- The Impact of Race and Age on Distribution of Metastases in Patients with Prostate Cancer. (2020) (11)
- The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis (2012) (11)
- Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study. (2019) (11)
- Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization. (2019) (11)
- Long‐term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy (2017) (11)
- THERE IS NO SIGNIFICANT DIFFERENCE BETWEEN ON-DEMAND PDE5-I VS. PDE5-I AS REHABILITATIVE TREATMENT IN PATIENTS TREATED BY BILATERAL NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY (2006) (11)
- The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma (2018) (11)
- Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes (2019) (11)
- Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy (2019) (11)
- A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy (2012) (11)
- Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer. (2017) (11)
- How to improve the ability to detect pelvic lymph node metastases of urologic malignancies. (2009) (10)
- Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum. (2008) (10)
- The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer (2018) (10)
- A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality. (2019) (10)
- Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study (2016) (10)
- Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy (2014) (10)
- Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy. (2020) (10)
- Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm? (2020) (10)
- Interim results from PURE-01: A phase 2, open-label study of neoadjuvant pembrolizumab (pembro) before radical cystectomy for muscle-invasive urothelial bladder carcinoma (MIUC). (2018) (10)
- Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study (2018) (10)
- Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer. (2019) (10)
- Does working channel position influence the effectiveness of flexible ureteroscopy? Results from an in vitro study (2020) (10)
- The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients (2016) (10)
- Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration. (2019) (10)
- ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer. (2020) (10)
- The Effect of Obesity on Perioperative Outcomes Following Percutaneous Nephrolithotomy. (2016) (10)
- Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections. (2020) (10)
- Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection (2009) (10)
- Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey. (2016) (10)
- Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates. (2019) (10)
- Predicting survival in node‐positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi‐institutional database (2016) (10)
- European Association of Urology (EAU) guidelines: do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group (2016) (10)
- Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature. (2018) (10)
- Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review. (2021) (10)
- Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study. (2014) (10)
- A novel tool to predict functional outcomes after robot‐assisted radical prostatectomy and the value of additional surgery for incontinence (2020) (10)
- Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. (2019) (10)
- Incidence rates and contemporary trends in primary urethral cancer (2021) (10)
- Potency after Radical Prostatectomy: From New Techniques to Better Results (2006) (10)
- 200 Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma (2015) (10)
- A critical analysis of Permixon™ in the treatment of lower urinary tract symptoms due to benign prostatic enlargement (2006) (10)
- Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis (2016) (10)
- Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma (2016) (9)
- The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration (2020) (9)
- The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy. (2019) (9)
- The effect of lymph node dissection on cancer‐specific survival in salvage radical prostatectomy patients (2021) (9)
- Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy. (2020) (9)
- Re: epithelial-to-mesenchymal transition in renal neoplasms. (2015) (9)
- An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer (2020) (9)
- Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma (2019) (9)
- Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery. (2019) (9)
- Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. (2020) (9)
- A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals. (2017) (9)
- Circulating sex steroids and prostate cancer: introducing the time-dependency theory (2013) (9)
- Reliability of classification of erectile function domain of the international index of erectile function in patients affected by localized prostate cancer who are candidates for radical prostatectomy. (2005) (9)
- Differences between rural and urban prostate cancer patients (2020) (9)
- The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience. (2017) (9)
- The number of cores at first biopsy may suggest the need for a confirmatory biopsy in patients eligible for active surveillance-implication for clinical decision making in the real-life setting. (2014) (9)
- Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle‐Invasive Bladder Cancer (2019) (9)
- Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi‐institutional study of 62 patients (2017) (9)
- New surgical approaches for clinically high-risk or metastatic prostate cancer (2017) (9)
- The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy (2019) (9)
- Open to debate. The motion: Nomograms should become a routine tool in determining prostate cancer prognosis. (2009) (9)
- Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis (2020) (9)
- Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy (2012) (9)
- The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer (2015) (9)
- A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer. (2019) (9)
- The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer. (2020) (9)
- Prevalence, assessment and surgical correction of penile curvature in hypospadias patients treated at one European Referral Center: description of the technique and surgical outcomes (2019) (9)
- Should We Use Nomograms to Predict Outcome (2008) (9)
- Salvage Lymph Node Dissection for Node-only Recurrence of Prostate Cancer: Ready for Prime Time? (2017) (9)
- Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality (2019) (9)
- Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population‐Based Study (2019) (9)
- Sex- and age-related differences in the distribution of bladder cancer metastases. (2021) (8)
- Prostate cancer nomograms are superior to neural networks. (2006) (8)
- A Comparative Review of Apomorphine Formulations for Erectile Dysfunction (2006) (8)
- Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer (2017) (8)
- Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer. (2016) (8)
- Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities (2021) (8)
- Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study. (2017) (8)
- [18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab. (2020) (8)
- External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients (2017) (8)
- Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma (2017) (8)
- Clinical and diagnostic assessment for therapeutic decisions in prostate cancer. (2012) (8)
- Asking "Dr. Google" for a Second Opinion: The Devil Is in the Details. (2019) (8)
- Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. (2020) (8)
- Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis. (2020) (8)
- Medical conditions associated with female sexual dysfunction (2005) (8)
- Measuring the Quality of Diagnostic Prostate Magnetic Resonance Imaging: A Urologist's Perspective. (2020) (8)
- Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma. (2018) (8)
- Epidemiology and Pathophysiology of LUTS/BPO (2014) (8)
- Salvage surgery for nodal recurrent prostate cancer (2017) (8)
- Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy? (2014) (8)
- Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) (2021) (8)
- The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis. (2020) (8)
- Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma. (2020) (8)
- Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients (2021) (8)
- Salvage radical prostatectomy in nonmetastatic castration-resistant prostate cancer patients who received previous radiotherapy: a feasibility study. (2014) (8)
- The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical Nephrectomy. (2018) (8)
- Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma. (2020) (7)
- Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long‐Term Survival Rates After Radical Cystectomy in Previous 25 Years (2017) (7)
- 228 ADJUVANT RADIOTHERAPY LEADS TO SUPERIOR BIO-CHEMICAL RECURRENCE FREE SURVIVAL COMPARED TO EARLY SALVAGE RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER: RESULTS OF A MATCHED-CONTROLLED MULTI-INSTITUTIONAL ANALYSIS (2011) (7)
- The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy (2021) (7)
- Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review (2021) (7)
- ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder. (2017) (7)
- SURE: An open label, sequential-arm, phase II study of neoadjuvant sacituzumab govitecan (SG), and SG plus pembrolizumab (pembro) before radical cystectomy, for patients with muscle-invasive bladder cancer (MIBC) who cannot receive or refuse cisplatin-based chemotherapy. (2021) (7)
- Long‐term penile morphometric alterations in patients treated with robot‐assisted versus open radical prostatectomy (2018) (7)
- IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines. (2020) (7)
- Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder (2020) (7)
- Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification? (2019) (7)
- Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer. (2017) (7)
- Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. (2020) (7)
- Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy. (2019) (7)
- Role of hK2 in predicting clinically insignificant prostate cancer. (2007) (7)
- Surgery and erectile dysfunction. (2010) (7)
- The effect of race on stage at presentation and survival in upper tract urothelial carcinoma. (2021) (7)
- Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer (2019) (7)
- Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer. (2017) (7)
- Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities. (2011) (7)
- Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysis. (2018) (7)
- Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis (2020) (7)
- Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors (2021) (7)
- Is there a link between erectile dysfunction and coronary artery disease (2004) (7)
- The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients. (2021) (7)
- Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years (2018) (7)
- Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database. (2017) (7)
- Impact of Intra‐ and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy (2017) (7)
- Renal Function Assessment Gap in Clinical Practice: An Awkward Truth (2020) (7)
- Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy. (2018) (7)
- When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database. (2016) (7)
- Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma. (2020) (7)
- Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection. (2018) (7)
- Tumor Volume and Clinical Failure in High‐Risk Prostate Cancer Patients Treated With Radical Prostatectomy (2017) (7)
- External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients (2021) (7)
- Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients. (2019) (7)
- Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities (2020) (7)
- Oestrogens and prostate cancer: novel concepts about an old issue. (2009) (7)
- Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis. (2022) (7)
- Dismiss Systematic Transrectal Ultrasound-guided and Embrace Targeted Magnetic Resonance Imaging-informed Prostate Biopsy: Is the Paradigm Ready to Shift? (2016) (7)
- Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study. (2021) (7)
- The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer (2007) (7)
- Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma (2019) (7)
- Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups. (2020) (7)
- An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer (2021) (7)
- Sociodemographic Disparities in the Nonoperative Management of Small Renal Masses. (2016) (6)
- Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study (2020) (6)
- Safety and Tolerability of Oral Erectile Dysfunction Treatments in the Elderly (2005) (6)
- Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients (2022) (6)
- The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node metastases in prostate cancer. (2008) (6)
- Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone. (2008) (6)
- Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. (2019) (6)
- Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity. (2022) (6)
- Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study (2019) (6)
- Patterns of Recurrence Following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies. (2021) (6)
- How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series. (2021) (6)
- Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer. (2020) (6)
- Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review (2021) (6)
- When to Perform Preoperative Bone Scintigraphy for Kidney Cancer Staging: Indications for Preoperative Bone Scintigraphy. (2017) (6)
- Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions (2021) (6)
- Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis (2021) (6)
- Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma. (2020) (6)
- Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience. (2019) (6)
- Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer (2020) (6)
- Partial nephrectomy in frail patients: Benefits of robot-assisted surgery. (2021) (6)
- Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. (2022) (6)
- Prostate evaluation for clinically important disease: Sampling using image-guidance or not? (The PRECISION study, NCT02380027) (2018) (6)
- Role of serum cholinesterase in patients treated with salvage radical prostatectomy. (2019) (6)
- Erectile Dysfunction and Radical Prostatectomy: An Update (2004) (6)
- How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection (2019) (6)
- External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients (2019) (6)
- Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294-306: Validating VI-RADS Criteria Within Immune-oncology Strategies (VI-RADS-IO). (2018) (6)
- Re: Low Adherence to Guidelines in Nonmuscle-invasive Disease. (2017) (6)
- Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial. (2021) (6)
- Reply to Christopher Chee Kong Ho, Siew Eng Ho, Srijit Das' letter to the editor re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol 2014;65:968-78. (2014) (6)
- What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer? (2021) (6)
- Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation. (2015) (6)
- Rationale for local treatment in the management of metastatic prostate cancer (2016) (6)
- Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges (2020) (6)
- 105 AMS three-piece inflatable implants for erectile dysfunction: A long-term multi-institutional study in 300 consecutive patients (2004) (6)
- Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer (2019) (6)
- Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy. (2020) (6)
- External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study (2020) (6)
- Comparison of the effect of sildenafil and apomorphine SL on nocturnal erections in healthy volunteers: a placebo-controlled study. (2005) (6)
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC). (2019) (6)
- Comparison Between Urothelial and Non-Urothelial Urethral Cancer (2021) (6)
- Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract (2017) (5)
- Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. (2019) (5)
- Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer. (2017) (5)
- Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30. (2016) (5)
- Adjuvant Radiotherapy in Prostate Cancer Patients Treated with Surgery: The Impact of Age and Tumor Characteristics. (2015) (5)
- Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy (2022) (5)
- Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond. (2021) (5)
- Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response (2021) (5)
- Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4. (2016) (5)
- Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2018) (5)
- 544 Long-term impact of adjuvant versus early salvage radiation therapy on clinical recurrence in pT3N0 prostate cancer patients treated with radical prostatectomy: Results of a multi-institutional analysis (2016) (5)
- Is node-positive prostate cancer always a systemic disease? (2008) (5)
- MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer? (2019) (5)
- Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospective survey. (2013) (5)
- Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration. (2020) (5)
- Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent (2019) (5)
- Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. (2021) (5)
- Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center Experience. (2017) (5)
- Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER Registries. (2021) (5)
- External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer. (2018) (5)
- Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]. (2020) (5)
- Prophylaxis of erectile function after radical prostatectomy with phosphodiesterase type 5 inhibitors. (2009) (5)
- DEVELOPMENT AND INTERNAL VALIDATION OF THE FIRST NOMOGRAM PREDICTING LONG-TERM PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2008) (5)
- The effect of gender on nephrectomy perioperative outcomes: a national survey. (2012) (5)
- Suspected clinical T3 prostate cancer is associated with a high rate of negative extended biopsies: clinical implications. (2009) (5)
- The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma (2018) (5)
- Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay (2019) (5)
- Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy. (2017) (5)
- Diagnostic value, oncological outcomes and safety profile of image-guided surgery technologies during robot-assisted lymph node dissection with sentinel node biopsy for prostate cancer (2021) (5)
- Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819-22. (2015) (5)
- Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients. (2021) (5)
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase III trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC). (2019) (5)
- Emerging oral drugs for erectile dysfunction (2004) (5)
- Editorial Comment to Risk factors for pelvic lymphoceles post‐radical prostatectomy (2011) (5)
- The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study (2022) (5)
- Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine (2017) (5)
- MP70-15 LONG TERM OUTCOMES OF SALVAGE LYMPH NODE DISSECTION FOR CLINICALLY RECURRENT PROSTATE CANCER: RESULTS OF A SINGLE INSTITUTION SERIES WITH A MINIMUM FOLLOW-UP OF 5 YEARS (2014) (5)
- How to Select the Optimal Candidates for Renal Mass Biopsy. (2020) (5)
- Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis. (2018) (5)
- 695Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of vessel involvement. The cobra trial (2005) (5)
- High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? (2021) (5)
- Surgical management of benign prostatic obstruction: Current practice patterns and attitudes in Europe (2015) (5)
- Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma (2020) (5)
- Open prostatectomy and the evolution of HoLEP in the management of benign prostatic hyperplasia. (2009) (5)
- Renal histology across the stages of chronic kidney disease (2021) (5)
- Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study. (2019) (5)
- Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review. (2021) (5)
- Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients. (2016) (5)
- Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity (2022) (5)
- Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? (2021) (5)
- Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients. (2020) (5)
- Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node‐positive prostate cancer patients: External validation on a multi‐institutional database (2018) (5)
- Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients. (2018) (5)
- Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder (2020) (5)
- A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis. (2020) (4)
- Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer? (2020) (4)
- Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study. (2020) (4)
- Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study. (2019) (4)
- A mechanistic insight into the anti-metastatic role of the prostate specific antigen (2021) (4)
- Radical prostatectomy improves survival in selected metastatic prostate cancer patients: A North American population‐based study (2021) (4)
- An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer (2017) (4)
- Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients. (2021) (4)
- Caveolin-1 Expression in Upper Tract Urothelial Carcinoma. (2017) (4)
- Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions. (2017) (4)
- The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance. (2016) (4)
- Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis (2017) (4)
- Improvement in overall and cancer‐specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients (2021) (4)
- The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery (2020) (4)
- Converging Roads to Early Bladder Cancer. (2020) (4)
- 1597 GENDER DIFFERENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY A POPULATION-BASED ANALYSIS (2012) (4)
- Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer. (2020) (4)
- Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy: Is Earlier Always Better? (2017) (4)
- PECULIAR: An open label, multicenter, single-arm, phase 2 study of neoadjuvant pembrolizumab (PEM) and epacadostat (EPA), preceding radical cystectomy (Cy), for patients (pts) with muscle-invasive urothelial bladder cancer (MIUBC). (2018) (4)
- The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy. (2022) (4)
- Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients (2020) (4)
- Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates. (2020) (4)
- Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. (2022) (4)
- Rates of other‐cause mortality after radical cystectomy are decreasing over time—A population‐based analysis over two decades (2020) (4)
- Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy. (2021) (4)
- Magnetic Resonance Imaging for Membranous Urethral Length Assessment Prior to Radical Prostatectomy: Can it Really Improve Prostate Cancer Management? (2017) (4)
- Emerging treatment landscape of non-muscle invasive bladder cancer (2022) (4)
- Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy (2018) (4)
- Regional differences in patient age and prostate cancer characteristics and rates of treatment modalities in favorable and unfavorable intermediate risk prostate cancer across United States SEER registries. (2021) (4)
- What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021 (2022) (4)
- Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines. (2020) (4)
- The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer. (2020) (4)
- Multiple-cohort analysis investigating FGFR3 alteration as a predictor of non-response to neoadjuvant pembrolizumab (pembro) in muscle-invasive bladder cancer (MIBC) (2019) (4)
- Improving the stratification of intermediate risk prostate cancer. (2021) (4)
- Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract (2018) (4)
- Comparison of Two Methods for Assessing Erectile Function Before Radical Prostatectomy. (2019) (4)
- Extended pelvic lymph‐node dissection is independently associated with improved overall survival in patients with prostate cancer at high‐risk of lymph‐node invasion (2020) (4)
- Comprehensive analysis of in-hospital delirium after major surgical oncology procedures. (2019) (4)
- The effect of race on survival after local therapy in metastatic prostate cancer patients. (2018) (4)
- Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? (2021) (4)
- Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies. (2019) (4)
- Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer. (2020) (4)
- The effect of primary urological cancers on survival in men with secondary prostate cancer (2021) (4)
- Improving Guideline Adherence in Urology. (2021) (4)
- THE EFFECT OF COMPETING MORTALITY ON THE RISK OF CANCER-SPECIFIC SURVIVAL IN KIDNEY CANCER (2006) (4)
- Contemporary seminal vesicle invasion rates in NCCN high‐risk prostate cancer patients (2022) (4)
- Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients. (2020) (4)
- Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study. (2021) (4)
- Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma. (2022) (4)
- EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy. (2022) (4)
- Discharge patterns after radical cystectomy: contemporary trends in the United States. (2012) (4)
- What is new in robot-assisted radical prostatectomy: a narrative review (2019) (4)
- Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent (2016) (4)
- Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients (2021) (4)
- Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU prostate cancer working group multi-institutional study (2021) (4)
- Prevention and Management of Postprostatectomy Erectile Dysfunction (2009) (4)
- Bladder cancer incidence rates and trends in young adults aged 20-39 years. (2020) (4)
- Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. (2021) (4)
- Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (2020) (4)
- Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol (2021) (4)
- DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM PREDICTING ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RETROPUBIC RADICAL PROSTATECTOMY FOR CLINICALLY LOCALISED PROSTATE CANCER (2008) (4)
- Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer. (2019) (4)
- Final results of PEANUT: Pembrolizumab and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC). (2020) (4)
- Vacuum physiotherapy after first stage buccal mucosa graft (BMG) urethroplasty in children with proximal hypospadias (2020) (4)
- The emerging role of PET-CT scan after radical prostatectomy: still a long way to go. (2019) (4)
- Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma. (2021) (3)
- MP14-09 SURVIVAL AFTER CONSERVATIVE MANAGEMENT VERSUS EXTERNAL BEAM RADIOTHERAPY IN VERY ELDERLY PATIENTS WITH LOCALIZED PROSTATE CANCER (2016) (3)
- Effect of the number of removed lymph nodes on prostate cancer recurrence and survival: evidence from an observational study (2018) (3)
- Excellent Erectile Function Recovery after Focal Therapy: Is This Enough? (2016) (3)
- Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration (2022) (3)
- 290 COMPARISON OF HOLMIUM LASER, COLD KNIFE AD DIATERMIC INCISION FOR THE ENDOSCOPIC TREATMENT OF ANASTOMOTIC STRICTURE AFTER RADICAL RETROPUBIC PROSTATECTOMY (2007) (3)
- Re: Marra et al. ‘Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases’ (2021) (3)
- Robot-assisted versus open cystectomy in the RAZOR trial (2019) (3)
- Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition. (2021) (3)
- Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate. (2020) (3)
- Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer (2020) (3)
- How can we expand active surveillance criteria in patients with low- and intermediate risk prostate cancer without increasing the risk of misclassification: Development of a novel risk calculator (2018) (3)
- A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer (2021) (3)
- Incidental Detection of Basaloid Thymic Carcinoma With 68Ga‐PSMA‐11 PET/CT in a Patient With Recurrent Prostate Cancer (2018) (3)
- 1001 The impact of re-TUR on clinical outcomes in a large cohort of t1g3 patients treated with BCG (2014) (3)
- The Association of Uromodulin Genotype with Renal Cancer Aggressiveness. (2017) (3)
- Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies (2019) (3)
- Comprehensive biomarker analyses and updated results of PURE-01 study: Neoadjuvant pembrolizumab (pembro) in muscle-invasive urothelial bladder carcinoma (MIBC). (2018) (3)
- 697 EXTENDED 24-SAMPLE TRUS PROSTATIC NEEDLE BIOPSY PROTOCOL FOR PROSTATE CANCER DETECTION AS INITIAL DIAGNOSTIC STRATEGY (2007) (3)
- The case for postoperative PDE-5 inhibitor drug treatment after radical prostatectomy. (2008) (3)
- Renal function outcomes in patients with muscle‐invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE‐01 study (2021) (3)
- Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity Indexes (2018) (3)
- 963 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM PREDICTING BIOCHEMICAL RECURRENCE AFTER EARLY SALVAGE RADIOTHERAPY IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2013) (3)
- Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial. (2022) (3)
- European Association of Urology Guidelines Office: How We Ensure Transparent Conflict of Interest Disclosure and Management. (2020) (3)
- Words of wisdom. Re: Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort. (2015) (3)
- Current role of surgery for high risk prostate cancer. (2013) (3)
- Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions (2022) (3)
- Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy (2021) (3)
- Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View (2017) (3)
- Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes. (2019) (3)
- Concomitant antibiotics (ATBs) use and survival outcomes in patients (pts) with muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab (PURE-01 study). (2021) (3)
- 679 IS SURGERY FOR HIGH-RISK LOCALIZED PROSTATE CANCER VALID IN THE ELDERLY POPULATION? AN ANALYSIS OF THE INFLUENCE OF AGE AN CANCER-SPECIFIC AND OVERALL SURVIVAL (2010) (3)
- Re: Family History and Probability of Prostate Cancer, Differentiated by Risk Category - A Nationwide Population-based Study. (2017) (3)
- The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy. (2021) (3)
- Extended lymph node dissection in prostate cancer: a procedure with therapeutic utility. (2014) (3)
- Stage and cancer‐specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population‐based study (2021) (3)
- Erectile Dysfunction in Coronary Artery Disease and Heart Failure (2015) (3)
- Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution. (2020) (3)
- Association Between Lesion Location and Oncological Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy. (2021) (3)
- A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study (2022) (3)
- Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer (2022) (3)
- In Non-Metastatic pT1b Kidney Cancer Patients Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy. (2019) (3)
- Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series (2021) (3)
- Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer. (2017) (3)
- Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases (2018) (3)
- Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026. (2014) (3)
- Non‐organ confined stage and upgrading rates in exclusive PSA high‐risk prostate cancer patients (2022) (3)
- Will active surveillance for clinically localized prostate cancer survive in the era of individualized medicine? (2014) (3)
- Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms (2015) (3)
- PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy (2010) (3)
- The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder (2020) (3)
- Lower urinary tract symptoms and sexual dysfunction in women (2007) (3)
- The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis. (2022) (3)
- Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow up. (2021) (3)
- Re:Mark K. Buyyounouski. Radiobiological modeling and the study of hypofractionated radiotherapy for prostate cancer. Eur Urol 2014;66:1031-2. (2015) (3)
- Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection. (2021) (3)
- 79 PREDICTING ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: A PROPOSAL OF A NOVEL RISK STRATIFICATION (2009) (3)
- Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer. (2022) (3)
- Development of the First Model of Radical Prostatectomy in the Mouse: A Feasibility Study. (2017) (3)
- 836 LONG-TERM OUTCOME OF GLEASON 8-10, NODE NEGATIVE PROSTATE CANCER: THE IMPORTANCE OF LOCAL CONTROL (2010) (3)
- Corporeal penile curvature (CPC) and surgical complications in hypospadias repairs: Associations and outcomes (2019) (3)
- Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer (2020) (3)
- Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects (2021) (3)
- Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder (2021) (3)
- 68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications. (2020) (3)
- Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study. (2019) (3)
- Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis (2019) (3)
- 471 THE NUMBER OF POSITIVE SECTION MARGINS IN HIGH-RISK PROSTATE CANCER IS A POWERFUL AND INDEPENDENT PREDICTOR OF CANCER-SPECIFIC AND OVERALL SURVIVAL IN HIGH-RISK LOCALIZED PROSTATE CANCER (2011) (3)
- Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma (2017) (3)
- PIONEER’s update and integration of a localised prostate cancer core outcome set for effectiveness trials and a standard set for clinical practice (2019) (3)
- Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy (2021) (3)
- PURE-02: An open label, multicenter, single-arm, phase 2 study of neoadjuvant pembrolizumab (Pembro), preceding radical nephroureterectomy (RNU), for patients with localized high-risk urothelial carcinoma of the upper urinary tract (UTUC) (2019) (3)
- Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes. (2021) (3)
- Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy (2022) (2)
- DISTRIBUTION OF PELVIC LYMPH NODES IS NOT SYMMETRIC. RESULTS FROM AN EXTENDED PELVIC LYMPH NODE DISSECTION SERIES (2009) (2)
- Relationship Between Age, Comorbidity, and the Prevalence of Erectile Dysfunction. (2022) (2)
- The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer (2021) (2)
- 660 RRP AS STAND-ALONE THERAPY FOR HIGH-RISK PROSTATE CANCER (2011) (2)
- Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non‐urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes (2020) (2)
- Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy. (2022) (2)
- Node-positive prostate cancer: a call for level 1 evidence. (2015) (2)
- Stool microbiota profiling of patients with muscle invasive bladder cancer receiving neoadjuvant pembrolizumab. (2021) (2)
- Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups (2022) (2)
- Salvage Radiation Therapy for Increasing Prostate-Specific Antigen After Radical Prostatectomy: Who, When, and How? (2017) (2)
- Medium term oncological outcomes in a large cohort of men treated with either focal- or hemi-ablation with HIFU for primary localized prostate cancer (2019) (2)
- Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution (2021) (2)
- 970: What is the Ideal Extent of Pelvic Lymphadenectomy (PLND)? A Sensitivity Analysis (2006) (2)
- Does Radiotherapy Plus Androgen-Deprivation Therapy Represent the Best Treatment Approach in Elderly Patients With Locally Advanced Prostate Cancer? (2015) (2)
- Lymph node dissection during radical prostatectomy for prostate cancer: extending the template in the right patients without increasing complications (2018) (2)
- Predicting Clinical Outcome Following Post Prostatectomy Radiation Therapy: A Poisson-Based Tumor Control Probability (TCP) Model Based on a Large Multi-institutional Series (2015) (2)
- EXTENDED LYMPHADENECTOMY SHOULD BE PERFORMED IN PATIENTS WITH PSA≥6, BIOPSY GLEASON SCORE 7-10 AND STAGE T2 OR HIGHER PROSTATE CANCER (2006) (2)
- Surgical expertise is the major determinant of decreased complication rates in contemporary patients treated with robot-assisted radical prostatectomy (2017) (2)
- Primary lymphomas of the genitourinary tract: A population-based study (2019) (2)
- Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-Review. (2022) (2)
- 188 Salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and imaging-detected nodal metastases (2013) (2)
- Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines. (2021) (2)
- Welcome to European Urology Oncology: Your New Journal, Where Multiple Disciplines Meet To Improve Care of Patients with Genitourinary Cancers. (2018) (2)
- Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer. (2020) (2)
- Attitude towards active surveillance: a cross-sectional survey among patients with uroandrological disorders (2018) (2)
- Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer-Not All That Glitters Is Gold. (2020) (2)
- RISK FACTORS FOR RESIDUAL DISEASE AT RE‐TUR IN T1G3 BLADDER CANCER: PD48‐03 (2017) (2)
- Cancer‐specific survival after radical prostatectomy versus external beam radiotherapy in high‐risk and very high‐risk African American prostate cancer patients (2021) (2)
- Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? (2022) (2)
- Comment on ‘Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome’ (2016) (2)
- 266 Pelvic lymph node dissection can be safely omitted in men with a risk of nodal metastases ≤5% based on the Briganti nomogram: Validation of the EAU guidelines reccommendations for nodal dissection based on patient outcome (2014) (2)
- Research Protocol for an Observational Health Data Analysis to Assess the Long-term Outcomes of Prostate Cancer Patients Undergoing Non-Interventional Management (i.e., Watchful Waiting) and the Impact of Comorbidities and Life Expectancy – PIONEER IMI’s “Big Data for Better Outcomes” program (2021) (2)
- Vacuum physiotherapy after first stage buccal mucosa graft (BMG) urethroplasty in proximal hypospadias: A feasibility, safety and protocol compliance assessment study (2019) (2)
- Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? (2022) (2)
- Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy. (2021) (2)
- PD12-11 SURVIVAL BENEFIT OF RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY ADVANCED PROSTATE CANCER: ESTIMATIONS OF THE NUMBER NEEDED TO TREAT BASED ON COMPETING-RISKS ANALYSIS (2014) (2)
- 936 Gleason score upgrading to 8–10 predicts biochemics from al recurrence in patients undergoing radical prostatectomy: Analysis on 7310 high-risk patient the EMPaCT database (2015) (2)
- Screening and Treating Prostate Cancer in the Older Patient: Decision Making Across the Clinical Spectrum. (2017) (2)
- Defining biochemical response after salvage lymph node dissection in patients treated for nodal recurrence of prostate cancer: Results from a large multi-institutional series (2018) (2)
- Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients. (2022) (2)
- Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy. (2021) (2)
- Evidence-based Urology: Surrogate Endpoints - Pro. (2021) (2)
- Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation‐recurrent Prostate Cancer (2017) (2)
- Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer. Letter. (2021) (2)
- Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer (2022) (2)
- Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate (2021) (2)
- ACCEPTANCE OF AND DISCONTINUATION RATE FROM PAROXETINE TREATMENT IN PATIENTS WITH LIFELONG PREMATURE EJACULATION: AN OBSERVATIONAL SURVEY AT A MAJOR TERTIARY ACADEMIC CENTRE (2009) (2)
- Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients (2019) (2)
- Impaired vascular reactivity in patients with erectile dysfunction. (2004) (2)
- Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients (2021) (2)
- PD14-09 THE IMPACT OF ROBOTIC-ASSISTED RADICAL PROSTATECTOMY ON THE USE AND EXTENT OF PELVIC LYMPH NODE DISSECTION IN THE “POST-LEARNING CURVE” ERA (2014) (2)
- Adjuvant versus early salvage radiation therapy in node positive prostate cancer patients: A long-term survival analysis (2017) (2)
- 1697 PROGNOSTIC FACTORS AND RISK GROUPS IN T1G3 PATIENTS INITIALLY TREATED WITH BCG: RESULTS OF A MULTICENTER RETROSPECTIVE SERIES IN 2530 PATIENTS (2013) (2)
- Early surgical safety outcomes from PURE-01: Secondary analysis from a phase 2 open-label study of neoadjuvant pembrolizumab (pembro) before radical cystectomy for muscle-invasive urothelial bladder carcinoma (MIUC) (2018) (2)
- Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma (2021) (2)
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC). (2022) (2)
- Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma. (2020) (2)
- Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients (2022) (2)
- Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities. (2019) (2)
- Peculiar: An open label, multicenter, single-arm, phase 2 study of neoadjuvant pembrolizumab (PEM) and epacadostat (EPA), preceding radical cystectomy (Cy), for patients (pts) with muscle-invasive urothelial bladder cancer (MIUBC) (2018) (2)
- The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy. (2020) (2)
- 81 PREDICTING FACTORS FOR ERECTILE FUNCTION RECOVERY FOLLOWING INTRAFASCIAL BILATERAL NERVE-SPARING RADICAL PROSTATECTOMY. A COMPARATIVE STUDY BETWEEN THE OPEN AND ROBOTIC APPROACH (2010) (2)
- Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy. (2019) (2)
- The impact of sex and age on distribution of metastases in patients with renal cell carcinoma (2021) (2)
- Defining the morbidity of Robotic-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: adoption of the Comprehensive Complication Index. (2022) (2)
- External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA. (2020) (2)
- MP51-15 TIME FROM SURGERY TO URINARY CONTINENCE SIGNIFICANTLY INFLUENCES THE SUBSEQUENT RECOVERY OF ERECTILE FUNCTION IN PATIENTS TREATED WITH BILATERAL NERVE-SPARING RADICAL PROSTATECTOMY (2014) (2)
- Diagnostic and prognostic factors in patients with prostate cancer: a systematic review (2022) (2)
- Association between rs6152 polymorphism in the androgen receptor gene and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy (2018) (2)
- Cytoreductive radical prostatectomy (cRP) is feasible in men with hormone-naive, metastatic prostate cancer (mPCA) (2017) (2)
- 1795 NUMBER OF METASTATIC SITES AND PERIOPERATIVE OUTCOMES AFTER CYTOREDUCTIVE NEPHRECTOMY: A POPULATION-BASED ANALYSES (2012) (2)
- 228 Predictive molecular biomarkers of renal clear cell carcinoma (2016) (2)
- 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data (2022) (2)
- Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns+ (2021) (2)
- Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer (2020) (2)
- Dose Escalation in Salvage Radiation Therapy and Urinary Toxicity: A Small Price to Pay for a Significant Prospective Benefit. (2016) (2)
- IS CLIMACTURIA FOLLOWING RADICAL PROSTATECTOMY ASSOCIATED WITH SURGICAL TECHNIQUE (2008) (2)
- MP55-11 DEVELOPMENT AND EXTERNAL VALIDATION OF NOMOGRAMS PREDICTING DISEASE-FREE AND CANCER SPECIFIC SURVIVAL AFTER RADICAL CYSTETCOMY (2014) (2)
- Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node positive prostate cancer patients: External validation on a multi-institutional database (2018) (2)
- Reimagining prostate cancer screening: the IMPACT of germline mutations. (2021) (2)
- 1252: Association Between Erectile Dysfunction and Coronary Artery Disease. Role of Coronary Clinical Presentation and Extent of Vessel Involvement. The Cobra Trial (2005) (2)
- Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9. (2015) (2)
- Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy. (2022) (2)
- Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study (2022) (2)
- MORTALITY PREDICTIONS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA (2009) (2)
- Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion. (2019) (2)
- What is the optimal post-operative management of men with lymph node recurrent prostate cancer after salvage lymph node dissection? Results from a large, multi-institutional series (2017) (2)
- PREOPERATIVE HEMOGLOBIN TO PLATELET RATIO AS A PREDICTOR OF SURVIVAL AFTER RADICAL CYSTECTOMY.: MP58‐10 (2017) (2)
- LAPAROSCOPIC RENAL CRYOABLATION (LRC) OF SMALL RENAL MASSES: LESSONS LEARNED FROM 104 CASES IN A 7-YEAR EXPERIENCE (2008) (2)
- 11C-choline versus 68Ga-PSMA PET/CT scan for the detection of nodal recurrence from prostate cancer: Results from a large, multi-institutional salvage lymph node dissection series (2017) (2)
- Erectile Dysfunction and Penile Rehabilitation After Robot-Assisted Radical Prostatectomy (2018) (2)
- Re: Histological comparison between predictive value of preoperative 3‐T multiparametric MRI and 68Ga‐PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer (2020) (2)
- Metabolic syndrome as a marker for prostate cancer: still a work in progress. (2015) (2)
- PD10-03 ASSESSING THE UNDER-ESTIMATION OF NODAL TUMOUR BURDEN BY 68GA-PSMA AND 11C-CHOLINE PET/CT SCAN IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: A LARGE MULTI-INSTITUTIONAL ANALYSIS (2018) (2)
- 647 The neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy: Validation and meta-analysis (2015) (2)
- 158 THE ROLE OF SALVAGE LYMPH NODE DISSECTION IN PATIENTS WITH [11C]CHOLINE PET/CT SCAN DETECTED NODAL RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY (2010) (2)
- STAMPEDE trial and patients with non-metastatic prostate cancer (2016) (2)
- Prevalence and surgical management of pubic hypertrophy in hypospadias patients: results from a high-volume surgeon (2019) (2)
- Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists. (2022) (2)
- PD55-04 MAGNETIC RESONANCE IMAGING ALONE SHOULD NOT BE CONSIDERED AS A STAND-ALONE TEST FOR DISEASE RECLASSIFICATION OF MEN IN ACTIVE SURVEILLANCE. (2019) (2)
- The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer. (2021) (2)
- Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification (2022) (2)
- Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients (2022) (2)
- Assessing the under-estimation of nodal tumour burden by 68Ga-PSMA and 11C-choline PET/CT scan in patients treated with salvage lymph node dissection for nodal recurrence of prostate cancer: A large multi-institutional analysis (2018) (2)
- 772 SALVAGE LYMPH NODE DISSECTION FOR PATIENTS TREATED WITH RADICAL PROSTATECTOMY WITH BIOCHEMICAL RECURRENCE AND IMAGING-DETECTED NODAL METASTASES (2013) (2)
- 771 SHOULD AN EXTENDED NODAL TEMPLATE FOR HIGH RISK PROSTATE CANCER ALWAYS INCLUDE REMOVAL OF COMMON ILIAC LYMPH NODES? (2012) (2)
- 1309: Intraoperative Assessment of an Implantable Electrode Array for Cavernous Nerve Stimulation (2006) (2)
- Survival benefit of local vs. no local treatment for metastatic prostate cancer - impact of baseline PSA and metastatic substages (2018) (2)
- Ensuring Consistent European-Wide Urological Care by the Use of Evidence-Based Clinical Practice Guidelines: Can We Do Better (2017) (2)
- 930 [11C]Choline PET/CT predicts survival in hormone-naïve prostate cancer patients with biochemical failure after radical prostatectomy (2015) (2)
- 1256: Five Year Followup of Plaque Incision and Vein Grafting for Peyronie's Disease (2004) (2)
- 959 THE IMPACT OF LOCAL AND DISTANT METASTASIS ON SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY WITH TUMOR THROMBECTOMY (2011) (2)
- The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective. (2008) (2)
- The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence (2022) (2)
- A SYSTEMATIC ANALYSIS OF THE DETRIMENTAL EFFECT OF ORCHIECTOMY ON THE SKELETAL CONDITION OF MEN WITH PROSTATE CANCER (2009) (2)
- THE EFFECT OF ANDROGEN DEPRIVATION THERAPY ON THE RATE OF SUBSEQUENT NON-CANCER MORBIDITIES (2008) (2)
- Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis. (2020) (2)
- Rebuttal from Authors re: Sidney Glina. How Much are Patients Interested in Erectile Dysfunction Treatment after Radical Prostatectomy? Eur Urol 2008;53:461–2 (2008) (2)
- Comparison of partial vs. radical nephrectomy effect on other cause mortality, cancer specific mortality and 30-day mortality in patients older than 75 years (2018) (2)
- Racial differences in the distribution of bladder cancer metastases: a population-based analysis (2020) (2)
- Adjuvant RT is associated with better cancer control compared to early salvage RT in patients with prostate cancer: results of a matched-controlled multi-institutional analysis (2010) (1)
- 46 ADJUVANT RADIOTHERAPY HAS A POSITIVE IMPACT ON CANCER-SPECIFIC SURVIVAL OF LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS OF A TWO-INSTITUTION SERIES WITH 703 LYMPH NODE POSITIVE PATIENTS (2009) (1)
- ARE INFERTILE MEN LESS HEALTHY THAN FERTILE MEN? PRELIMINARY RESULTS OF A SURVEY AT A MAJOR TERTIARY ACADEMIC CENTRE (2008) (1)
- 374 EXTERNAL VALIDATION OF THE EAU GUIDELINES FOR PELVIC LYMPH NODE DISSECTION AMONG PATIENTS TREATED WTH ROBOTIC ASSISTED RADICAL PROSTATECTOMY (2013) (1)
- Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas (2020) (1)
- Prostate cancer: AUA–ASTRO guidelines for post-RP radiation fail to go nuclear (2013) (1)
- Re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016 (2022) (1)
- TESTING THE MOST STRINGENT CRITERIA FOR ACTIVE SURVEILLANCE: AN ANALISIS BASED ON PATHOLOGICAL FEATURES AT RADICAL PROSTATECTOMY (2009) (1)
- SEVERE DROPOUT RATE FROM THE TREATMENT FOR ERECTILE DYSFUNCTION IN NON-COUNSELLED PATIENTS WHO UNDERWENT BILATERAL NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY (2006) (1)
- Re: Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J. M. Choi, C. J. Nelson, J. Stasi and J. P. Mulhall. J Urol 2007; 177: 2223-2226. (2008) (1)
- SP018THE ASSOCIATION OF UROMODULIN GENOTYPE WITH RENAL CANCER AGGRESSIVENESS (2017) (1)
- There Are Cooler Ways to Die Than Smoking: Urologists of the World, Unite Against This Health Care Tragedy. (2015) (1)
- MP55-20 INCONGRUENCE BETWEEN TURB AND RADICAL CYSTECTOMY FINDINGS IN TERMS OF HISTOLOGICAL VARIANT IDENTIFICATION: ANALYSIS OF ALL POTENTIAL CLINICAL RISK FACTORS (2020) (1)
- Should we rely on multiparametric MRI of the prostate performed at non-academic centres? Implications for optimized target biopsy approaches (2019) (1)
- PD40-07 CLINICAL OUTCOMES AND ADVERSE EVENTS AFTER FIRST-LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2021) (1)
- Assessing the 20-year outcomes of radical prostatectomy for high risk prostate cancer: Results from a large, multi-institutional series (2017) (1)
- Association of Negative Followup Biopsy and Reclassification during Active Surveillance of Prostate Cancer: A Systematic Review and Meta-Analysis. Letter. (2021) (1)
- Lower urinary tract symptoms among Caucasian-European men who have sex with men: findings from a real-life survey (2015) (1)
- Prostate Cancer Pretreatment Tables Predicting Pathologic Stage of Locally Advanced Prostate Cancer (2014) (1)
- PIONEER’s systematic review of outcomes reported in effectiveness trials for interventions in locally advanced prostate cancer (2019) (1)
- SIGNIFICANCE OF PSA INTER-ASSAY VARIABILITY ON CLINICAL PROSTATE CANCER DETECTION-AIDS (2008) (1)
- MP43-08 INCREASING RATES OF NCCN HIGH AND VERY HIGH-RISK PROSTATE CANCER VS. NUMBER OF PROSTATE BIOPSY CORES (2021) (1)
- Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis (2022) (1)
- IDENTIFYING THE OPTIMAL CANDIDATE FOR SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: RESULTS FROM A LARGE, MULTI‐INSTITUTIONAL ANALYSIS: PD15‐09 (2017) (1)
- Contemporary trends and survival outcomes after aborted radical prostatectomy in lymph node metastatic prostate cancer patients (2018) (1)
- Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.035. (2020) (1)
- 1616: Sex Hormone Binding Globulin: A Novel Marker for Predicting Lymph Node Metastases in Patients with Clinically Localized Prostate Cancer Undergoing an Extended Pelvic Lymph Node Dissection (2007) (1)
- Urologists, You'll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non-muscle-invasive Bladder Cancer. (2021) (1)
- Clinical Case Debate: Immunotherapy Versus Alternative Therapies in the Neoadjuvant and Adjuvant Setting of Localized, High-Risk Prostate Cancer (2022) (1)
- 78 WHICH IS THE OPTIMAL TIMING OF ERECTILE FUNCTION ASSESSMENT AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY? RESULTS FROM A PROSPECTIVE ANALYSIS (2009) (1)
- Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables (2022) (1)
- Spatial distribution of positive cores improves the selection of patients with low‐risk prostate cancer as candidates for active surveillance (2013) (1)
- Reducing Complications After Surgery: Still a Long Way To Go. (2016) (1)
- NON-CANCER RELATED MORTALITY RATES IN EUROPEAN PATIENTS WITH T1A AND T1B RENAL CELL CARCINOMA (2009) (1)
- 1838 WHEN TO PERFORM LYMPH NODE DISSECTION IN RENAL CELL CARCINOMA PATIENTS: A NOVEL APPROACH TO PREOPERATIVELY ASSESS THE RISK OF LYMPH NODE INVASION AT SURGERY AND NODAL PROGRESSION DURING FOLLOW UP (2013) (1)
- Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma. (2022) (1)
- Assessing the 20-year outcomes of lymph node positive prostate cancer patients: A plea for lifelong follow-up (2018) (1)
- Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience. (2020) (1)
- 300 When to perform a staging chest-CT scan before surgical treatment for kidney cancer (2016) (1)
- Contemporary analysis of the effect of marital status on survival in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: A population-based study. (2021) (1)
- Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values. (2008) (1)
- Preoperative hemoglobin to platelet ratio as a predictor of survival after radical cystectomy due to bladder cancer, synergic effect of anemia and thrombocytosis (2017) (1)
- RE: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer. (2015) (1)
- IS THERE AN AGE LIMIT FOR THE INDICATION OF EXTENDED PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER?: MP64‐10 (2017) (1)
- 752 ADJUVANT RADIOTHERAPY HAS NO IMPACT ON BIOCHEMICAL RECURRENCE FREE SURVIVAL IN PROSTATE CANCER PATIENTS WITH SEMINAL VESICLES INVASION TREATED WITH RADICAL PROSTATECTOMY (2009) (1)
- Re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A multinational, multi-institutional study comparing positive surgical margin rates among 22,393 open, laparoscopic, and robot-assisted radical prostatectomy patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo. (2014) (1)
- Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? RE: Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer, CUAJ, Jan 2021 (with author reply). (2021) (1)
- Thulium fibre laser achieves faster lithotripsy during ureteroscopic treatment of upper urinary tract stones: An observational study emulating a target trial (2022) (1)
- Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry. (2023) (1)
- Subtype and site specific-induced metabolic vulnerabilities in prostate cancer. (2022) (1)
- Timing of androgen-deprivation therapy for prostate cancer: still a long way to go. (2016) (1)
- Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients (2021) (1)
- Reply to Berardino De Bari, Stefano Arcangeli, and Filippo Alongi's letter to the editor re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur Urol 2014;65:546-51. (2015) (1)
- Survivorship and quality of life in prostate cancer (2015) (1)
- 963: Number of Lymph Nodes Removed and Examined and the Continent of Origin Represent the Foremost Predictors of Lymph Node Invasion in Men with Clinically Localized Prostate Cancer (2006) (1)
- MP69-10 GLYCATED HEMOGLOBIN (HBA1C) LEVELS ARE INDEPENDENTLY ASSOCIATED WITH UNFAVOURABLE PROSTATE CANCER AND DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY (2014) (1)
- Effect of African-American race on cancer specific mortality differs according to clear-cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma (2018) (1)
- Collecting duct carcinoma: Epidemiology, clinical characteristics and survival. (2022) (1)
- Outcome of non-responders to neoadjuvant immunotherapy compared to cisplatin-based chemotherapy before radical cystectomy in muscle-invasive bladder cancer (2020) (1)
- Squamous-cell carcinoma variant histology (SCC-VH) in muscle-invasive bladder cancer (MIBC): A comprehensive clinical, genomic, and therapeutic assessment from multiple datasets. (2019) (1)
- SURGICAL EXPERTISE IS THE MAJOR DETERMINANT OF DECREASED COMPLICATION RATES IN CONTEMPORARY PATIENTS TREATED WITH ROBOT‐ASSISTED RADICAL PROSTATECTOMY: PD15‐10 (2017) (1)
- PIONEER’s systematic review of outcomes in RCTs of men with non-metastatic castration resistant prostate cancer: Is there a need for a core outcome set? (2020) (1)
- The effect of annual hospital volume on perioperative outcomes after urethroplasty (2019) (1)
- Charlson score to predict overall survival and cancer-related death in elderly patients featuring high-risk prostate cancer. (2015) (1)
- External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population‐based Study (2017) (1)
- Editorial Comment to Nodal involvement at nephrectomy is associated with worse survival: A stage‐for‐stage and grade‐for‐grade analysis (2013) (1)
- Short- and long-term outcomes of salvage lymph node dissection in patients with clinically recurrent prostate cancer. (2017) (1)
- Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology – Young Academic Urologists (2022) (1)
- NOT ALL HIGH RISK PROSTATE CANCER PATIENTS HAVE THE SAME RISK OF BIOCHEMICAL RECURRENCE AFTER SURGERY. A MULTI-INSTITUTIONAL ANALYSIS OF PREDICTORS OF GOOD OUTCOME (2009) (1)
- MP80-03 PROGNOSTIC DIFFERENCES AND SURVIVAL OUTCOMES IN PATIENTS WITH PAPILLARY RENAL CELL CARCINOMA SUBTYPES &NDASH; A COMPARISON BETWEEN TYPE I VS. TYPE II (2020) (1)
- 724: Excellent Long-Term Outcome of Patients with Low Volume of Lymph Node Invasion Treated with Extended Pelvic Lymph Node Dissection at the time of Radical Prostatectomy (2007) (1)
- Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer (2022) (1)
- Which patients with PI-RADs 3 lesion at multiparametric MRI can avoid prostate biopsy (2018) (1)
- Follow up of Men with PI-RADS 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter. (2021) (1)
- Requiem for Open Radical Cystectomy in Bladder Cancer Patients. (2019) (1)
- Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary update. (2018) (1)
- V11-02 99M-TECHNETIUM-PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: A PHASE 2 PROSPECTIVE, SINGLE-INSTITUTION STUDY (2022) (1)
- Where is mp-MRI more accurate in detecting clinically significant prostate cancer? An analysis based on anatomical prostate areas (2019) (1)
- Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates (2022) (1)
- RACE, GENDER AND REGIONAL VARIABILITY IN THE USE OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A POPULATION-BASED ANALYSIS (2009) (1)
- Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations (2022) (1)
- 961 PREDICTORS OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND ADJUVANT RADIOTHERAPY IN MEN WITH PT3N0 PROSTATE CANCER. IMPLICATIONS FOR MULTI-MODAL THERAPIES (2013) (1)
- PO-0719: Excellent 5 year outcome with image guided moderate hypofractionation in prostate cancer : phase I-II study results (2015) (1)
- Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports. (2023) (1)
- An up-to-date catalogue of urinary markers for the management of prostate cancer. (2020) (1)
- 1010 ASSESSING THE RISK OF LYMPH NODE INVASION IN PATIENTS WITH INTERMEDIATE RISK PROSTATE CANCER. A NOVEL PREDICTION TOOL (2010) (1)
- COMPETING RISKS NOMOGRAM PREDICTING THE PROBABILITY OF BLADDER CANCER RECURRENCE AFTER CYSTECTOMY CAN RELIABLY DISTINGUISH BETWEEN TUMOURS DESTINED TO RECUR AND PATIENTS WHO MAY DIE OF OTHER CAUSES BEFORE RECURRENCE (2006) (1)
- MP62-04 COMPARATIVE EFFECTIVENESS OF ROBOT ASSISTED VS. OPEN RADICAL PROSTATECTOMY IN INTERMEDIATE AND HIGH RISK PATIENTS (2015) (1)
- Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab. (2022) (1)
- Multiparametric MRI represents an added value but not a substitute of follow-up biopsies in patients on active surveillance for low-risk prostate cancer (2017) (1)
- Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy (2018) (1)
- Delivering Optimal Care for Metastatic Prostate Cancer: A Strengthening Alliance Between Urologists and Medical Oncologists. (2016) (1)
- MP36-12 WHERE IS MP-MRI MORE ACCURATE IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER? AN ANALYSIS BASED ON ANATOMICAL PROSTATE AREAS (2019) (1)
- 736: Erectile Function Following a Bilateral Nerve-Sparing Radical Retropubic Prostatectomy. Results of Multivariate Analysis (2005) (1)
- Using adjuvant radiotherapy to improve cancer-specific survival in patients with highly aggressive prostate cancer: Examining recently released criteria. (2014) (1)
- ANDROGEN DEPRIVATION THERAPY DOES NOT PREDISPOSE TO OSTEOPENIA IN PROSTATE CANCER PATIENTS (2008) (1)
- 262 Atypical small acinar proliferation on initial extended prostate biopsy: Cancer detection on second and third extended biopsy (2004) (1)
- Multi-institutional external validation of the EAU guidelines recommendations for the use of staging mpMRI prior to radical prostatectomy in men with intermediate and high-risk prostate cancer (2018) (1)
- Micropapillary bladder cancer: an evolving biology (2022) (1)
- Impact of human papillomavirus (HPV) infection on the outcome of perioperative treatments for penile squamous-cell carcinoma (PSCC). (2020) (1)
- 627 30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM (2007) (1)
- 113 TADALAFIL IMPROVES HYPOXIA, STRUCTURAL DETRUSOR CHANGES AND BLADDER COMPLIANCE AFTER CAVERNOUS NERVE INJURY (2013) (1)
- PIONEER: European Commission Innovative Medicines Initiative funded BD4BO (Big data for better outcome) project on prostate cancer (2020) (1)
- PD22-08 CLINICALLY MEANINGFUL IMPROVEMENTS IN LUTS/BPH SEVERITY IN MEN TREATED WITH SILODOSIN PLUS SERENOA REPENS OR SILODOSIN ALONE (2016) (1)
- Trend of use of adjuvant and salvage radiation therapy after radical prostatectomy and impact on long-term outcomes: Results from three high volume centers over the last two decades (2018) (1)
- Clinical recurrence after radical cystectomy for bladder cancer, defining optimal surveillance after surgery (2019) (1)
- Abstract PR07: Development of a biomarker-based nomogram to predict the pathologic response to neoadjuvant pembrolizumab in muscle-invasive urothelial bladder cancer (MIBC) (2020) (1)
- How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? (2022) (1)
- PIONEER consensus on clinician reported outcome measurements (2020) (1)
- Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: The impact of nephrons loss (2018) (1)
- Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study (2021) (1)
- 1340: Erectile Dysfunction Predicts Extension of Coronary Artery Disease by Angiography in Acute Coronary Syndromes. The Dead Goose Study (2006) (1)
- PD12-12 ADJUVANT RADIOTHERAPY IMPROVES CANCER-SPECIFIC SURVIVAL ONLY IN PATIENTS WITH HIGHLY AGGRESSIVE PROSTATE CANCER. VALIDATION OF RECENTLY RELEASED CRITERIA (2014) (1)
- 674 ADJUVANT RADIOTHERAPY REDUCES THE RATE OF URINARY CONTINENCE RECOVERY AFTER RADICAL PROSTATECTOMY IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS (2011) (1)
- 978 ACCEPTANCE OF AND DISCONTINUATION RATE FROM PAROXETINE TREATMENT IN PATIENTS WITH LIFELONG PREMATURE EJACULATION: AN OBSERVATIONAL SURVEY AT A MAJOR TERTIARY ACADEMIC CENTRE (2009) (1)
- Comprehensive genomic profiling (CGP) to reveal new opportunities and challenges in muscle-invasive bladder cancer (MIBC). (2021) (1)
- An Introduction on Immunotherapy in Prostate Cancer (2022) (1)
- The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients (2021) (1)
- Screening and Treating Prostate Cancer in the Older Patient: Decision Making Across the Clinical Spectrum. (2017) (1)
- Prospective evaluation of the performance of 68Ga-PSMA 11-PET CT/MRI imaging for lymph node staging in patients with biochemical recurrence after radical prostatectomy (2018) (1)
- TEN-YEAR OUTCOME OF PATIENTS RECEIVING THREE-PIECE PENILE IMPLANT FOR PEYRONIE'S DISEASE AND THEIR PARTNERS: RESULTS OF A PROSPECTIVE STUDY (2006) (1)
- Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core. (2022) (1)
- Erectile dysfunction in the aging male (2007) (1)
- Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer. (2021) (1)
- Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes (2022) (1)
- Abstract CT003: Preoperative pembrolizumab (pembro) before radical cystectomy (RC) for muscle-invasive urothelial bladder carcinoma (MIUC): Interim clinical and biomarker findings from the phase II PURE-01 study (2018) (1)
- Reply from Authors re: Michel Bolla. Adjuvant or Immediate External Irradiation After Radical Prostatectomy with Pelvic Lymph Node Dissection for High-Risk Prostate Cancer: A Multidisciplinary Decision. Eur Urol 2013;63:1009–10 (2013) (1)
- MP87-13 IMPACT OF PRE-TREATMENT PSA LEVEL ON CANCER CONTROL AFTER EARLY SALVAGE RADIATION THERAPY POST RADICAL PROSTATECTOMY: NEED FOR PATIENT STRATIFICATION ACCORDING TO PROSTATE CANCER FEATURES (2015) (1)
- The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy (2022) (1)
- Re: Alessandro Volpe, Kamran Ahmed, Prokar Dasgupta, et al. Pilot Validation Study of the European Association of Urology Robotic Training Curriculum. Eur Urol 2015;68:292-9. (2015) (1)
- IS EXTENDED PELVIC LYMPH NODE DISSECTION JUSTIFIED IN PATIENTS WITH LOW RISK PROSTATE CANCER (2008) (1)
- When to perform preoperative bone scan for kidney cancer staging (2016) (1)
- Effect of extended pelvic lymph node dissection on oncologic outcomes in D’Amico intermediate- and high-risk radical prostatectomy patients (2018) (1)
- Incidence and risk factors for venous thromboembolism after transurethral resection of bladder tumor: A population-based analysis (2017) (1)
- 621 Comparative effectiveness of robot-assisted vs. open radical prostatectomy in intermediate- and high-risk patients (2015) (1)
- 112 ACCURACY OF PERCENT FREE PSA TO PREDICT PROSTATE CANCER DIAGNOSIS IN MEN WITH TOTAL PSA RANGES LOWER THAN 2.5 NG/ML (2007) (1)
- Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. (2022) (1)
- 1831 THE NUMBER OF LYMPH NODES REMOVED IN RENAL CELL CARCINOMA DOES AFFECT CANCER SPECIFIC SURVIVAL IN SPECIFIC SUBGROUPS OF PATIENTS: RESULTS FROM A SYSTEMATIC ANALYSIS (2013) (1)
- Salvage radiation therapy after prostatectomy: Understanding the dose-response effect. (2017) (1)
- The Future of Prostate Cancer Diagnosis: Biomarkers, Biopsy, Both, or Neither? (2015) (1)
- Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series (2022) (1)
- MP77-01 WHICH PATIENTS WITH PIRADS 3 LESION AT MULTIPARAMETRIC MRI CAN AVOID PROSTATE BIOPSY? (2018) (1)
- CRITICAL ANALYSIS AND ASSESSMENT OF CLINICAL UTILITY OF NEPHROMETRY SCORES FOR THE PREDICTION OF COMPLICATIONS AFTER NEPHRON SPARING SURGERY: MP59‐05 (2017) (1)
- Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial. (2020) (1)
- 187 A competing risks analysis of long term survival on node positive prostate cancer patients treated with radical prostatectomy (2013) (1)
- Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation (2021) (1)
- 774 HEAD-TO-HEAD COMPARISON OF LYMPH NODE DENSITY AND NUMBER OF POSITIVE LYMPH NODES IN STRATIFYING THE OUTCOME OF PATIENTS WITH LYMPH NODE POSITIVE PROSTATE CANCER SUBMITTED TO RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION (2013) (1)
- 291 IN HIGH-RISK PROSTATE CANCER, A PELVIC LYMPH NODE DISSECTION WITH >20 LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY SIGNIFICANTLY IMPROVES OVERALL SURVIVAL (2011) (1)
- PD60-03 SHOULD WE RELY ON MULTIPARAMETRIC MRI OF THE PROSTATE PERFORMED AT NON-ACADEMIC CENTRES? IMPLICATIONS FOR OPTIMIZED TARGET BIOPSY APPROACHES (2019) (1)
- Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomy. (2021) (1)
- The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate Cancer (2021) (1)
- GENOMIC CLASSIFIER AUGMENTS THE ROLE OF PATHOLOGICAL FEATURES IN IDENTIFYING OPTIMAL CANDIDATES FOR ADJUVANT RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER: DEVELOPMENT AND INTERNAL VALIDATION OF A MULTIVARIABLE PROGNOSTIC MODEL: PD72‐02 (2017) (1)
- Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review (2021) (1)
- PD45-11 IDENTIFYING THE OPTIMAL DEFINITION FOR EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: A RISK-STRATIFIED APPROACH TO OPTIMIZE POSTOPERATIVE FOLLOW-UP AND THE USE OF TIMELY SALVAGE THERAPIES (2019) (1)
- Should we combine systematic with MRI-targeted biopsy? Implications for the management of patients with prostate cancer (2022) (1)
- Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27. (2020) (1)
- PD07-06 COMPARISON OF PARTIAL VS. RADICAL NEPHRECTOMY EFFECT ON OTHER CAUSE MORTALITY, CANCER SPECIFIC MORTALITY AND 30-DAY MORTALITY IN PATIENTS OLDER THAN 75 YEARS (2018) (1)
- Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival. (2022) (1)
- Words of Wisdom. Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer. (2016) (1)
- A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy--A large, retrospective, single-center study. (2022) (1)
- PD11-11 INTERIM RESULTS FROM PURE-01: A PHASE 2, OPEN-LABEL STUDY OF NEOADJUVANT PEMBROLIZUMAB (PEMBRO) BEFORE RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA (MIUC) (2018) (1)
- Gleason score 6 prostate cancer is not always harmless (2018) (1)
- Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity. (2022) (1)
- Hypospadias complexity score (HCS): A new tool for predicting operating time and complications in hypospadias surgery (2019) (1)
- Long‐term outcomes of robot‐assisted radical prostatectomy: Where do we stand? (2015) (1)
- Comparison between small renal masses 0–2cm vs. 2.1–4 cm in size: a population-based study (2020) (1)
- Words of wisdom. Re: Detection of occult nodal metastases in locally advanced node-negative prostate cancer. (2006) (1)
- The importance of negative baseline multiparametric MRI to reduce the rate of early reclassification in low-risk prostate cancer patients managed with active surveillance (2018) (1)
- 263 LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS WITH PSA <10 NG/ML: WHICH PATIENTS DESERVE A PELVIC LYMPH NODE DISSECTION? (2007) (1)
- DEVELOPMENT AND INTERNAL VALIDATION OF A NOVEL NOMOGRAM PREDICTING BLADDER CANCER SPECIFIC SURVIVAL OF PATIENTS WITH PT0 DISEASE FOLLOWING RADICAL CYSTECTOMY. RESULTS FROM A TWO INSTITUTION SERIES (2008) (1)
- Secondary analysis of PURE-01: Role of FDG-PET/CT in evaluating lymph node involvement of patients with muscle invasive bladder cancer (MIBC) receiving neoadjuvant pembrolizumab and radical cystectomy (RC). (2020) (1)
- EP-1230: The level of lymphopenia inversely correlates with the risk for late urinary toxicity after WPRTfor prostate cancer (2015) (1)
- Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058-66. (2014) (1)
- 695: There is no Significant difference between on-Demand PDE5-I Vs PDE5-I As Rehabilitative Treatment in Patients Treated by Bilateral Nerve-Sparing Radical Retropubic Prostatectomy (2006) (1)
- Peri-operative mortality and long-term survival after partial versus radical cystectomy for muscle invasive bladder cancer (2015) (1)
- 895: AMS Three-Piece Inflatable Implants for Erectile Dysfunction: A Long-Term Multi-Institutional Study in 300 Consecutive Patients (2004) (1)
- Reply to C.G. Rusthoven et al. (2015) (1)
- 697 SEX HORMONE BINDING GLOBULIN IS A SIGNIFICANT PREDICTOR OF EXTRA CAPSULAR EXTENSION IN PATIENTS UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY (2009) (1)
- Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy. (2019) (1)
- Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries. (2023) (1)
- Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi (2023) (1)
- P-04 Erectile dysfunction (2008) (1)
- MP53-16 THE MORE YOU SEE, THE MORE YOU MISS: ASSOCIATION BETWEEN PI-RADS SCORE OF THE INDEX LESION AND MULTI-FOCAL, CLINICALLY SIGNIFICANT PROSTATE CANCER (2018) (1)
- ADJUVANT VERSUS EARLY SALVAGE RADIATION THERAPY IN NODE POSITIVE PROSTATE CANCER PATIENTS: A LONG‐TERM SURVIVAL ANALYSIS: PD72‐06 (2017) (1)
- The introduction of a surgical checklist for the transurethral resection of the bladder improves recurrence-free survival in non-muscle invasive bladder cancer patients (2018) (1)
- Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course (2022) (1)
- Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer. (2022) (1)
- Radical prostatectomy versus radiotherapy in M1a and low volume M1b prostate cancer patients: an indirect comparison with the STAMPEDE trial arm H (2020) (1)
- Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis (2020) (1)
- IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time. (2022) (1)
- 115 SPONTANEOUS PERISTALTIC IN VIVO URETER ACTIVITY IS ALTERED IN RATS WITH PARTIAL URETHRAL OBSTRUCTION (2012) (1)
- 263 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS (2011) (1)
- 1008 PARTIAL CYSTECTOMY DOES NOT UNDERMINE CANCER CONTROL IN APPROPRIATELY SELECTED PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER: A POPULATION-BASED MATCHED ANALYSIS (2009) (1)
- Assessing the role of frailty status on oncologic and functional outcomes in patients treated with robot-assisted radical prostatectomy for localized prostate cancer (2022) (0)
- MP05-13 SATURATION OF THE MPMRI LESION IS NOT NECESSARY TO MINIMIZE THE RISK OF MISSING CLINICALLY SIGNIFICANT PROSTATE CANCER AT TARGETED BIOPSY. ANALYSIS OF A LARGE, MULTI-INSTITUTIONAL SERIES (2021) (0)
- 1515: Clinical Outcome and Factors Predicting Cancer Specific Survival of Patients with PT0 Disease Following Radical Cystectomy (2007) (0)
- 768 DO NODAL METASTASES INVARIABLY IMPACT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER? IMPORTANCE OF LOCAL DISEASE STATUS (2012) (0)
- 1006 The impact of a robotic programme on prostate cancer stage migration at a single tertiary referral center (2012) (0)
- The Rapidly Evolving Role of Imaging in Urology: How to Balance Breakthroughs in Knowledge with Overuse. (2016) (0)
- Grade and stage misclassification in unfavorable intermediate vs high-risk NCCC prostate cancer candidates for RT plus short vs long-term androgen ADT (2022) (0)
- Development of a procedure-specific classification system for reporting postoperative complications in prostate cancer patients undergoing robot-assisted radical prostatectomy (2019) (0)
- A HEAD TO HEAD COMPARISON OF NOMOGRAMS PREDICITNG THE PROBABILITY OF LYMPHNODE INVASION IN PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION (2009) (0)
- LOWER URINARY TRACT SYMPTOMS AFFECT CONTINENCE BUT NOT ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2008) (0)
- PD27-05 RELIABILITY OF 68GA-PSMA PET/CT IN ASSESSING REAL NODAL BURDEN IN MEN WITH CN1 DISEASE: CLINICAL IMPLICATIONS FOR PATIENT COUNSELLING AND MULTI-MODAL TREATMENTS (2022) (0)
- PD35-02 WHEN IS NEOADJUVANT ANDROGEN DEPRIVATION THERAPY BENEFICIAL FOR HIGHLY AGGRESSIVE PROSTATE CANCER CANDIDATES TO RADICAL PROSTATECTOMY? IMPLICATIONS FOR MULTI-MODAL TAILORED APPROACHES AND TRIALS DESIGN (2021) (0)
- 1244 TUMOR NECROSIS AFFECT PATIENTS SURVIVAL IN NON METASTATIC RENAL CELL CARCINOMA (2010) (0)
- 59 When to perform bilateral intrafascial nerve-sparing robot-assisted laparoscopic radical prostatectomy. Identification of the ideal candidate based on pre-operative information (2011) (0)
- O8 Senior adults have comparable cancer-specific survival rates after radical prostatectomy and pelvic lymphadenectomy when compared to their younger counterparts (2013) (0)
- Impact of molecular subtyping and immune infiltration on response and outcome following neoadjuvant pembrolizumab (pembro), versus neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (2020) (0)
- 182 Validation of the European Association of Urology guidelines for couple's infertility in terms of genetic assessment in a cohort of Caucasian-European men with primary infertility in the real-life setting (2016) (0)
- REPLY (2012) (0)
- Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve. (2023) (0)
- Incidence rates and cancer control outcomes of contemporary primary neuroendocrine prostate cancer: Analysis of SEER database (2017) (0)
- SAT-093 THE STRANGE CASE OF RENAL FUNCTION AFTER RADICAL NEPHRECTOMY: A FOGGY FORECAST (2020) (0)
- MP58-08 CONCORDANCE OF RENAL SINUS OR CALYCES INVASION BETWEEN PREOPERATIVE IMAGING AND FINAL PATHOLOGY AFTER SURGERY FOR KIDNEY CANCER (2023) (0)
- 1048 DEVELOPMENT AND INTERNAL VALIDATION OF NOMOGRAMS PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH HIGH RISK DISEASE. RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS (2011) (0)
- Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis. (2021) (0)
- 68Ga PSMA PET/CT for staging high risk prostate cancer patients suitable for radical treatments: Effective clinic implication and preliminary diagnostic performance (2021) (0)
- Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer. (2023) (0)
- When is central histological review of prostate biopsy really needed to reduce the risk of misclassification of prostate cancer? The importance of patient risk stratification (2023) (0)
- 401 LEARNING CURVE IS ENDLESS: BIOCHEMICAL RECURENCE RATES KEEP VARYI NG AMONG HIGH VOLUME RADICAL RETROPUBIC PROSTATECTOMY SURGEONS (2009) (0)
- SURGICAL TREATMENT FOR CLINICAL NODE POSITIVE BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY: MP58‐19 (2017) (0)
- African American vs. Caucasian race/ethnicity in adrenocortical carcinoma patients. (2023) (0)
- Can we modulate the extent of nodal dissection according to the preoperative risk of lymph node invasion in prostate cancer patients undergoing radical prostatectomy (2017) (0)
- 1122 DEVELOPMENT OF A NOVEL PREOPERATIVE NOMOGRAM INCLUDING THE BIOMARKER MICRO-RNA 221 - PREDICTING CANCER SPECIFIC MORTALITY IN HIGH RISK PROSTATE CANCER (2012) (0)
- EP-2053: In-vivo imaging of rat leukocytes redistribution after pelvic irradiation (2016) (0)
- DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients. (2020) (0)
- PD33-10 THE PRESENCE OF RESIDUAL CARCINOMA IN SITU ALONE (PTIS) IN PATIENTS TREATED WITH RADICAL CYSTECTOMY DOES NOT AFFECT LONG TERM RECURRENCE AND SURVIVAL RATES (2016) (0)
- Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era? (2020) (0)
- ARE IN VITRO FERTILIZATION TECHNIQUES OF INTEREST TO PATIENTS TREATED FOR GERM-CELL TESTICULAR CANCER? (2009) (0)
- Identifying the optimal postoperative strategies for clinically node positive patients treated with radical prostatectomy and extended pelvic lymph node dissection: Is androgen deprivation therapy always mandatory? (2019) (0)
- 467 Are the effort towards prostate cancer early detection associated with a significant reduction in tumor volume? An analysis stratified according to risk categories (2013) (0)
- MP55-14 THE IMPACT OF TREATMENT MODALITY ON SURVIVAL IN PATIENTS WITH CLINICAL NODE POSITIVE BLADDER CANCER (2020) (0)
- MP11-08 EXPLORING THE EFFECT OF METASTASIS DIRECTED THERAPY ON PROGRESSION PATTERNS OF PATIENTS WITH POSITIVE 68Ga-PSMA PET/CT AND BIOCHEMICAL RECURRENCE FROM PROSTATE CANCER (2023) (0)
- 832 VALUE OF EXTENDED LYMPH NODE DISSECTION IN NODE POSITIVE HIGH-RISK LOCALIZED PROSTATE CANCER IS UNCERTAIN (2010) (0)
- 35 How to expand indications for active surveillance without compromising cancer control: A systematic assessment of the currently used criteria for prostate cancer patients (2014) (0)
- Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy (2020) (0)
- PD60-12 THE IMPACT OF FRAILTY STATUS ON SURGICAL OUTCOMES AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY - A PROSPECTIVE ASSESSMENT USING A STANDARDIZED COLLECTION SYSTEM FOR PERIOPERATIVE OUTCOMES (2022) (0)
- 743 CONCORDANCE BETWEEN CLINICAL AND PATHOLOGICAL LYMPH NODE INVASION IN RENAL CELL CARCINOMA (2013) (0)
- Defining the optimal target-to-background count rate to identify positive lymph nodes in patients undergoing robot-assisted 99mtc-PSMA-radioguided surgery for prostate cancer: A per-region analysis of a prospective, phase II study (2023) (0)
- Individualized risk stratification of patients candidate to radical prostatectomy based on clinical and multi-parametric MRI parameters: Beyond the conventional clinical risk models (2021) (0)
- Re: Thulium Laser Transurethral Vaporesection of the Prostate Versus Transurethral Resection of the Prostate for Men with Lower Urinary Tract Symptoms or Urinary Retention (UNBLOCS): A Randomised Controlled Trial. (2020) (0)
- 371 Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy: Results from a single institution series (2015) (0)
- 169 Impact of prostate volume on the risk of biochemical recurrence after radical prostatectomy (2014) (0)
- Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics (2021) (0)
- PD47-09 FIRST SURVIVAL OUTCOMES AND ADDITIONAL SECONDARY ANALYSES FROM PURE-01: PEMBROLIZUMAB (PEMBRO) BEFORE RADICAL CYSTECTOMY (RC) IN MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA (MIBC) (2019) (0)
- Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort. (2021) (0)
- Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT) (2019) (0)
- MP36-14 IS ONE TARGETED BIOPSY CORE OF THE INDEX LESION SUFFICIENT TO ACCURATELY DETECT CLINICALLY SIGNIFICANT PROSTATE CANCER ACROSS ALL PI-RADS SCORES? (2019) (0)
- Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model (2017) (0)
- Impact of radiologist expertise on PI-RADS distribution and detection of clinically significant prostate cancer: Results from a single, high volume center (2023) (0)
- Development and external validation of a novel model to identify patients with equivocal lesion at multiparametric MRI who can avoid prostate biopsy (2019) (0)
- 436 The time elapsed between radical prostatectomy and postoperative radiotherapy has a significant impact on the subsequent recovery of erectile function (2016) (0)
- MP18-19 DIFFICULT URETERAL ACCESS IN CANDIDATES TO URETEROSCOPY FOR URINARY STONES: RESULTS AND TECHNICAL TRICKS ADOPTED IN A TERTIARY REFERRAL CENTRE (2021) (0)
- The Authors Respond. (2016) (0)
- MP82-01 LONG-TERM OUTCOMES OF VERY HIGH RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY WITH OR WITHOUT ADJUVANT TREATMENTS. RESULTS OF A COMPETING RISKS, MULTI INSTITUTIONAL ANALYSIS (2015) (0)
- Salvage radiotherapy for patients with rising PSA. (2016) (0)
- 723 ADJUVANT RADIOTHERAPY REDUCES THE RATE OF URINARY CONTINENCE RECOVERY AFTER RADICAL PROSTATECTOMY IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS (2011) (0)
- MP56-05 EARLY POST-OPERATIVE PSA AFTER RADICAL PROSTATECTOMY IS A MAJOR PREDICTOR OF PROGRESSION AND DEATH IN PATIENTS WITH LYMPH NODE METASTASES. RESULTS FROM A TERTIARY CARE CENTER (2015) (0)
- Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer? (2023) (0)
- MP80-01 THE SURGICAL LEARNING CURVE FOR POSITIVE SURGICAL MARGINS AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY: RESULTS FROM A MULTI-INSTITUTIONAL COLLABORATION (2022) (0)
- 936 Has the new edition of the TNM improved the lymph node staging for renal cell carcinoma (2014) (0)
- MP09-02 ADDED VALUE OF MPMRI, MRI-TARGETED AND SYSTEMATIC BIOPSY IN THE PREDICTION OF ADVERSE PATHOLOGIC FEATURES IN CONTEMPORARY PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2019) (0)
- Care pathways for the management of localised and locally advanced prostate cancer: Experience of the EAU guidelines office (2018) (0)
- PD08-04 A NOVEL PROGNOSTIC MODEL FOR PATIENTS UNDERGOING SALVAGE RADIOTHERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2021) (0)
- LACK OR RELIABILITY OF RECOLLECTED INTERNATIONAL INDEX OF ERECTILE FUNCTION DOMAINS IN CANDIDATES TO RADICAL PROSTATECTOMY (2006) (0)
- Reply by Authors. (2019) (0)
- 570 The effect of preoperative cancer aggressiveness on learning curve among high volume surgeons performing radical retropubic prostatectomy: You never stop getting better in challenging cases (2012) (0)
- PROPOSAL AND VALIDATION OF A DYNAMIC CRITERION FOR PATIENT INCLUSION IN KIDNEY CANCER ACTIVE SURVEILLANCE PROTOCOLS: PD59‐08 (2017) (0)
- 1046 THREE OR MORE POSITIVE NODES AT RADICAL PROSTATECTOMY REPRESENT A SIGNIFICANT CUT-OFF VALUE FOR CSS IN HIGH-RISK PROSTATE CANCER, WHILE 1 OR 2 POSITIVE NODES DO NOT INFLUENCE CSS (2011) (0)
- Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse (2022) (0)
- IMPACT OF RATIO BETWEEN GLAND SIZE AND NUMBER OF BIOPSY CORES ON REPEAT PROSTATE BIOPSY: DEVELOPMENT AND INTERNAL VALIDATION OF A NEW REPEAT BIOPSY NOMOGRAM IN MEN ASSESSED WITH 10 OR MORE CORES (2006) (0)
- The ability of three comorbity indeces to predict postosperative mortality in renal cell carcinoma patients: The impending need of a new disease-specific index (2017) (0)
- 640 Current trends in management of high-risk prostate cancer in Europe: Results of a web-based survey by the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology (2014) (0)
- Definition and impact on oncologic outcomes of persistently elevated PSA after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Clinical Implications for multi-modal therapy (2021) (0)
- Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis. (2023) (0)
- THE IMPACT OF BASELINE SERUM TESTOSTERONE ON THE RISK OF BIOCHEMICAL FAILURE AFTER DEFINITIVE RADIATION THERAPY FOR PROSTATE CANCER: MORE FAVOURABLE ONCOLOGICAL OUTCOMES IN HYPOGONADAL INVIDIDUALS: MP05‐08 (2017) (0)
- MP62-01 FUNCTIONAL OUTCOMES IN PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER (PCA) TREATED WITH ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) (2015) (0)
- Dose-effect relationship for 1-year incontinence after post-prostatectomy intensity-modulated radiotherapy (MRT) (2019) (0)
- MP15-01 CONTEMPORARY ANALYSIS OF MEDICARE REIMBURSEMENTS RELATED TO TREATMENT OF LOCALIZED PROSTATE CANCER (2016) (0)
- P0729AKARDI: A NEW PREDICTIVE MODEL FOR RENAL DECAY AFTER NEPHRECTOMY (2020) (0)
- Re: Comparison of Initial Experience with Transrectal MRI Cognitive Guided Micro-ultrasound Biopsies versus Established Transperineal Robotic Ultrasound-Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer. (2020) (0)
- PD16-05 THE INVERSE CORRELATION BETWEEN OBESITY AND MORTALITY IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER: RESULTS FROM THE CONTROL ARMS OF ASCENT2, MAINSAL AND VENICE TRIALS (2020) (0)
- Re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.026. (2021) (0)
- Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database (2022) (0)
- MP48-01 HOW TO OPTIMIZE PATIENT SELECTION BEFORE SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENT PROSTATE CANCER: A NOVEL RISK STRATIFICATION TOOL (2022) (0)
- Reply by Authors. (2021) (0)
- 1054 A novel tool for the prediction of urinary incontinence after bilateral nerve sparing radical prostatectomy (2012) (0)
- The prognostic role of 68Ga-PSMA PET/CT and the impact of metastasis-directed therapy on cancer progression in men with biochemical recurrence from prostate cancer. Results from a large, single Institution series (2023) (0)
- Immediate and early postoperative complications after ureteroscopy and ho: Yag laser lithotripsy for urinary stones: Real-life findings from a single centre series (2019) (0)
- Proposal and validation of a dynamic criterion for patient inclusion in kidney cancer active surveillance protocols (2017) (0)
- Ureteral stenting does not increase the risk of metachronous upper tract urothelial carcinoma in patients with bladder cancer presenting with hydronephrosis in comparison with percutaneous nephrostomy: A multicenter analysis (2021) (0)
- A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer. (2023) (0)
- POST-OPERATIVE ORGASMIC FUNCTION INCREASES OVER TIME IN PATIENTS SUBMITTED TO BILATERAL NERVE SPARING OPEN RADICAL PROSTATECTOMY (2009) (0)
- Pelvic Lymph Node Dissection for Prostate Cancer and Nomograms (2018) (0)
- DEVELOPMENT AND EXTERNAL VALIDATION OF AN EUROPEAN POST-OPERATIVE NOMOGRAM PREDICTING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2008) (0)
- 340 LONG TERM DIABETES MELLITUS INCREASES THE RISK OF POORLY DIFFERENTIATED TUMOR IN PROSTATE CANCER PATIENTS (2013) (0)
- Re: Jana S. Hopstaken, Joyce G.R. Bomers, Michiel J.P. Sedelaar, et al. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol 2022;81:5-33. (2022) (0)
- 707 DEVELOPMENT AND INTERNAL VALIDATION OF NOMOGRAMS PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH HIGH RISK DISEASE. RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS (2011) (0)
- 1009: Comparison of Holmium Laser, Cold Knife AD Diatermic Incision for the Endoscopic Treatment of Anastomotic Stricture After Radical Retropubic Prostatectomy (2007) (0)
- PO-0852: External validation of a TCP model predicting PSA relapse after post-prostatectomy Radiotherapy (2017) (0)
- 2204 HOW TO EXPAND INDICATIONS FOR ACTIVE SURVEILLANCE WITHOUT COMPROMISING CANCER CONTROL. THE IMPORTANCE OF THE EXTENT OF BIOPSY SAMPLING (2012) (0)
- MP21-04 THE EFFECT OF AGE ON CANCER-SPECIFIC MORTALITY IN T1A STAGE RENAL CELL CARCINOMA PATIENTS ACROSS ALL TREATMENT’S MODALITIES: A SEER-BASED STUDY (2020) (0)
- 782 Assessing the role of time from prostate cancer diagnosis to radical prostatectomy: Can surgery be postponed safely? (2016) (0)
- Is individual surgeon experience the optimal measure to assess learning curve during robot-assisted radical prostatectomy? (2016) (0)
- 455 A detailed analysis on the association between post-operative phosphodiesterase type 5 inhibitors use and the risk of biochemical recurrence after radical prostatectomy (2015) (0)
- 1012 Evaluation of lymph node recurrent prostate cancer with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: Validation by histological analysis (2012) (0)
- P0249ESSFSFDSVXVXCVXVVVVDVDDDCVVV (2020) (0)
- Is the ICIQ-SF questionnaire reliable in predicting QoL outcomes: Results of a prospective single-center study (2018) (0)
- A patient tailored follow-up protocol for men with prostate cancer managed with active surveillance with the use of multiparametric magnetic resonance imaging: Identifying predictors of early and late reclassification in a large single institution cohort (2023) (0)
- 507Normative androgens values throughout the menstrual cycle in healthy fertile women with normal sexual function (2005) (0)
- The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials (2020) (0)
- MP70-21 ASSESSING THE OPTIMAL POST-OPERATIVE MANAGEMENT OF NODE POSITIVE PROSTATE CANCER PATIENTS:RESULTS FROM MULTI-INSTITUTIONAL SERIES (2014) (0)
- Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages (2023) (0)
- MP14-07 RADIOMIC AND GENOMIC APPROACHES FOR THE ENHANCED DIAGNOSIS OF RENAL CANCER (REDIRECT): A TRANSLATIONAL PILOT STUDY (2019) (0)
- 2111 SERUM SEX STEROIDS DEPICT A NON LINEAR U-SHAPED ASSOCIATION WITH HIGH RISK PROSTATE CANCER AT RADICAL PROSTATECTOMY - IMPLICATIONS FOR INDIVIDUALIZED HORMONAL THERAPY (2012) (0)
- Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: a stage-specific analysis from a large multi-institutional series (2020) (0)
- OC-0053: Factors predicting Grade 3-4 late urinary toxicity in 1176 patients treated with post-prostatectomy irradiation (2013) (0)
- MP43-12 ASSESSING THE NEED FOR SYSTEMATIC BIOPSIES IN ADDITION TO TARGETED BIOPSIES ACCORDING TO THE VOLUME OF THE INDEX LESION DIAGNOSED AT MPMRI. RESULTS FROM A LARGE, MULTI-INSTITUTIONAL DATABASE (2021) (0)
- Oncologic surveillance for variant histology upper tract urothelial carcinoma (2022) (0)
- PD57-11 IDENTIFICATION OF THE BEST CANDIDATES FOR PSMA PET/CT AMONG PATIENTS EXPERIENCING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2021) (0)
- When to omit lymphadenectomy during radical prostatectomy in patients with clinical localized prostate cancer: A clinical net benefit analysis weighting staging accuracy, risk of morbidity and life expectancy (2020) (0)
- 865: Public-Awareness does not Promote Shortening of the Delay in Seeking First Medical Help for Erectile Dysfunction (ED) in the PDE5-Is ERA. Preliminary Results at Single Major Tertiary Academic Centre (2007) (0)
- Systematic review and meta-analysis of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma (2018) (0)
- 533 Impact on post-operative survival of the status of distal ureteral margin. Is it necessary to achieve a negative margins at the time of radical cystectomy? (2015) (0)
- 448 Is a well-performed robot-assisted radical prostatectomy the real focal therapy for the treatment of clinically localized prostate cancer? (2016) (0)
- COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F‐FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI‐CENTER STUDY: PD11‐01 (2017) (0)
- PD17-01 DERIVATION AND EXTERNAL VALIDATION OF A RAPID RISK SCORE FOR PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH AN MRI VISIBLE LESION: A MULTINATIONAL COHORT STUDY (2022) (0)
- EFFICACY OF SILDENAFIL 100 MG ON DEMAND IN PATIENTS UNDERGOING BILATERAL NERVE-SPARING RADICAL PROSTATECTOMY IS BASED ON PRECISE PREDICTING FACTORS (2006) (0)
- MP57-14 PROSTATE BIOPSY CENTRALIZATION AT HIGH VOLUME, TERTIARY CARE CENTERS REPRESENTS THE MOST REFINED DIAGNOSTIC TOOL FOR PROSTATE CANCER PATIENTS: RESULTS FROM A PROSPECTIVE SERIES (2018) (0)
- Magnetic Resonance Imaging and Ultrasound Fusion Biopsy in follow-up of patients in Active Surveillance protocol. Can PSA density discriminate patients at higher risk of reclassification? (2019) (0)
- PD28-06 SURVIVAL OUTCOMES IN OCTOGENARIAN AND NONAGENARIAN PATIENTS TREATED WITH FIRST-LINE ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER (2016) (0)
- Pattern of positive node metastases in patients treated with extended and super extended pelvic lymph node dissection and radical cystectomy due to bladder cancer (2017) (0)
- 566 THE NUMBER OF POSITIVE NODES IS THE STRONGEST PREDICTOR OF CANCER-SPECIFIC MORTALITY IN PATIENTS WITH POSITIVE LYMPH NODES AFTER RADICAL PROSTATECTOMY. LOCATION AND LATERALITY DO NOT COUNT (2011) (0)
- 518 Contemporary analysis of comorbid diseases used to define Charlson comorbidity index score among radical cystectomy candidates (2016) (0)
- Re: Idir Ouzaid and Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. Eur Urol 2015;68:542-3. (2016) (0)
- Treatment patterns and outcomes of patients with penile squamous-cell carcinoma (PSCC) undergoing inguinal lymph node dissection (ILND): An analysis of a multicenter contemporary database. (2020) (0)
- 180 [11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY (2012) (0)
- Recurrence and progression according to stage at re-TUR in t1g3 bladder cancer patients treated with BCG: Not as bad as previously thought (2017) (0)
- 962 PREDICTION OF LONG-TERM CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH LYMPH NODE INVASION: RESULTS OF CONDITIONAL SURVIVAL ANALYSES (2013) (0)
- Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities (2023) (0)
- Selective cytology in detection of high grade upper urinary tract urothelial cancer: A systematic review and meta-analysis (2019) (0)
- MP08-14 LONG TERM OUTCOMES OF REPEATED MITOMYCIN C INSTILLATION IN LOW RISK AND INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS (2023) (0)
- 20 A HEAD TO HEAD COMPARISON OF NOMOGRAMS PREDICTING THE PROBABILITY OF LYMPHNODE INVASION IN PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION (2009) (0)
- 271 Lymph nodes in prostate cancer patients treated with radical prostatectomy: Oncological outcomes of patients with positive nodes and complications of an extended pelvic lymphadenectomy with robotic assisted approach: Results from a single tertiary care center (2014) (0)
- Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries (2022) (0)
- MP40-07 HAS THE INTRODUCTION OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE AND TARGETED BIOPSIES LED TO A RISK OF OVERGRADING OF HIGH RISK PROSTATE CANCER? RESULTS FROM A CONTEMPORARY LARGE MULTI-INSTITUTIONAL SERIES. (2023) (0)
- Increasing trend of non-interventional treatment management in patients candidate to active surveillance with localized prostate cancer (2018) (0)
- 456 Patterns of clinical recurrence and impact of site of metastasis on mortality of patients with node positive prostate cancer after radical prostatectomy and extended pelvic lymph node dissection (2015) (0)
- PD16-04 RADICAL PROSTATECTOMY VERSUS RADIOTHERAPY IN M1A AND LOW VOLUME M1B PROSTATE CANCER PATIENTS: AN INDIRECT COMPARISON WITH THE STAMPEDE TRIAL ARM H (2020) (0)
- The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma (2022) (0)
- 217 DOES BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY AND ADJUVANT RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER INVARIABLY IMPACT CANCER-SPECIFIC MORTALITY? (2011) (0)
- PD58-10 IMPLEMENTING THE FOLLOW-UP SCHEDULE AFTER RADICAL NEPHROURETRECTOMY FOR LOW RISK UPPER TRACT UROTHELIAL CARCINOMA (2022) (0)
- 751 IMPACT OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH PT3A PROSTATE CANCER: SURGICAL MARGINS COUNT (2009) (0)
- The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate Cancer (2021) (0)
- 567 MORE EXTENSIVE PELVIC LYMPH NODE DISSECTION IS ASSOCIATED WITH REDUCED RISK OF CANCER PROGRESSION IN NODE NEGATIVE ORGAN CONFINED PROSTATE CANCER PATIENTS (2011) (0)
- Prognostic differences in patients with T1a renal cell carcinoma according to clinical size (2020) (0)
- DOES PROSTATE CANCER REPRESENT THE MAIN CAUSE OF DEATH IN ALL NODE POSITIVE PROSTATE CANCER PATIENTS? THE IMPACT OF COMPETING CAUSES OF MORTALITY ACCORDING TO TUMOR CHARACTERISTICS AND RECURRENCE STATUS: PD03‐03 (2017) (0)
- 771 IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION (2013) (0)
- 1002 The 2011 national comprehensive cancer network guidelines recommendations for pelvic lymph node dissection in prostate cancer patients are not accurate. A plea for renewal (2012) (0)
- MP57-04 ASSOCIATION BETWEEN FAMILY HISTORY AND ONCOLOGIC OUTCOMES AFTER RADICAL PROSTATECTOMY FOR CLINICALLY NONMETASTATIC PROSTATE CANCER (2022) (0)
- MP14-08 LONG-TERM IMPACT OF ADJUVANT VERSUS EARLY SALVAGE RADIATION THERAPY ON CLINICAL RECURRENCE IN PT3N0 PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS (2016) (0)
- How to maximize the diagnostic rate of endoscopic biopsy during flexible ureteroscopy for upper tract urothelial carcinoma (2022) (0)
- Impact of perioperative complications on length of hospitalizations, readmission rate and treatment failure after urethroplasty (2021) (0)
- MP17-07 INCREASING RATE OF NON-INTERVENTIONAL TREATMENT MANAGEMENT IN LOCALIZED PROSTATE CANCER CANDIDATES FOR ACTIVE SURVEILLANCE (2018) (0)
- PD60-04 SURVIVAL AFTER RADICAL PROSTATECTOMY VS. RADIATION THERAPY IN CLINICAL NODE-POSITIVE PROSTATE CANCER (2022) (0)
- 995 A MULTICENTER PROSPECTIVE SURVEY TO IDENTIFY THE PREDICTORS OF CONTINENCE RECOVERY 1 MONTH AFTER RADICAL PROSTATECTOMY (2011) (0)
- Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines. (2022) (0)
- 1656 IMPACT OF THE INVASION OF PERINEPHRIC OR RENAL SINUS FAT IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2010) (0)
- Re: The MRI in Active Surveillance "MRIAS" Trial: Use of Baseline mpMRI and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies. (2020) (0)
- Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients (2020) (0)
- The association of type and number of d’amico high-risk criteria with rates of pathologically non organ confined prostate cancer (2022) (0)
- Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer (2023) (0)
- 170 Hypogonadism independently predicts pathological Gleason pattern 5 at the time of radical prostatectomy (2016) (0)
- Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in patients with pN+ bladder cancer (2021) (0)
- 1801: Atypical Small Acinar Proliferation (ASAP) on Initial Extended Prostate Biopsy: Cancer Detection on Second and Tidrd Extended Biopsy (2004) (0)
- MP47-13 AN UNACKNOWLEDGED CLINICAL DEPRESSION IS HIGHLY PREVALENT IN TESTOSTERONE DEFICIENT CAUCASIAN-EUROPEAN MEN SEEKING MEDICAL HELP FOR SEXUAL DYSFUNCTION (2016) (0)
- Regression-tree analysis for identifying the best candidates to neoadjuvant chemotherapy in patients with clinical node-positive penile squamous-cell carcinoma (2020) (0)
- A Critical assessment of extracorporeal shock-wave therapy for Peyronie’s disease (2004) (0)
- Reply by Authors. (2021) (0)
- PH-0660 Independent role of dose-escalation and prophylactic WPRT in salvage RT after radical prostatectomy (2021) (0)
- 68Ga-Prostate-Specific Membrane Antigen PET Radiomics For the Prediction of PostSurgical International Society of Urological Pathology Grade in Patients with Primary Prostate Cancer (2023) (0)
- MP40-19 HOW TO IDENTIFY PATIENTS SUITABLE FOR CONSERVATIVE MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA (UTUC) ACCORDING TO TUMOR SIZE: IMPLICATIONS FOR CLINICAL GUIDELINES (2022) (0)
- MP36-11 WHICH CANCERS ARE STILL DIAGNOSED BY STANDARD PROSTATE BIOPSY WITHOUT AN UPFRONT MULTIPARAMETRIC MRI? RESULTS FROM A TERTIARY CARE, HIGH VOLUME CENTRE (2019) (0)
- Effect of the number of removed lymph nodes on prostate cancer recurrence and survival: evidence from an observational study (2018) (0)
- Estimated glomerular filtration rate: Do we measure the real renal function or are we still groping in the dark? (2018) (0)
- 965: Extended Lymphadenectomy Should be Performed in Patients with PSA≥6, Biopsy Gleason Score 7-10 and Stage T2 or Higher Prostate Cancer (2006) (0)
- with High-Risk Prostate Cancer: a Population-Based Study (2014) (0)
- Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC). (2020) (0)
- MP82-17 ONCOLOGICAL OUTCOMES IN PN1 PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) (2015) (0)
- Is there a role for pure clinical prediction models in prostate cancer in the contemporary era? (2017) (0)
- A novel model Integrating clinical, mp-MRI, and epigenomic features to predict lymph node invasion in prostate cancer patients undergoing radical prostatectomy and pelvic lymph node dissection (2023) (0)
- IMPACT OF INTRA‐ AND POST‐OPERATIVE BLOOD TRANSFUSION ON THE INCIDENCE, TIMING AND PATTERN OF DISEASE RECURRENCE AFTER RADICAL CYSTECTOMY: MP58‐11 (2017) (0)
- Comparison of salvage radiation therapy delivered for PSA persistence versus PSA relapse after radical prostatectomy: How is the outcome changing? (2021) (0)
- Efficacy and toxicity of antibody-drug conjugates (ADCs) in the treatment of metastatic urothelial cancer (mUC): A systematic review. (2022) (0)
- The impact of variant histology on the probability of lymph node involvement at imaging: CT scan vs FDG PET (2022) (0)
- Molecular subtyping and immune-gene signatures identify a subset of clinical T1 high-grade (cT1 HG) and cT2 bladder urothelial carcinoma (UC) as candidates for single-agent immune checkpoint inhibition (ICI) (2020) (0)
- OC-0222: GnRH receptor blockade reduces radiation-induced bladder toxicity: first evidence in a rat model (2017) (0)
- Radiation therapy after radical prostatectomy is associated with higher other-cause mortality (2021) (0)
- MP58-19 DETECTION OF PULMONARY LESION DURING FOLLOW-UP AFTER SURGERY FOR LOCALIZED RENAL CELL CARCINOMA: DISEASE PROGRESSION OR A PRIMARY LUNG CANCER? (2023) (0)
- 1007 ARE THE EAU GUIDELINES ON PROSTATE CANCER FOLLOWED BY ITALIAN UROLOGISTS? RESULTS FROM THE M.I.R.R.O.R. (MULTICENTER ITALIAN REPORT ON RADICAL PROSTATECTOMY OUTCOMES AND RESEARCH) GROUP (2010) (0)
- Frailty status predicts worse postoperative outcomes and long-term oncologic outcomes in patients treated with partial nephrectomy (2022) (0)
- MP49-18 PRE-OPERATIVE RISK CALCULATOR OF THE PROBABILITY OF COMPLETING NEPHRON-SPARING SURGERY FOR KIDNEY CANCER: THE KEY ROLE OF TUMOR COMPLEXITY AND APPROACH (2021) (0)
- Is one targeted biopsy core of the index lesion sufficient to accurately detect clinically significant prostate cancer across all PI-RADS scores? (2019) (0)
- MP73-05 WHEN TO PERFORM A STAGING CHEST-CT SCAN BEFORE SURGICAL TREATMENT FOR KIDNEY CANCER (2016) (0)
- MP43-18 EARLY REGULAR TREATMENT WITH A CANNABINOID 2 RECEPTOR AGONIST PROTECTED ERECTILE FUNCTION IN A RAT MODEL OF CAVERNOUS NERVE CRUSH INJURY (2014) (0)
- External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study (2020) (0)
- 565: 30-Day Mortality after Radical Prostatectomy in Over 9000 Patients: Validation of a Predictive Nomogram (2007) (0)
- 155 [11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING (2010) (0)
- 439 When is tumour volume an exclusion criteria for focal therapy? Results from a radical prostatectomy series (2016) (0)
- PD27-08 PREDICTORS OF EARLY FAILURE AFTER TIMELY ADMINISTERED SALVAGE RADIOTHERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2014) (0)
- Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies (2019) (0)
- MP64-02 THE KEY ROLE OF LEVATOR ANI THICKNESS FOR EARLY URINARY CONTINENCE RECOVERY IN PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL STUDY (2021) (0)
- PD30-06 ASSESSING THE ROLE OF TIME FROM PROSTATE CANCER DIAGNOSIS TO RADICAL PROSTATECTOMY: CAN SURGERY BE POSTPONED SAFELY? (2016) (0)
- PD38-04 PATIENTS ADHERING TO STANDARDIZED PROTOCOLS FOR FUNCTIONAL OUTCOME ASSESSMENT AFTER RADICAL PROSTATECTOMY SHOW HIGHER RATES OF RETURN TO PRE-OPERATIVE STATUS: IMPLICATIONS FOR POSSIBLE SELECTION BIASES (2018) (0)
- Reply to M. Valerio et al. (2014) (0)
- 783 Local anaesthesia in trans-rectal biopsy of prostate: EMLA® vs. placebo (2004) (0)
- The learning curve of mpMRI targeted biopsy for the detection of clinically significant prostate cancer is related to the characteristics of the index lesion (2021) (0)
- 634 Long-term survival patterns of young patients with high risk prostate cancer treated with radical prostatectomy. Results of a multi-institutional, conditional survival analysis (2015) (0)
- 1203 WHICH IS THE BEST DEFINITION OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY? ANALYSIS OF PATIENT SATISFACTION (2010) (0)
- PD15-07 ASSESSING THE OPTIMAL EXTENT OF SALVAGE LYMPH NODE DISSECTION IN PATIENTS WITH SINGLE PELVIC NODAL UPTAKE AT [11C]-CHOLINE PET/CT SCAN FROM RECURRING PROSTATE CANCER (2014) (0)
- MP67-04 VALIDATION OF NOVEL PREOPERATIVE RISK CATEGORIES ON THE PREDICTION OF CLINICAL RECURRENCE IN PATIENTS CANDIDATE FOR RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER. RESULTS OF A LARGE, MULTI-INSTITUTIONAL SERIES (2023) (0)
- MP64-05 A NEW MODEL FOR PREDICTION OF HIGH-RISK FEATURES AMONG UNFAVORABLE INTERMEDIATE RISK PROSTATE CANCER PATIENTS (2021) (0)
- Defining clinically meaningful positive surgical margins in patients undergoing radical prostatectomy for localized prostate cancer: A stage-by-stage analysis on the risk of clinical recurrence (2018) (0)
- 1065 PREDICTORS OF ONCOLOGIC OUTCOMES AFTER SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT PROSTATE CANCER: A MULTI-INSTITUTIONAL COLLABORATION (2010) (0)
- Independent role of dose-escalation and prophylactic lymph-nodal irradiation in salvage radiotherapy after prostatectomy. A retrospective, multi-institute analysis on 725 men treated with high-dose radiotherapy and eight years follow-up (2021) (0)
- When is mp-MRI reliable in predicting extra-prostatic extension in prostate cancer patients treated with radical prostatectomy? Results from a large, multi-institutional series (2020) (0)
- MP12-06 ONCOLOGIC OUTCOMES IN PATIENTS DIAGNOSED WITH pT3aN0M0 RENAL CELL CANCER ACCORDING TO RENAL VEIN THROMBUS OR FAT INVASION (2022) (0)
- 631 WHICH ARE THE PATIENTS AT RISK TO RECUR BEYOND 10 YEARS AFTER RADICAL PROSTATECTOMY (2009) (0)
- Added value of concomitant systematic biopsies in predicting upgrading in patients with localized prostate cancer diagnosed by MRI-targeted biopsy: Implications for patient selection (2019) (0)
- MP60-18 THE NUMBER OF TRANSURETHRAL RESECTIONS IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH MUSCLE- INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY (2014) (0)
- 870 LYMPHATIC SPREAD OF NODAL METASTASES IN PROSTATE CANCER: A MAPPING SINGLE-INSTITUTION STUDY (2010) (0)
- When should salvage radiation therapy be associated with concomitant hormonal therapy in patients affected by prostate cancer? The key role of PSA doubling time (2018) (0)
- 744 TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE (2009) (0)
- 621 THE NUMBER OF BIOPSY CORES REPRESENTS ONE OF THE FOREMOST PREDICTOR OF CLINICALLY SIGNIFICANT GLEASON SUM UPGRADING IN LOW RISK PROSTATE CANCER PATIENTS (2009) (0)
- IMPACT OF STAGE MIGRATION ON METASTATIC PROSTATE CANCER: EVIDENCE OF MORE FAVOURABLE DISEASE CHARACTERISTICS OVER TIME: PD37‐05 (2017) (0)
- What is the best definition of biochemical response to salvage radiation therapy in prostate cancer patients treated for PSA rising after radical prostatectomy? Results from a multi-institutional series (2019) (0)
- Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer (2022) (0)
- MP61-14 PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: UPDATED RESULTS OF PLANNED INTERIM ANALYSES OF A PROSPECTIVE PHASE 2 STUDY (2023) (0)
- FIRST REPEATED BIOPSY REPRESENTS THE MOST INFORMATIVE PREDICTOR OF PROGRESSION‐FREE SURVIVAL AT 3 YEARS FOLLOW‐UP IN PATIENTS INCLUDED IN AN ACTIVE SURVEILLANCE PROTOCOL FOR LOW‐RISK PROSTATE CANCER: MP77‐16 (2017) (0)
- 153P Efficacy and toxicity of HER2-targeted antibody-drug conjugates (ADCs) in the treatment of metastatic urothelial cancer (mUC): A systematic review (2022) (0)
- MP56-10 LONG-TERM SURVIVAL PATTERNS OF YOUNG PATIENTS WITH HIGH RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY. RESULTS OF A MULTI INSTITUTIONAL, CONDITIONAL SURVIVAL ANALYSIS (2015) (0)
- Multiparametric magnetic resonance imaging in fusion with transrectal ultrasound for targeted prostate biopsy by BioJet™ System. Technical details and results (2016) (0)
- NOT ALL MPMRI TARGETED BIOPSIES ARE EQUAL: THE IMPACT OF THE TYPE OF APPROACH AND OPERATOR EXPERTISE ON THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: MP03‐05 (2017) (0)
- The current role of renal tumor biopsy in the management of small renal masses: Long-term results from a prospective, single-institutional database (2023) (0)
- 694 Prediction of long-term cancer recurrence after radical prostatectomy in patients with lymph node invasion: Results of conditional survival analysis (2013) (0)
- Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. (2023) (0)
- 529 CANCER SPECIFIC OUTCOMES OF PATIENTS WITH GLEASON 8-10 AT RADICAL PROSTATECTOMY: RESULTS OF A SINGLE-INSTITUTION SERIES (2009) (0)
- PD16-05 A SYSTEMATIC REVIEW TO EVALUATE PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR METASTATIC PROSTATE CANCER ACCORDING TO THE COSMIN METHODOLOGY: A PIONEER WP2 PROJECT (2023) (0)
- 329: When to Perform a Bone Scan in Patients with Prostate Cancer. A novel Nomogram (2007) (0)
- PD54-04 CHALLENGING THE DOGMA: SHOULD UNILATERAL PELVIC LYMPH NODE DISSECTION BE ENVISIONED IN THE MULTIPARAMETRIC PROSTATE MRI ERA? (2022) (0)
- 661 Surgical expertise represents a strong determinant of early continence recovery after robot-assisted radical prostatectomy (2016) (0)
- PD34-02 THE KEY ROLE OF PSA DOUBLING TIME IN PATIENTS TREATED WITH SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR THE EXTENT OF RADIATION AND THE CONCOMITANT USE OF HORMONAL THERAPY (2021) (0)
- A novel prognostic model for patients undergoing salvage radiotherapy for biochemical recurrence after radical prostatectomy (2021) (0)
- 718 Proposal of novel risk groups for outcome prediction following radical prostatectomy in contemporary prostate cancer patients (2014) (0)
- Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer (2020) (0)
- 800: Defining the Ideal Number of Nodes to Remove at Pelvic Lymphadenectomy for Prostate Cancer: Validation of a Nomogram for Intermediate to High Risk Patients (2006) (0)
- MP72-04 IMPACT OF THE SITE OF RECURRENCE AFTER RADICAL CYSTECTOMY ON SURVIVAL: DIFFERENT SITES FOR DIFFERENT OUTCOMES. (2015) (0)
- Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis (2022) (0)
- MP18-13 VALIDATION OF EAU GUIDELINE’S PRETREATMENT RISK STRATIFICATION PARAMETERS IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC) (2018) (0)
- 230 120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION (2007) (0)
- 166 External validation of the pathological nodal staging score for prostate cancer in a contemporary cohort: A population-based study (2014) (0)
- Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy (2020) (0)
- 912 High volume of lymph node invasion at radical prostatectomy: A proxy for systemic disease. Analyses on metastatic progression and patient survival (2015) (0)
- Long-term outcomes and patterns of recurrence in patients with clinical lymphadenopathies undergoing radical prostatectomy as part of a multimodal treatment (2019) (0)
- 250 SAFETY OF SURGERY FOR NODAL RECURRENCE OF PROSTATE CANCER AFTER RADICAL RETROPUBIC PROSTATECTOMY (2007) (0)
- Assessing the impact of TURBT specimens review by a dedicated uropathologist on clinical decision making process: Results from a single tertiary referral center (2023) (0)
- MP61-08 PROGRESSION OF T1 HIGH RISK INTO MUSCLE-INVASIVE BLADDER CANCER IS AN INDEPENDENT PROGNOSTIC FACTOR OF MORTALITY AFTER RADICAL CYSTECTOMY (2014) (0)
- Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study (2023) (0)
- 1047 LYMPH NODE DENSITY PREDICTS SURVIVAL OF PATIENTS WITH NODAL METASTASES AND PROSTATE CANCER ONLY IN PRESENCE OF MORE EXTENSIVE NODAL DISSECTION. IMPORTANCE OF ACCURATE STAGING (2011) (0)
- 345 CHANGING AND UNCHANGING FACE OF HIGH RISK PROSTATE CANCER. RESULTS FROM A 15-YEAR, SINGLE INSTITUTION SERIES (2013) (0)
- MP35-18 NEUTROPHIL TO LYMPHOCYTE RATIO IS ASSOCIATED WITH LYMPH NODE INVASION AND HIGHER NODAL BURDEN IN CONTEMPORARY HIGH RISK PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION (2018) (0)
- 801 ACCURACY OF PERCENT FREE PSA IN PSA RANGES LOWER THAN 2.5NG/ML (2007) (0)
- 361 Predicting prostate cancer specific mortality in high risk prostate cancer. A novel preoperative nomogram including the new biomarker micro-RNA 221 (2012) (0)
- PD45-12 DEVELOPMENT AND EXTERNAL VALIDATION OF A NOVEL RISK SCORE TO PREDICT LONG-TERM CLINICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2019) (0)
- FP094ESTIMATED GLOMERULAR FILTRATION RATE: DO WE MEASURE THE REAL RENAL FUNCTION OR ARE WE STILL GROPING IN THE DARK? (2017) (0)
- P100 Not all node positive high-risk prostate cancer patients are the same (2013) (0)
- Prognostic factors and risk groups in T1G3 patients initially treated with BCG: Results of a multicenter retrospective series in 1743 patients (2013) (0)
- The role of percutaneous renal tumor biopsy in frail patients with indeterminate small renal masses (2022) (0)
- PD57-10 OPTIMIZING THE NUMBER OF SYSTEMATIC CORES DURING AN MRI TARGET BIOPSY: PRELIMINARY RESULTS FROM THE PROSPECTIVE, SINGLE CENTER SCOT TRIAL (NCT 04183699) (2021) (0)
- PSA doubling time as predictor of relapse after early salvage radiation therapy: When should imaging be used to select patients who might not benefit from early local treatments? (2022) (0)
- MP41-02 VARIANT HISTOLOGY AS PREDICTOR OF UPSTAGING AT RADICAL CYSTECTOMY FOR UROTHELIAL BLADDER CANCER (2021) (0)
- 21 Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma (2014) (0)
- Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial? (2020) (0)
- Anatomical prostate mpMRI features and continence recovery after robot assisted radical prostatectomy: is there something beyond membranous urethral length? results from a large, multi-institutional cohort (2020) (0)
- Sarcomatoid vs. urothelial bladder cancer: Impact of radical cystectomy on cancer control outcomes (2023) (0)
- 186 Does surgical approach impact on the risk of positive surgical margin at radical prostatectomy in patients with clinically localized prostate cancer? A single institution analysis (2015) (0)
- 724 Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2015) (0)
- INTRAFASCIAL NERVE SPARING TECHNIQUE IMPROVES THE RATE OF ERECTILE FUNCTION RECOVERY AFTER RETRO PUBIC RADICAL PROSTATECTOMY, COMPARED TO STANDARD TECHNIQUE (2008) (0)
- PD24-02 SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA PATIENTS: A POPULATION-BASED STUDY (2018) (0)
- Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study. (2023) (0)
- 963 PREDICTION OF 30-DAY MORTALITY AFTER CHANNEL TRANSURETHRAL RESECTION FOR PROSTATE CANCER (2009) (0)
- Correction to: Renal histology across the stages of chronic kidney disease (2021) (0)
- Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly –An International Multicenter Study (2021) (0)
- MP78-01 CONTEMPORARY MANAGEMENT OF PROSTATE CANCER PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: A POPULATION-BASED STUDY. (2015) (0)
- Response to Re: Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer (2013) (0)
- Rebuttal from Authors re: Urs E. Studer, Laurence Collette. Morbidity from Pelvic Lymphadenectomy in Men Undergoing Radical Prostatectomy. Eur Urol 2006;50:887–9. (2006) (0)
- 806 Predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in men with pT3 N0 prostate cancer. Implications for multi-modal therapies (2013) (0)
- MP09-09 HISTORICAL TRENDS IN HIGH-RISK PROSTATE CANCER PATIENTS CHARACTERISTICS: A 27 YEARS OLD OBSERVATIONAL STUDY FROM A MULTICENTER PROSTATE CANCER CLINICAL AND TRANSLATIONAL RESEARCH GROUP (2016) (0)
- IF A PELVIC LYMPH NODE DISSECTION AT RADICAL PROSTATECTOMY IS PLANNED, THIS MUST BE EXTENDED : RESULTS OF A SENSITIVITY ANALYSIS (2009) (0)
- PD55-08 SELECTING THE BEST CANDIDATES FOR CISPLATIN-BASED ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY IN PN+ BLADDER CANCER PATIENTS (2021) (0)
- Development and validation of a novel EPS-metabolomic signature for the diagnosis of clinically significant prostate cancer (2019) (0)
- 682 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS (2010) (0)
- 799 ASSESSING THE RISK OF BONE METASTASES IN CONTEMPORARY PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER (2009) (0)
- Editorial comment on: Erectile dysfunction after external beam radiotherapy for prostate cancer. (2009) (0)
- MP54-16 IMMEDIATE RADICAL CYSTECTOMY VS. BCG IMMUNOTHERAPY FOR T1 HIGH GRADE NON-MUSCLE-INVASIVE BLADDER CANCER: AN INTERNATIONAL MULTICENTRE COLLABORATION (2022) (0)
- Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019 (2022) (0)
- Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients? (2022) (0)
- Surgical management of locally advanced bladder cancer: Is radical cystectomy a valid option for clinical T4 bladder cancer? (2016) (0)
- 311 Prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma patients treated with nephrectomy and extended lymph node dissection (2015) (0)
- MP14-15 CLINICO-DOSIMETRIC FACTORS PREDICTING LONG-TERM SEVERE URINARY INCONTINENCE AFTER POST-PROSTATECTOMY RT. RESULTS OF A LONGITUDINAL OBSERVATIONAL STUDY. (2016) (0)
- PD39-09 IMPACT OF PROSTATE IMAGING QUALITY (PI-QUAL) SCORE ON THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN UNDERGOING MRI-TARGETED BIOPSY (2023) (0)
- 756P Molecular subtyping and immune-gene signatures identify a subset of clinical T1 high-grade (cT1 HG) and cT2 bladder urothelial carcinoma (UC) as candidates for single-agent immune checkpoint inhibition (ICI) (2020) (0)
- MP15-19 CAN LOW RISK DISEASE OUTSIDE THE INDEX LESION BE LEFT UNTREATED IN MEN SUITABLE FOR FOCAL THERAPY? DEVELOPMENT OF NOVEL CRITERIA TO IDENTIFY POTENTIAL CANDIDATES FOR FOCAL THERAPY AMONG PATIENTS WITH INTERMEDIATE RISK PROSTATE CANCER AND POSITIVE MULTI-PARAMETRIC MRI (2022) (0)
- MP22-03 LONG-TERM ONCOLOGIC OUTCOMES OF PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2019) (0)
- PD39-06 INTEGRATING INDEX LESION VOLUME TO BETTER CLASSIFY MEN WITH INDOLENT PROSTATE CANCER AMONG PATIENTS WITH INTERMEDIATE RISK DISEASE. RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2023) (0)
- Epidemiology of Unconventional Histological Subtypes of Urethral Cancer (2022) (0)
- MP61-06 NEOADJUVANT CHEMOTHERAPY IS NOT ASSOCIATED WITH WORSE SHORT-TERM OUTCOMES IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY: A POPULATION-BASED STUDY (2014) (0)
- COMPARISON BETWEEN TRANSRECTAL AND TRANSPERINEAL PROSTATE CANCER DETECTION RATE AT SATURATION BIOPSY AFTER PREVIOUS NEGATIVE BIOPSIES. RESULTS OF A TWO-INSTITUTION EXPERIENCE (2009) (0)
- PD33-12 PRE-OPERATIVE RISK CALCULATOR OF THE PROBABILITY OF COMPLETING NEPHRON-SPARING SURGERY FOR KIDNEY CANCER BASED ON TUMOUR COMPLEXITY AND SURGICAL APPROACH (2022) (0)
- 1628 AT LEAST ONE PHOSPHODIESTERASE TYPE 5 INHIBITOR DOSE PER WEEK SHOULD BE TAKEN IN ORDER TO IMPROVE ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2011) (0)
- 724 Association between tumour volume and unfavourable prostate cancer characteristics: Implications for patient stratificaton (2014) (0)
- The introduction of robotic assisted radical cystectomy with intracorporeal diversion did not impact on intra and peri-operative outcomes as compared to open radical cystectomy: A single tertiary institution center analysis (2019) (0)
- Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity (2022) (0)
- 163 Historical trends in high-risk prostate cancer patients characteristics: A 27 years old observational study from the European multicenter prostate cancer clinical and translational research group (EMPaCT) data base (2016) (0)
- Prognostic variability among high-risk prostate cancer patients with pN1 disease according to the primary tumour pathologic features after radical prostatectomy (2021) (0)
- Reply by Authors. (2020) (0)
- Identifying the optimal clinical setting for the use of multiparametric magnetic resonance imaging of the prostate as local staging tool in men candidate to radical prostatectomy. Results from a multi-institutional series (2021) (0)
- LBA03-12 BIOLOGY AND PERFORMANCE OF PRE- AND POST-PEMBROLIZUMAB (PEMBRO) VESICAL IMAGING-REPORTING AND DATA SYSTEM (VI-RADS) TO PREDICT THE PATHOLOGICAL RESPONSE IN MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER (MIBC): FULL DATA ANALYSIS FROM A CLINICAL TRIALS PIPELINE (2023) (0)
- Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL (2020) (0)
- MP83-17 IMPACT OF INTRA-OPERATIVE TRANSFUSION ON SURVIVAL OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY (2015) (0)
- MP48-12 ONCOLOGIC SURVEILLANCE FOR SURGICALLY-TREATED HIGH RISK UPPER TRACT UROTHELIAL CARCINOMA (2021) (0)
- 1793 AGE AND AGGRESSIVE PROSTATE CANCER IN PATIENTS WITH LOW RISK CHARACTERISTICS. IMPLICATIONS FOR CONSERVATIVE MANAGEMENT (2011) (0)
- 341 INTRA-OPERATIVE AND FUNCTIONAL RESULTS OF ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY. COMPARISON OF SURGEONS WITH DIFFERENT OPERATIVE BACKGROUNDS (2011) (0)
- Testing the external validity of ProtecT trial results in North American men with clinically localized prostate cancer (PCa) (2017) (0)
- Which patients with low-risk prostate cancer are still receiving radical prostatectomy? Impact of patient selection on inverse stage migration at two european, tertiary referral centers (2018) (0)
- The impact of HER2 status on oncological outcomes of patients with invasive bladder cancer (2016) (0)
- MP11-09 REGRESSION-TREE ANALYSIS FOR IDENTIFYING THE BEST CANDIDATES TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH CLINICAL NODE-POSITIVE PENILE SQUAMOUS-CELL CARCINOMA (2020) (0)
- ARE THE RESULTS OF THE PROTECT TRIAL APPLICABLE TO CONTEMPORARY PROSTATE CANCER PATIENTS TREATED AT TWO HIGH‐VOLUME EUROPEAN INSTITUTIONS?: PD51‐01 (2017) (0)
- Lymphovascular invasion predicts lymph node involvement in patients with renal cell carcinoma (2023) (0)
- Rehabilitation of sexual function (2007) (0)
- 627 Preoperative favourable characteristics in bladder cancer patients cannot substitute the necessity of extended lymphadenectomy during radical cystectomy: A sensitivity curve and a survival analysis (2016) (0)
- PD30-03 PREDICTING UNFAVORABLE PROSTATE CANCER IN ACTIVE SURVEILLANCE CANDIDATES TREATED WITH RADICAL PROSTATECTOMY: A POPULATION-BASED STUDY (2015) (0)
- 122 A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis (2012) (0)
- PD57-12 THE IMPACT OF PERSISTENTLY ELEVATED PSA LEVELS ON PROGRESSION AND SURVIVAL OF PATIENTS UNDERGOING CYTOREDUCTIVE RADICAL PROSTATECTOMY FOR OLIGOMETASTATIC PROSTATE CANCER (2020) (0)
- MP18-02 EFFICACY OF PREOPERATIVE CHEMOTHERAPY ON OUTCOMES OF HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA (UTUC) (2018) (0)
- MP44-18 PROLONGED ENDOUROLOGICAL TRAINING IS THE KEY TO IMPROVE SURGICAL OUTCOMES OF STONE PATIENTS TREATED WITH FLEXIBLE URETEROSCOPY (2022) (0)
- MP32-17 CLINICAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER, DEFINING OPTIMAL SURVEILLANCE AFTER SURGERY (2019) (0)
- MP62-09 CAN MULTIPARAMETRIC MRI IMPROVE OUR ABILITY TO PREDICT EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY IN CONTEMPORARY PATIENTS? RESULTS FROM A MULTI-INSTITUTIONAL ANALYSIS (2020) (0)
- MP56-12 AGE AND GLEASON SCORE UPGRADING BETWEEN PROSTATE BIOPSY AND RADICAL PROSTATECTOMY. IS THIS STILL TRUE IN THE MRI ERA? (2020) (0)
- MP56-13 THE PERCENTAGE OF POSITIVE MRI TARGETED BIOPSY CORES IS INVERSELY ASSOCIATED WITH GLEASON SCORE UPGRADING AT RADICAL PROSTATECTOMY. THE IMPORTANCE OF ACCURATE TARGETED SAMPLING (2020) (0)
- PURE-02: An open-label, single-arm, feasibility study of neoadjuvant pembrolizumab before Radical Nephroureterectomy (RNU) in patients with high-risk, Upper-Tract Urothelial Carcinoma (UTUC) (2021) (0)
- 302 Characteristics of secondary, primary, and compensated hypogonadism in Caucasian-European men presenting for primary couple's infertility – results of a cross-sectional survey (2015) (0)
- Impact of the time elapsed between prostate biopsy and surgery on the accuracy of the Briganti nomogram predicting lymph node invasion in men with clinically localized prostate cancer (2022) (0)
- Response to Re: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population‐based analysis (2013) (0)
- 355 Radical prostatectomy for very high risk T3b/4 prostate cancer – results of a multiinstitutional experience (2012) (0)
- External validation of a TCP model predicting PSA relapse after post-prostatectomy radiotherapy (2017) (0)
- PO-0870: Fitting data of relapse-free survival after postprostatectomy RT with a comprehensive TCP model (2016) (0)
- Oncologic outcomes in patients diagnosed with pT3a non-metastatic renal cell cancer according to renal vein thrombus or fat invasion (2022) (0)
- Comparison of perioperative outcomes between open and robotic radical cystectomy: A population based analysis (2018) (0)
- MP48-14 WHEN NODE-POSITIVE PROSTATE CANCER SHOULD BE CONSIDERED A SYSTEMIC DISEASE? ASSESSING THE PROGNOSTIC ROLE OF PREOPERATIVE 68GA-PSMA PET/CT RESULTS IN PATIENTS WITH LYMPH NODE INVASION AT FINAL PATHOLOGY (2022) (0)
- A new proposal to improve the surveillance of renal cell carcinoma patients after surgery (2018) (0)
- Distribution of histological subtypes and tumor grade according to tumor size in T1-T2 surgically treated renal cell carcinoma (2020) (0)
- Salvage lymph node dissection in nodal recurrent prostate cancer is not devoid of complications: Results from a single tertiary referral center (2017) (0)
- The prognostic significance of persistently elevated PSA after radical prostatectomy is highly associated with pathological stage: Implications for timely use of salvage treatments (2018) (0)
- Optimizing the number of systematic cores during an MRI target biopsy: Preliminary results from the prospective, single center SCOT Trial (NCT 04183699) (2021) (0)
- MP58-13 FUNCTIONAL OUTCOMES AFTER SURGERY IN PATIENTS WITH RENAL CANCER AND TUMOR THROMBUS (2023) (0)
- Is surgery for high-risk localized prostate cancer valid in the elderly population? An analysis of the influence of age and cancer-specific and overall survival (2010) (0)
- SP045CHRONIC KIDNEY DISEASE CLASSIFICATION: IS THE CORRECT METHOD TO DEFINE RENAL DAMAGE OR IS IT JUST AN ILLUSION? (2018) (0)
- PO-0749: Factors predicting late severe urinary incontinence after postprostatectomy RT: a longitudinal study (2016) (0)
- Incongruence between turb and radical cystectomy findings in terms of histological variant identification: analysis of all potential clinical risk factors (2020) (0)
- Development of novel criteria for active surveillance based on multiparametric MRI alone in men with Gleason 3+4 prostate cancer: Use of imaging to safely expand the eligibility for active surveillance (2019) (0)
- 214 Metabolic syndrome, obesity and radical cystectomy complications: A Clavien classification system-based analysis (2014) (0)
- 636 INSURANCE STATUS IS A DETERMINANT OF THE STAGE AT PRESENTATION AND OF CANCER CONTROL IN EUROPEAN MEN SUBJECTED TO RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER (2007) (0)
- Case Presentation: A Man with Two Synchronous and Symptomatic Malignancies Related to Smoking. (2015) (0)
- Which patients with clinically node prostate cancer benefit from radical prostatectomy? The impact of the size and site of nodal involvement on long-term outcomes (2018) (0)
- Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience (2022) (0)
- Re: Hiten D. Patel, Farzana A. Faisal, Bruce J. Trock, et al. Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.05.001. (2020) (0)
- Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer (2023) (0)
- Added value of concomitant systematic biopsies in predicting upgrading in patients with localized prostate cancer diagnosed by MRI-targeted biopsy: Implications for treatment selection (2019) (0)
- MP15-20 SURVIVAL AFTER RADICAL PROSTATECTOMY VS. RADIATION THERAPY IN DUCTAL CARCINOMA OF THE PROSTATE (2022) (0)
- 739: The Effect of Competing Mortality on the Risk of Cancer-Specific Survival in Kidney Cancer (2006) (0)
- Does prostate cancer represent the main cause of death in all node positive prostate cancer patients? The impact of competing causes of mortality according to tumor characteristics and recurrence status (2017) (0)
- MP47-12 FRAILTY STATUS PREDICTS WORSE POSTOPERATIVE AND LONG-TERM ONCOLOGIC OUTCOMES IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY FOR SMALL RENAL MASSES (2022) (0)
- 740 UNSUCCESSFUL INVESTIGATION OF PREOPERATIVE COUPLES AND SEXUAL RELATIONSHIP ISSUES IN CANDIDATES TO RADICAL PROSTATECTOMY (2007) (0)
- Comparing oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity match analysis (2017) (0)
- The effect of the da Vinci® Vessel Sealer on robot-assisted laparoscopic prostatectomy complications. (2023) (0)
- 620 PATHOLOGICAL GLEASON SCORE DICTATES SURVIVAL IN PATIENTS WITH SEMINAL VESICLE INVASION TREATED WITH RADICAL PROSTATECTOMY AND ADJUVANT RADIATION THERAPY. RESULTS FROM A TWO-INSTITUTION SERIES ANALYSIS (2010) (0)
- 219 Probability of erectile function recovery in young men treated with radical prostatectomy – findings of a contemporary series (2018) (0)
- Association between BRCA 1/2 polymorphisms and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy (2020) (0)
- MP15-15 WHO ARE THE PATIENTS WHO BENEFIT THE MOST FROM EXTENDED PELVIC LYMPH NODE DISSECTION IN LOCALIZED PROSTATE CANCER? IDENTIFICATION OF THE OPTIMAL CANDIDATES TO BE INCLUDED IN A RANDOMIZED CONTROLLED TRIAL (2021) (0)
- First survival outcomes and additional secondary analyses from PURE-01: Pembrolizumab (pembro) before radical cystectomy (RC) in muscle-invasive urothelial bladder carcinoma (MIBC). (2019) (0)
- PSMA-PET for recurrent prostate cancer and guidance of salvage treatments: Is the sooner always the better? (shoot blind or sharpshooting?) (2023) (0)
- 662: Internal Validation of a Competing-Risks Survival Nomogram for Patients Treated with Radical Prostatectomy (RP) for Clinically Prostate Cancer (PCA) (2006) (0)
- A NOVEL NOMOGRAM PREDICTING A POSITIVE [11C]CHOLINE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/TC) SCAN IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
- MP53-04 RATES OF UPGRADING AND UPSTAGING IN PROSTATE CANCER PATIENTS WITH SINGLE GGG1 POSITIVE BIOPSY CORE (2022) (0)
- MP48-17 URETERAL STENTING DOES NOT INCREASE THE RISK OF METACHRONOUS UPPER TRACT UROTHELIAL CARCINOMA IN PATIENTS WITH BLADDER CANCER PRESENTING WITH HYDRONEPHROSIS IN COMPARISON WITH PERCUTANEOUS NEPHROSTOMY (2021) (0)
- PD59-08 PRE-SURGICAL MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FEATURES PREDICTING CONTINENCE AFTER ROBOTIC RADICAL CYSTECTOMY WITH ORTHOTOPIC BLADDER RECONSTRUCTION: PRELIMINARY FINDINGS FORM PURE-01 TRIAL (2021) (0)
- Proposal of a novel risk score to identify biopsy naïve men with elevated PSAwho should be considered for a multiparametric MRI (2018) (0)
- Fascial Layers in Nerve Sparing Robot‐Assisted Radical Prostatectomy (2014) (0)
- Dissecting patterns of care in patients with variant histology of bladder cancer and lymph node invasion (2021) (0)
- Outcomes of prostate cancer patients with seminal vesicle invasion at multiparametric MRI managed with radical prostatectomy. Do all patients really need for a multi-modal approach? (2022) (0)
- Comparison of robot-assisted and open surgery partial nephrectomy: An observational prospective study on pathologic and early functional outcomes (2017) (0)
- 709 MORE EXTENSIVE PELVIC LYMPH NODE DISSECTION IS ASSOCIATED WITH REDUCED RISK OF CANCER PROGRESSION IN NODE NEGATIVE ORGAN CONFINED PROSTATE CANCER PATIENTS (2011) (0)
- Development of novel criteria to identify the optimal candidates for active surveillance among men with low-risk prostate cancer and a positive family history. Results from a large, single institution series (2021) (0)
- RECONFIGURATION OF THE SEVERELY FIBROTIC PENIS WITH A PENILE IMPLANT: 3-YEAR FOLLOW-UP (2006) (0)
- Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guerin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial. (2020) (0)
- Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis (2022) (0)
- 1061 VALUE OF ELND IN LYMPH NODE NEGATIVE PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER IS UNCERTAIN (2010) (0)
- How can we optimize the use of prostate cancer registries? (2016) (0)
- 238 SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2009) (0)
- Development of a biomarker-based calculator to predict the probability to achieve a pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer (2019) (0)
- MP4-14 LONG-TERM CANCER CONTROL OUTCOMES IN PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A MULTI-INSTITUTIONAL DATABASE ANALYSIS. (2015) (0)
- Reply to Berardino De Bari, Filippo Alongi, Stefano Arcangeli's letter to the editor re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 11 (2014) (0)
- Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy (2017) (0)
- Diagnostic value of FDG-positron emission tomography (PET/CT) for lymph node staging in patients with upper tract urothelial carcinoma (UTUC) (2019) (0)
- 182 EVALUATION OF LYMPH NODE RECURRENT PROSTATE CANCER WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL PROSTATECTOMY: VALIDATION BY HISTOLOGICAL ANALYSIS (2012) (0)
- MP82-14 SINGLE NUCLEOTIDE POLYMORPHISMS AND RISK OF PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A NOVEL GENETIC RISK SCORE FOR INDIVIDUALIZED SCREENING AND DIAGNOSTIC PROGRAMMES (2018) (0)
- Association of sex with oncologic outcomes in pTa bladder cancer (2021) (0)
- Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study (2019) (0)
- Acute kidney injury after partial nephrectomy: Epidemiology, predictive factors and implications for clinical practice (2019) (0)
- Hypertension and cardiovascular morbidity following radical nephrectomy are only sustained by renal parenchyma loss and cardiovascular morbidity (2020) (0)
- MP37-09 MORE EXTENSIVE PELVIC LYMPH NODE DISSECTIONS DURING ROBOTIC ASSISTED RADICAL PROSTATECTOMY ARE ASSOCIATED WITH HIGHER RATES OF PERI-OPERATIVE COMPLICATIONS. RESULTS OF A SINGLE INSTITUTION SERIES (2014) (0)
- SP236THE RADICAL NEPHRECTOMY PARADOX: THE UNEXPECTED AKI'S RISK (2019) (0)
- 1013 Long-term outcomes of very high risk prostate cancer patients treated with radical prostatectomy with or without adjuvant treatments. Results of a competing risks, multiinstitutional analysis (2015) (0)
- The Utility of PDE5 Inhibitors After Radical Prostatectomy (2009) (0)
- Does the working channel position have a role on the effectiveness of flexible ureteroscopy? Results from an in vitro study (2019) (0)
- MP48-17 ONCOLOGICAL OUTCOMES IN PATIENTS WITH RECURRENT PROSTATE CANCER STAGED WITH PSMA PET/CT: RESULTS FROM 3 EUROPEAN TERTIARY CENTERS (2022) (0)
- Very long-term outcomes, time patterns of recurrence and other-cause mortality in patients treated with salvage radiation therapy for recurrent prostate cancer after radical prostatectomy: Implications for risk tailored follow-up strategies (2021) (0)
- MP14-11 WHEN IS THE OPTIMAL TIMING FOR SALVAGE RADIATION THERAPY IN PATIENTS WITH INCREASING PSA AFTER RADICAL PROSTATECTOMY? A PATIENT RISK STRATIFICATION MODEL BASED ON PROSTATE CANCER AGGRESSIVENESS (2016) (0)
- MP22-10 WHICH POSITIVE SURGICAL MARGINS FEATURES IMPACT ON THE RISK OF PROSTATE CANCER SPECIFIC MORTALITY? A DISEASE-TAILORED, COMPETING-RISK, LONG-TERM ANALYSIS (2019) (0)
- Benign Prostatic Hyperplasia: Surgical Therapy and New TechnologyPodium 56: Wednesday, May 18, 2011: 1:00 PM-3:00 PM2271 RADICAL PROSTATECTOMY AFTER PREVIOUS PROSTATE SURGERY: CLINICAL AND FUNCTIONAL OUTCOMES (2011) (0)
- Rebuttal from Authors re: John Mulhall. Can Penile Size be Preserved after Radical Prostatectomy? Eur Urol 2007;52:626–8 (2007) (0)
- Beware of Bugs! Hot Issues in Urinary Tract Infections and Inflammation. (2016) (0)
- SP-0022: Should oligometastatic disease in prostate cancer be treated systemically?: The urologist point of view (2014) (0)
- Assessing the impact on morbidity and mortality of neoadjuvant chemotherapy in patients with high-risk and muscle invasive bladder cancer eligible for radical cystectomy. (2015) (0)
- The key role of concomitant androgen-deprivation therapy on the efficacy of imaging guided treatments in men with biochemical recurrent prostate cancer after radical prostatectomy and 68Ga-PSMA PET/CT scan (2022) (0)
- 1926 PREDICTING FACTORS FOR INSIGNIFICANT CANCER AFTER A DIAGNOSIS OF ONE SINGLE MINUTE FOCUS OF PROSTATE CANCER ON NEEDLE BIOPSY (2011) (0)
- MP27-03 DELAYING POST-OPERATIVE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY IS ASSOCIATED WITH INCREASED FUNCTIONAL OUTCOMES: RESULTS FROM A LARGE SINGLE, REFERRAL CENTER SERIES (2022) (0)
- MP82-09 THE CHUN NOMOGRAM SIGNIFICANTLY OUTPERFORMS THE PCPT, ERSPC, KAWAKAMI AND KARAKIEWICZ NOMOGRAMS IN THE PREDICTION OF PROSTATE CANCER: A SINGLE CENTER COHORT-STUDY (2018) (0)
- ESTIMATED GLOMERULAR FILTRATION RATE: DO WE MEASURE THE REAL RENAL FUNCTION OR ARE WE STILL GROPING IN THE DARK?: MP22‐08 (2017) (0)
- Urinary Incontinence: Moving the Field Forward. (2016) (0)
- Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? development and external validation of a novel T-stage classification based on clinical and MRI findings (2020) (0)
- 905 Predicting lymph node invasion in contemporary North-American patients treated with robot-assisted radical prostatectomy (2015) (0)
- 68Ga-PSMA PET/CT for Recurrent Prostate Cancer after Radical Prostatectomy: What’s next? Analysis from a single, high volume tertiary referral center (2021) (0)
- A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) (2006) (0)
- Reply to G. Pomara, G. Morelli (2005) (0)
- 305 THE IMPACT OF PERCENTAGE OF POSITIVE CORES IN PREDICTING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. IMPORTANCE OF BASELINE TUMOR CHARACTERISTICS (2011) (0)
- 1379 THE KEY ROLE OF TIME IN PREDICTING POST-RADICAL PROSTATECTOMY ERECTILE FUNCTION RECOVERY: CONDITIONAL SURVIVAL ANALYSES (2012) (0)
- Impact of family history on pathologic outcome and biochemical recurrence after radical prostatectomy (2016) (0)
- The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy (2020) (0)
- Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma. (2022) (0)
- Optimizing timing and indications for 68Ga-PSMA PET/CT in patients with biochemical recurrent prostate cancer after radical prostatectomy (2022) (0)
- PD03-08 THE NECESSITY OF A SECOND TRANSURETHRAL RESECTION FOR PATIENTS DIAGNOSED WITH PTAHG TUMOR AT FIRST TUR: A MULTICENTER COLLABORATION OF EAU YOUNG ACADEMIC UROLOGISTS UROTHELIAL CARCINOMA GROUP (2020) (0)
- 32 PREOPERATIVE CIRCULATING ESTRADIOL, TESTOSTERONE AND SEX HORMONE BINDING GLOBULIN ARE NOT PREDICTORS OF POSITIVE SURGICAL MARGINS AT OPEN RADICAL PROSTATECTOMY (2010) (0)
- Editorial Comment to Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database (2016) (0)
- How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series (2020) (0)
- Which patients are at risk of post-operative sepsis? Results from a large prospective series of patients elected for urologic surgery (2018) (0)
- The effect of pathologic T-stage and Gleason score on cancer-specific survival for specimen-confined high-risk prostate cancer. (2014) (0)
- MP15-19 68Ga-PSMA PET/CT For RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: WHAT IS NEXT? (2021) (0)
- Three year-survival outcomes after neoadjuvant pembrolizumab and radical cystectomy: final results from the pure-01 study (2022) (0)
- MP67-07 CAN WE PREDICT THE SITE OF POSITIVE SURGICAL MARGINS (PSM) BASED ON THE SITE OF THE INDEX LESION AT MULTIPARAMETRIC MRI? A TOPOGRAPHIC SINGLE CENTER STUDY (2023) (0)
- Added value of radiological tumor stage in predicting early oncological outcomes in prostate cancer patients undergoing radical prostatectomy within clinical stage: A stage-by-stage analysis (2021) (0)
- SP272KIDNEY ENDOWMENT PRESERVATION AND CLINICAL OUTCOME IN PATIENTS WITH RENAL CANCER: IS NEPHRON SPARING SURGERY ALWAYS SUPERIOR TO RADICAL NEPHRECTOMY IN TERM OF OTHER CAUSES MORTALITY? (2016) (0)
- Prostate Cancer: Staging IIIModerated Poster 11395 ASSESSING THE RISK OF LYMPH NODE INVASION IN PATIENTS WITH INTERMEDIATE RISK PROSTATE CANCER. A NOVEL PREDICTION TOOL (2010) (0)
- Natural history of patients treated with salvage radiation therapy for rising PSA after radical prostatectomy: A long-term survival analysis (2017) (0)
- PD27-12 ASSESSING THE ROLE OF FRAILTY STATUS ON ONCOLOGIC AND FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER (2022) (0)
- 971 Oncological and functional outcomes of patients eligible for active surveillance treated with radical prostatectomy (2012) (0)
- PD16-01 A POSITIVE PSMA PET/CT PREDICTS MORE AGGRESSIVE DISEASE PROGRESSION IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2020) (0)
- Are extended pelvic lymph node dissection-related complications still an issue in contemporary patients treated with robot-assisted radical prostatectomy? A prospective assessment using a standardized collection system (2022) (0)
- PD51-11 CONCOMITANT VS STAGED LYMPHADENECTOMY IN CLINICALLY NODE-POSITIVE PENILE SQUAMOUS CELL CARCINOMA: RECURRENCE PATTERNS AND SURVIVAL OUTCOMES (2022) (0)
- Young men with low risk prostate cancer can be safely candidate to active surveillance regardless of the extent of biopsy involvement: Results from a single center series with pathological confirmation (2019) (0)
- Should the follow-up schedule after radical nephroureterectomy be revised? An analysis on the timing and location of recurrences (2021) (0)
- Development of a risk calculator of recurrence in inguinal lymph-node metastatic (ILNM) patients with surgically-resected penile squamous-cell carcinoma (PSCC) (2020) (0)
- Impact of implementation of the EAU guidelines panel recommendations on reporting and grading of complications on perioperative outcomes after robot-assisted radical prostatectomy (2018) (0)
- MRI-targeted biopsies: What’s next? (2019) (0)
- PD62-05 THE IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN IN UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS TREATED WITH NEPHROURETERECTOMY: A MULTICENTER COLLABORATION (2019) (0)
- The effect of age on cancer-specifc mortality in T1a stage renal cell carcinoma patients: A population-based study across all treatment’s modalities (2022) (0)
- Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal approach (2020) (0)
- 959 PUBLIC-AWARENESS DOES NOT PROMOTE SHORTENING OF THE DELAY IN SEEKING FIRST MEDICAL HELP FOR ERECTILE DYSFUNCTION (ED) IN THE PDE5-IS ERA. PRELIMINARY RESULTS AT SINGLE MAJOR TERTIARY ACADEMIC CENTRE (2007) (0)
- PD27-06 INCREASED AWARENESS OF SURGICAL OUTCOMES IMPROVES LONG-TERM FUNCTIONAL OUTCOMES AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY. A PROSPECTIVE ASSESSMENT FOLLOWING IMPLEMENTATION OF PROSPECTIVE DATA COLLECTION (2022) (0)
- MP22-01 WHAT IS THE BEST DEFINITION OF BIOCHEMICAL RESPONSE TO SALVAGE RADIATION THERAPY IN PROSTATE CANCER PATIENTS TREATED FOR PSA RISING AFTER RADICAL PROSTATECTOMY? RESULTS FROM A MULTI-INSTITUTIONAL SERIES (2019) (0)
- 11C‐CHOLINE VERSUS 68GA‐PSMA PET/CT SCAN FOR THE DETECTION OF NODAL RECURRENCE FROM PROSTATE CANCER: RESULTS FROM A LARGE, MULTI‐INSTITUTIONAL SALVAGE LYMPH NODE DISSECTION SERIES: MP77‐01 (2017) (0)
- 641 ISOLATED BLADDER NECK INVOLVEMENT FROM PROSTATE CANCER SHOULD NOT BE CONSIDERED AS PT4 DISEASE (2009) (0)
- Contemporary conditional cancer‐specific survival rates in surgically treated adrenocortical carcinoma patients: A stage‐specific analysis (2022) (0)
- PD34-10 ATTRACTIVENESS AND ACCESSIBILITY OF FOCAL THERAPY FOR PROSTATE CANCER: RESULTS OF AN INTERNATIONAL WEB-BASED SURVEY (2018) (0)
- 2235 THE NUMBER OF BIOPSY CORES TAKEN IS A MAJOR PREDICTOR OF UNFAVORABLE PROSTATE CANCER AT FINAL PATHOLOGY IN PATIENTS CANDIDATE FOR ACTIVE SURVEILLANCE: CLINICAL IMPLICATIONS (2013) (0)
- Synchronous metastases rates in T1 renal cell carcinoma: A SEER-based study (2020) (0)
- MP53-07 HISTOLOGICAL VARIANTS OF PROSTATE CANCER ARE UNDER-REPORTED IN PROSTATE BIOPSIES ASSESSED OUTSIDE TERTIARY REFERRAL CENTERS. A PLEA FOR BIOPSY REVIEW FOR OPTIMAL PATIENT MANAGEMENT (2022) (0)
- 1650: Significant Upgrading Affects One in Four Men Diagnosed with Prostate Cancer. Predictive Nomogram (2006) (0)
- MP78-13 PROGNOSTIC VALUE OF TUMOR VOLUME ON DISEASE PROGRESSION OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR NODE POSITIVE PROSTATE CANCER (2015) (0)
- Is there an age limit for the indication of extended pelvic lymph node dissection during radical prostatectomy in patients with clinically localized prostate cancer (2018) (0)
- MP22-20 ASSESSING THE IMPACT AND PREDICTORS OF OTHER-CAUSE MORTALITY IN PATIENTS TREATED WITH POST-PROSTATECTOMY SALVAGE RADIATION THERAPY IN ORDER TO AVOID POSSIBLE OVERTREATMENT: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL STUDY (2019) (0)
- Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma (2022) (0)
- MP18-12 THE USE OF URETERAL ACCESS SHEATH DOES NOT REDUCE THE RATE OF INFECTIOUS COMPLICATIONS AFTER FLEXIBLE URETEROSCOPY AND Ho:YAG LASER LITHOTRIPSY FOR RENAL STONES (2021) (0)
- How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis. (2022) (0)
- The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy (2020) (0)
- 213 THE YORK-MASON TECHNIQUE FOR RECTO-URINARY FISTULAS: A SINGLE SURGEON 18-YEAR EXPERIENCE (2010) (0)
- Selecting the best candidates for platinum-based adjuvant chemotherapy after radical cystectomy in pN+ bladder cancer patients (2021) (0)
- A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaboration. (2022) (0)
- Inclusion of mpMRI into the European Randomized study of Screening for Prostate Cancer (ERSPC) risk calculator: A new proposal to improve the accuracy of prostate cancer detection (2017) (0)
- MP46-08 DIAGNOSTIC PERFORMANCE OF PET-CT COMPARED TO CONVENTIONAL CT FOR LYMPH NODE STAGING IN BLADDER CANCER PATIENTS UNDERGOING RADICAL CYSTECTOMY AND BILATERAL PELVIC LYMPH NODE DISSECTION (2023) (0)
- Management of atypical recurrence after treatment of localized renal cell carcinoma: Retrograde intrarenal surgery as an option (2023) (0)
- A systematic review protocol of diagnostic and prognostic factors in patients with prostate cancer (2020) (0)
- PD43-10 TEMPORAL TRENDS AND UTILIZATION RATES OF LYMPH NODE DISSECTION IN PATIENTS WITH RENAL CELL CARCINOMA: IMPLICATIONS FOR ADJUVANT THERAPIES (2023) (0)
- 1655 IMPACT OF TUMOR THROMBUS CONSISTENCY (SOLID VS FRIABLE) ON CANCER-SPECIFIC MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2011) (0)
- PD10-09 A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2023) (0)
- What is the optimal management of nodal oligorecurrent prostate cancer? Results from a large series of patients treated with salvage lymph node dissection (2022) (0)
- MP36-16 THE ROLE OF HISTOLOGIC SUBTYPES IN FOLLOW-UP SCHEME OF POSTSURGICAL KIDNEY CANCER PATIENTS (2018) (0)
- Active surveillance for very small renal masses: Analysis from an observational prospective trial (NCT03804320) (2023) (0)
- Assessing the impact of radiologist expertise on the misdiagnosis of clinically significant prostate cancer among men receiving multi-parametric MRI (2018) (0)
- 1615: Sex Hormone Binding Globulin is a Significant Predictor of Extra Capsular Extension in Patients Undergoing Radical Retropubic Prostatectomy (2007) (0)
- Long-term oncologic outcomes of robot-assisted radical cystectomy: update series from a high-volume robotic center beyond 10 years of follow-up. (2022) (0)
- MP05-11 THE LEARNING CURVE OF MPMRI TARGETED BIOPSY FOR THE DETECTION OF CLINICALLY SIGNICANT PROSTATE CANCER IS RELATED TO THE CHARACTERISTICS OF THE INDEX LESION (2021) (0)
- 1796 AN ASSESSMENT OF LYMPHADENECTOMY OMISSION AT CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A POPULATION-BASED ANALYSIS (2012) (0)
- MP53-01 DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN MPMRI VISIBLE LESIONS: SIZE MATTERS. RESULTS FROM A LARGE, TWO-INSTITUTIONAL SERIES (2022) (0)
- Identifying the optimal candidates for radiation therapy after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Results from a multi-institutional collaboration (2021) (0)
- 184 Factors predicting severe (Grade 3–4) late urinary toxicity after post-prostatectomy irradiation. A single institution analysis of 1151 patients treated with adjuvant or salvage radiotherapy with different radiation techniques and fractionations (2013) (0)
- 563 IN HIGH-RISK PROSTATE CANCER, THE NUMBER OF LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY DOES NOT AFFECT THE RISK OF CANCER RELATED DEATH OR DEATH FROM ANY CAUSE (2011) (0)
- PD29-11 IMPACT OF BILATERAL NEUROVASCULAR BUNDLE PRESERVATION ON ONCOLOGICAL OUTCOMES IN NON-ORGAN CONFINED PROSTATE CANCER (2018) (0)
- 537 Early, intermediate and late recurrence after radical cystectomy due to bladder cancer: The necessity of a tailored follow up (2015) (0)
- The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain (2022) (0)
- PD43-11 THE USE OF URETERAL ACCESS SHEATH DOES NOT MODIFY THE PATTERN OF DISEASE RECURRENCE DURING CONSERVATIVE MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA (2021) (0)
- Tailoring the optimal use of androgen-deprivation therapy concomitant to post-operative radiotherapy among men with pN1 prostate cancer. Long-term results of a large, single Institution series (2023) (0)
- Reply by Authors. (2020) (0)
- Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treated with post-prostatectomy radiation therapy: Results from a large, multi-institutional study (2021) (0)
- THE ABILITY OF THREE COMORBITY INDECES TO PREDICT POSTOSPERATIVE MORTALITY IN RENAL CELL CARCINOMA PATIENTS: THE IMPENDING NEED OF A NEW DISEASE‐SPECIFIC INDEX: MP55‐14 (2017) (0)
- Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma. (2023) (0)
- VALIDATION OF THE CRITERIA SUGGESTED BY CURRENT GUIDELINES TO INDICATE THE NEED FOR BASELINE STAGING BONE SCAN IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER (2009) (0)
- DEFINING THE IDEAL NUMBER OF NODES TO REMOVE AT PELVIC LYMPHADENECTOMY FOR PROSTATE CANCER: VALIDATION OF A NOMOGRAM FOR INTERMEDIATE - TO HIGH RISK PATIENTS (2006) (0)
- RECURRENCE AND PROGRESSION ACCORDING TO STAGE AT RE‐TUR IN T1G3 BLADDER CANCER PATIENTS TREATED WITH BCG: NOT AS BAD AS PREVIOUSLY THOUGHT: PD48‐07 (2017) (0)
- 833 THE INFLUENCE OF THE BIOPSY SCHEME ON THE ABILITY OF THE EPSTEIN CRITERIA TO PREDICT A “CLINICALLY INSIGNIFICANT” PROSTATE CANCER (2009) (0)
- WHEN TO PERFORM AN INTRAFASCIAL NERVE SPARING APPROACH WITHOUT COMPROMISING CANCER CONTROL. RESULTS OF A HIGH VOLUME SINGLE SURGEON SERIES (2009) (0)
- Identification of the best candidates for PSMA PET/CT among patients experiencing biochemical recurrence after radical prostatectomy. A new tool to optimize of Patient Selection (2021) (0)
- 471 Risk stratification among men undergoing radical prostatectomy for high-risk prostate cancer in a U.S. cohort: An EMPaCT validation study (2013) (0)
- 267 Long term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: Results of a single institution series with a minimum follow-up of 5 years (2014) (0)
- Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level (2022) (0)
- Pathological features and predictors of oncologic outcomes in patients with small renal masses (2020) (0)
- Stage-migration and survival of lymph node positive prostate cancer patients: A comprhensive trend analyses of surgically treated men over the last two decades (2018) (0)
- 862 THE VALUE OF COMPUTED TOMOGRAPHY IN DETECTING PROSTATE CANCER LYMPH NODE METASTASIS IS NEGLIGIBLE EVEN IN CONTEMPORARY PATIENTS WITH VERY HIGH RISK OF NODAL INVOLVEMENT (2011) (0)
- Do performance characteristics of multi-parametric MRI of the prostate change according to patient age? Clinical implications for age-tailored biopsy approaches (2019) (0)
- 508 Association of cigarette smoking and smoking cessation with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer (2015) (0)
- MP58-12 VENOUS TUMOUR THROMBUS IN RENAL CELL CARCINOMA: LOCALLY ADVANCED OR METASTATIC DISEASE? (2023) (0)
- Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy (2022) (0)
- MP72-14 CLINICAL LYMPHADENOPATHY (CN+) IN RADICAL CYSTECTOMY(RC)PATIENTS: A TRANSATLANTIC COLLABORATION (2015) (0)
- 2233 AN INITIAL SERUM PSA LEVEL LESS THAN 5 NG/ML AT DIAGNOSIS DOES NOT CORRELATE WITH TUMOR VOLUME IN LOW RISK PROSTATE CANCER PATIENTS. IMPLICATIONS FOR CONSERVATIVE TREATMENTS (2012) (0)
- PERCENTAGE OF POSITIVE CORES STRONGLY INFLUENCES THE RATE OF GLEASON SUM AGREEMENT BETWEEN PROSTATE BIOPSY AND RADICAL PROSTATECTOMY (2009) (0)
- There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy (2019) (0)
- Urological Survey Urological Oncology : Adrenal , Renal , Ureteral and Retroperitoneal Tumors Re : (2015) (0)
- 187 IS [11C]CHOLINE PET/CT RECOMMENDED FOR RESTAGING PROSTATE CANCER PATIENTS AFTER RADICAL PROSTATECTOMY WHEN PSA IS LOWER THAN 1 NG/ML? (2012) (0)
- 928: The Importance of Parental Perspectives in Patients Treated by Feminising Genitoplasty (2007) (0)
- MP23-15 IMPACT OF PREVIOUS TREATMENTS FOR PROSTATE CANCER ON PERIOPERATIVE AND ONCOLOGICAL OUTCOMES IN PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR BLADDER CANCER (2022) (0)
- Survival outcomes of urothelial carcinoma with squamous differentiation versus pure squamous cell carcinoma (2021) (0)
- 577 CAN UNILATERAL PROSTATE CANCER BE PREDICTED? IMPLICATIONS FOR FOCAL THERAPIES (2010) (0)
- Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders (2020) (0)
- Central prostate biopsy revision at referral center is key for correct patient management: Results from a prospective, single center series (2018) (0)
- PD26-04 IS THE ICIQ-SF QUESTIONNAIRE RELIABLE IN PREDICTING QOL OUTCOMES? RESULTS OF A PROSPECTIVE SINGLE-CENTER STUDY (2018) (0)
- MP32-10 COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY IN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION (2019) (0)
- MP58-14 FRAILTY INDEX IN PREDICTING SURGICAL OUTCOMES AFTER PARTIAL NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA (2023) (0)
- Interim results of PEANUT: An open-label, single-arm, phase 2 study evaluating pembrolizumab plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC) (2020) (0)
- WHICH ARE THE PATIENTS AT RISK TO RECUR BEYOND 10 YEARS AFTER RADICAL PROSTATECTOMY (2009) (0)
- Impact of 68Ga-PSMA PET/CT and metastasis-directed therapy on clinical recurrence in patients with biochemical recurrence after radical prostatectomy. results from a single center series (2022) (0)
- MP62-05 SYSTEMATIC ASSESSMENT OF POSITIVE SURGICAL MARGINS FEATURES IN OPEN VS. ROBOT ASSISTED RADICAL PROSTATECTOMY: IS THERE A DIFFERENCE? (2015) (0)
- When is neoadjuvant androgen deprivation therapy beneficial for highly aggressive prostate cancer before radical prostatectomy? Implications for multi-modal tailored approaches and trials design (2022) (0)
- 530 OUTCOME OF PATIENTS WITH PSA ≥ 50 NG/ML TREATED WITH A MULTIMODAL APPROACH: A SINGLE INSTITUTION SERIES OF 104 PATIENTS (2009) (0)
- MP22-16 LONG-TERM OUTCOMES AND PATTERNS OF RECURRENCE IN PATIENTS WITH CLINICAL LYMPHADENOPATHIES UNDERGOING RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT (2019) (0)
- 1474 PT3-PROSTATE CANCER-POSITIVE SURGICAL MARGIN AT BLADDER NECK IS AN INDEPENDANT PREDICTOR OF LOCAL FAILURE AND PROSTATE CANCER MORTALITY: RESULTS OF A PROSPECTIVE SINGLE INSTITUTION SERIES (2011) (0)
- 255 The impact of prostate gland volume on prostate cancer detection by means of extended needle biopsy and re-biopsy (2004) (0)
- 609 Are all pathologic Gleason scores 8 created equal? Implications for the applicability of new prostate cancer grading system (2016) (0)
- 183 Pelvic lymph-nodal irradiation improves biochemical relapse-free survival of node-negative patients treated with high-dose salvage radiotherapy after radical prostatectomy. A single-institute analysis of 206 patients (2013) (0)
- Prostate Cancer: Localized: Radiation TherapyMP14-10 DETRIMENTAL ROLE OF PRE-PROSTATECTOMY NEOADJUVANT ANDROGEN DEPRIVATION IN NODE-NEGATIVE PATIENTS TREATED WITH ADJUVANT RT (2016) (0)
- Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations (2023) (0)
- 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-risk Prostate Cancer Patients: a Prospective Pilot Trial (2021) (0)
- Differences in survival of clear cell metastatic renal cell carcinoma patients according to partial vs. radical nephrectomy (2023) (0)
- Assessment of other‐cause mortality in localized renal cell carcinoma patients within 15 years: A population‐based analysis (2020) (0)
- A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology (2022) (0)
- PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY AFTER RADICAL NEHRECTOMY OF NEPHROMETRY SCORES: DISCORDANCE RATES AND OVERTREATMENT RISK (2022) (0)
- The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy (2022) (0)
- PD60-11 IMPACT OF THE TIME ELAPSED BETWEEN PROSTATE BIOPSY AND SURGERY ON THE ACCURACY OF THE BRIGANTI NOMOGRAM PREDICTING LYMPH NODE INVASION IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER (2022) (0)
- Is robotic transperitoneal partial nephrectomy safe in the management of cystic renal cell masses? Outcomes of an ERUS multicenter study including 216 patients (2021) (0)
- A novel nomogram to identify patients with lymph node metastases in the extended lymph node dissection area at radical cystectomy (2019) (0)
- The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer (2020) (0)
- 1390: Number of Positive Cores does not Improve Ability in Predicting Pathological Stage and Biochemical Recurrence (BCR) (2006) (0)
- PIONEER’s operational definitions: Harmonising clinical characteristics and phenotypes data of prostate cancer patients (2020) (0)
- Frailty status predicts worse postoperative and long-term oncologic outcomes in patients treated with partial nephrectomy for small renal masses (2022) (0)
- PD59-04 APPLICATION OF THE KEYNOTE-564 TRIAL RESULTS TO REAL LIFE POPULATION: WHICH PATIENTS WITH ADVANCED KIDNEY CANCER SHOULD RECEIVE ADJUVANT PEMBROLIZUMAB (2022) (0)
- PD55-12 INCREMENTAL UTILITY OF MP-MRI PERFORMED BEFORE CONFIRMATORY BIOPSY IN REDUCING THE RISK OF PROGRESSION DURING ACTIVE SURVEILLANCE FOR MEN WITH LOW RISK PROSTATE CANCER: IS IMAGING ALWAYS USEFUL? (2019) (0)
- Assessing the role of frailty status on surgical, oncologic and functional outcomes in patients treated with robot-assisted radical prostatectomy for prostate cancer (2022) (0)
- Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer. (2014) (0)
- 938 When should a positive surgical margin (SM) ring a bell? An analysis of a multi-institutional Robotic-Assisted Laparoscopic radical Prostatectomy (RALP) database (2015) (0)
- 770 A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS (2012) (0)
- Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints. (2021) (0)
- Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages (2023) (0)
- 358 DOES INCREASING THE NODAL YIELD IMPROVE OUTCOMES IN PATIENTS WITHOUT NODAL METASTASIS AT RADICAL PROSTATECTOMY (2013) (0)
- 917 WHAT IS THE AGE LIMIT FOR RADICAL THERAPY IN PROSTATE CANCER PATIENTS? ANALYSIS ON PATIENT SURVIVAL (2010) (0)
- MP70-08 FOCAL THERAPY FOR PROSTATE CANCER: DO APICAL LESIONS CORRELATE WITH WORSE OUTCOMES? (2020) (0)
- Impact of neoadjuvant immune-checkpoint inhibitor on intra and post operative outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy (2023) (0)
- Adjuvant chemotherapy improves survival outcomes in patients treated with neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Results of a multi-institutional collaboration (2019) (0)
- Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of clinical tumour size on postoperative renal function (2020) (0)
- MP55-07 THE EFFECT OF ANNUAL HOSPITAL VOLUME (AHV) ON PERIOPERATIVE OUTCOMES AFTER URETHROPLASTY (2019) (0)
- 801 The impact of insurance status on tumor characteristics and treatment selection in contemporary prostate cancer patients (2015) (0)
- MP45-13 ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2022) (0)
- PD32-09 VERY LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR NODE POSITIVE PROSTATE CANCER: A MULTI-INSTITUTIONAL, CONDITIONAL SURVIVAL ANALYSIS (2015) (0)
- What are the barriers and facilitators to prescribing and instilling immediate post-operative instillations of chemotherapy in non-muscle-invasive bladder cancer (NMIBC) patients? A theory informed, multi centre qualitative study (2020) (0)
- THE 2002 AJCC PATHOLOGICAL T2 SUBSTAGES CONFER NO PROGNOSTIC INFORMATION ON THE RATE OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS WITH PATHOLOGICALLY ORGAN CONFINED DISEASE AT RADICAL PROSTATECTOMY (2006) (0)
- 634 In high-risk prostate cancer, prognostic factors predict cancer related death in a time-dependent fashion following surgery: A multi-institutional competing risk analysis (2014) (0)
- 373 PATHOLOGICAL NODAL STAGING SCORE FOR PROSTATE CANCER: A TOOL TO ADDRESS ADEQUATE NODAL DISSECTION IN MEN TREATED WITH RADICAL PROSTATECTOMY (2013) (0)
- PD12-07 PREOPERATIVE FRAILTY PREDICTS ADVERSE SHORT-TERM POST-OPERATIVE OUTCOMES IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY (2021) (0)
- 928 – Association between early urinary continence and erectile function recovery after robot-assisted radical prostatectomy: Development of a novel postoperative risk score to optimize patient counseling and follow-up (2017) (0)
- TIMING OF SALVAGE RADIATION THERAPY AND USE OF CONCOMITANT HORMONAL THERAPY FOR PATIENTS WITH PSA RISING AFTER RADICAL PROSTATECTOMY: A LONG‐TERM SURVIVAL ANALYSIS: PD72‐03 (2017) (0)
- 644 Very long term outcomes of radical prostatectomy in patients with clinically localized prostate cancer. Results from a single institution series (2015) (0)
- 566 Impact of holmium laser enucleation (Holep) versus trans-urethral resection (TURP) of the prostate on sexual function: Results of a prospective multicentric randomized trial (2004) (0)
- PD-0462: Post-prostatectomy WPRT does not increase the risk of second cancers: A single institution analysis of 953 patients (2013) (0)
- Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis. (2021) (0)
- Race/ethnicity is an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients (2021) (0)
- Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey (2015) (0)
- 354 CLINICAL OUTCOME AND FACTORS PREDICTING CANCER SPECIFIC SURVIVAL OF PATIENTS WITH PTO DISEASE FOLLOWING RADICAL CYSTECTOMY (2007) (0)
- 1258: Normative Androgens Values Throughout the Menstrual Cycle in Healthy Fertile Women with Normal Sexual Function (2005) (0)
- Bibliometric analysis of academic journal recommendations and requirements for surgical and anesthesiologic adverse events reporting. (2023) (0)
- V5 Robot-assisted adrenalectomy in case of bulky pheochromocytoma (2016) (0)
- Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients (2021) (0)
- Incidental prostate cancer (pT1a-pT1b) detection at BPH surgery in the modern era - are we modifying the detection rate? (2017) (0)
- Partial nephrectomy in frail patients: Effect of surgical approach on complications and health-care expenditures (2021) (0)
- 83 IDENTIFYING THE BEST CANDIDATES FOR PENILE PHARMACOLOGICAL REHABILITATION AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2010) (0)
- Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches (2020) (0)
- Radical cystectomy in pathological T4a and T4b patients: Is there any space for sub stratification? (2018) (0)
- 1738P Three-year follow-up update and survival outcomes of the PURE-01 study (2022) (0)
- P098 Intermediate and long-term survival rates of high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymphadenectomy (2013) (0)
- PD12-04 THE EFFECT OF AGE AT DIAGNOSIS ON PROSTATE CANCER MORTALITY: A GRADE-FOR-GRADE AND STAGE-FOR-STAGE ANALYSIS (2014) (0)
- MP48-19 STAGE AND CANCER SPECIFIC MORTALITY DIFFERS WITHIN SPECIFIC ASIAN ETHNIC GROUPS IN UPPER TRACT UROTHELIAL CARCINOMA (2021) (0)
- The key role of PSA doubling time in patients treated with salvage radiation therapy after radical prostatectomy: Implications for the extent of radiation and the concomitant use of hormonal therapy (2021) (0)
- Utility of pre- and post-pembrolizumab (Pembro) Vesical Imaging–Reporting and Data System (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): An analysis of the PURE-01 cohort (2023) (0)
- 761 How to expand the indication criteria for active surveillance without compromising cancer control. The importance of the extent of biopsy sampling (2012) (0)
- MP40-14 ARE EAU RISK GROUPS RELIABLE IN THE STRATIFICATION OF MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND RESTAGED WITH PSMA-PET? (2023) (0)
- Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. (2021) (0)
- Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient stratification for tailored post-operative treatments (2020) (0)
- MP84-13 A NEW APPROACH FOR AN IMPROVED PSA DOUBLING TIME COMPUTATION FOR SELECTING PATIENTS CANDIDATE TO TIMELY SALVAGE RADIOTHERAPY FOR A BIOCHEMICAL RECURRENCE AFTER PROSTATECTOMY (2016) (0)
- MORE EXTENSIVE LYMPH NODE DISSECTION AT RADICAL PROSTATECTOMY IS ASSOCIATED WITH IMPROVED OUTCOMES AFTER SALVAGE RADIOTHERAPY FOR RISING PSA AFTER SURGERY: A LONG‐TERM, MULTI‐INSTITUTIONAL ANALYSIS: PD15‐11 (2017) (0)
- MP50-06 SURVIVAL OF TESTICULAR PURE TERATOMA VS. MIXED GERM CELL TUMOR PATIENTS ACROSS ALL STAGES (2023) (0)
- MP82-02 LONG-TERM OUTCOMES OF PATIENTS WITH SEMINAL VESICLE INVASION AT RADICAL PROSTATECTOMY: THE IMPORTANCE OF A MULTIMODAL APPROACH TO INCREASE PATIENT SURVIVAL (2015) (0)
- PD53-10 PREDICTING LIMITED SURVIVAL FOR PATIENTS WITH PENILE CANCER UNDERGOING INGUINAL LYMPH NODE DISSECTION (2021) (0)
- MP67-06 OUTCOMES OF PROSTATE CANCER PATIENTS WITH SEMINAL VESICLE INVASION AT MULTIPARAMETRIC MRI MANAGED WITH RADICAL PROSTATECTOMY. DO ALL PATIENTS REALLY NEED A MULTI-MODAL APPROACH? (2023) (0)
- PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCALIZED PROSTATE CANCER (2023) (0)
- Can pelvic lymph node dissection be omitted at the time of radical prostatectomy in patients with a negative preoperative 68Ga-PSMA PET/CT? The importance of patient risk stratification according to individual risk of lymph node metastases (2022) (0)
- ANDROGEN DEPRIVATION THERAPY VERSUS SKELETAL FRACTURES. THE EFFECT OF TIME DEPENDENT VARIABLES ON OBSERVED RISK (2008) (0)
- PET/CT allows for a reliable assessment of the real nodal burden in clinically node-positive prostate cancer patients candidate for radical prostatectomy: Results from a multi-institutional series (2021) (0)
- MP64-08 99mTC- SESTAMIBI SPECT/CT FOR THE CHARACTERIZATION OF SMALL RENAL MASSES: INITIAL EXPERIENCE FROM a TERTIARY REFERRAL CENTER (2023) (0)
- MP68-17 MANAGEMENT OF PATIENTS DIAGNOSED WITH ANGIOMYOLIPOMA ACCORDING TO EAU GUIDELINES: PROFILE OF SURGICAL ADVERSE EVENTS TO AID CLINICAL DECISION MAKING (2020) (0)
- MP78-05 CHANGING TRENDS IN THE CLINICAL PRESENTATION OF HIGH-RISK PROSTATE CANCER OVER THE LAST 22 YEARS. (2014) (0)
- Which patients should be still considered for late salvage radiotherapy for rising or persistently elevated PSA after radical prostatectomy: Results from a large multi-institutional study (2018) (0)
- The use of ureteral access sheath does not reduce the rate of infectious complications after flexible ureteroscopy and Ho:YAG laser lithotripsy for renal stones (2021) (0)
- MP09-05 DOES THE NEW PROSTATE CANCER GRADING SYSTEM IMPROVE PREDICTION OF CLINICAL RECURRENCE? (2016) (0)
- 687 A competing-risks analysis of survival after alternative treatment modalities for locally advanced prostate cancer patients: A population-based study (2013) (0)
- 897 IS 10-YEAR FOLLOW-UP LONG ENOUGH TO EVALUATE ONCOLOGICAL OUTCOMES OF PATIENTS AFTER RADICAL PROSTATECTOMY? IMPORTANCE OF LONG- TERM ASSESSMENT (2011) (0)
- Oncological outcomes, patterns of recurrence and impact of competing causes of mortality in clinically node-positive prostate cancer patients treated with radical prostatectomy (2022) (0)
- Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance. results from a single institution series (2020) (0)
- Radical cystectomy for bladder cancer in patients previously treated for prostate cancer: Perioperative and oncological outcomes (2022) (0)
- Kidney Cancer: Many Important Advances but Still a Lot to Debate. (2016) (0)
- Reducing the risk of postoperative complications after robot-assisted radical prostatectomy in prostate cancer patients: results of a prospective audit and feedback intervention following the implementation of prospective data collection (2021) (0)
- 185 MODELS ASSESSING THE NEED FOR PELVIC LYMPH NODE DISSECTION CANNOT BE RELIABLY USED IN MEN WITH PROSTATE CANCER PREVIOUSLY TREATED WITH SURGERY FOR BENIGN PROSTATIC ENLARGEMENT (2012) (0)
- MP30-03 POSITIVE PREDICTIVE VALUE OF MPMRI IN MEN UNDER ACTIVE SURVEILLANCE: CAN THE BIOPSY HISTORY INFLUENCE RADIOLOGICAL ASSESSMENT? (2021) (0)
- The role of lymph node dissection in patients undergoing salvage radical prostatectomy for radiation recurrent prostate cancer (2022) (0)
- IMPACT OF REVERSE STAGE MIGRATION ON THE OUTCOME OF NODE POSITIVE PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A LARGE, TWO‐CENTER EXPERIENCE: MP97‐07 (2017) (0)
- How to follow patients with negative targeted prostate biopsy but positive multi-parametric MRI? Results from a large, single institution series (2021) (0)
- MULTIPARAMETRIC MRI REPRESENTS AN ADDED VALUE BUT NOT A SUBSTITUTE OF FOLLOW‐UP BIOPSIES IN PATIENTS ON ACTIVE SURVEILLANCE FOR LOW‐RISK PROSTATE CANCER: MP77‐20 (2017) (0)
- PD05-01 THE OBESITY PARADOX IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (2021) (0)
- What is the definition of misclassification in patients with grade group 2 prostate cancer eligible for active surveillance and diagnosed with MRI targeted biopsy? A multi-institutional analysis with pathological confirmation (2021) (0)
- The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Letter. (2021) (0)
- MP15-10 THE ROLE OF LYMPH NODE DISSECTION IN PATIENTS UNDERGOING SALVAGE RADICAL PROSTATECTOMY (2021) (0)
- 664 IMPACT OF ADJUVANT RADIOTHERAPY ON CANCER SPECIFIC SURVIVAL OF PATIENTS WITH SEMINAL VESICLE INVASION AND NODE POSITIVE DISEASE. RESULTS OF A MATCHED-ANALYSIS (2010) (0)
- POD-03.02 Prognostic Factors for Locally Advanced Prostate Cancer: A Multi-Center Experience (2011) (0)
- Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter. (2022) (0)
- The diagnostic issue of variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? (2022) (0)
- P097 Revision of the definition of high-risk prostate cancer (PCa): cT2c remains an independent risk factor (2013) (0)
- CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IS FEASIBLE IN MEN WITH HORMONE‐NAIVE, METASTATIC PROSTATE CANCER (MPCA).: MP53‐19 (2017) (0)
- A prospective, randomized, phase 3 trial assessing the impact of Early Dorsal Venous Complex (EDVC) ligation on urinary continence recovery after robot-assisted radical prostatectomy. results of an interim analysis on early post-operative outcomes (2020) (0)
- MP46-11 LONG-TERM ONCOLOGIC OUTCOMES OF ROBOT-ASSISTED RADICAL CYSTECTOMY: UPDATE SERIES FROM A HIGH-VOLUME ROBOTIC CENTER BEYOND 10 YEARS OF FOLLOW-UP (2023) (0)
- 552 Predicting the 5-year risk of biochemical relapse after post-prostatectomy radiotherapy in ≥pT2 patients with a comprehensive radiobiological model (2016) (0)
- Can multiparametric MRI improve our ability to predict early biochemical recurrence after radical prostatectomy in contemporary patients? results from a multi-institutional analysis (2020) (0)
- 841 THE VALUE OF COMPUTED TOMOGRAPHY IN DETECTING PROSTATE CANCER LYMPH NODE METASTASIS IS LIMITED EVEN IN CONTEMPORARY PATIENTS WITH VERY HIGH RISK OF NODAL INVOLVEMENT (2011) (0)
- Are the results of the ProtecT trial applicable to contemporary prostate cancer patients treated at two high-volume European Institutions? (2017) (0)
- 365 IDENTIFYING PATIENTS AT REAL RISK OF DYING FROM PROSTATE CANCER. A NOVEL RISK SCORE FOR THE SELECTION OF CANDIDATES FOR ADJUVANT RADIATION THERAPY (2012) (0)
- 136: The Effect of Competing Mortality on Prostate Cancer (PCA)-Specific Survival and Rate of Metastatic Disease after Radical Prostatectomy (RP) (2006) (0)
- MP60-04 IMPACT OF PRE-OPERATIVE HEMOGLOBIN VALUES AND PERI-OPERATIVE BLOOD TRANSFUSION ON CANCER SPECIFIC AND OVERALL MORTALITY AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: RESULTS FROM A SINGLE INSTITUTION COHORT (2014) (0)
- Negative histology after salvage lymph node dissection for patients with PET/CT documented lymph node recurrence from prostate cancer: False positive findings or missed disease (2018) (0)
- The importance of the size of nodal metastases in predicting recurrence of node positive prostate cancer patients treated with radical prostatectomy and extended pelvic lymph node dissection: Implications for post-operative treatment tailoring (2018) (0)
- 451 Biochemical recurrence after radical prostatectomy: Who is at risk of dying from prostate cancer? (2015) (0)
- 882 Determining the optimal tumor volume cut-off for prediction of biochemical recurrence after radical prostatectomy in high-risk prostate cancer patients (2012) (0)
- 301 When to perform preoperative bone scan for kidney cancer staging (2016) (0)
- 68Ga-PSMA PET radiomics for the prediction of post-surgical ISUP grade in primary prostate cancer patients (2023) (0)
- Development and Validation of the First AJCC Compliant Clinical Staging System for Localized Prostate Cancer: Results from a Multicenter International Study (2019) (0)
- Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma (2023) (0)
- PD37-06 CAN WE PREDICT LATE RECURRENCES AFTER RADICAL PROSTATECTOMY IN MEN WITH HIGH RISK PROSTATE CANCER? A VERY LONG TERM ANALYSIS FROM A LARGE, MULTI-INSTITUTIONAL ANALYSIS (2016) (0)
- 1009 CUMULATIVE NUMBER OF HIGH-RISK FACTORS IS HIGHLY PREDICTIVE OF CANCER-RELATED OUTCOMES AND OVERALL SURVIVAL IN PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER (2010) (0)
- MP82-07 DOES LOCAL TREATMENT OF THE PRIMARY TUMOR IMPROVE SURVIVAL OF METASTATIC PROSTATE CANCER PATIENTS? RESULTS FROM A POPULATION-BASED STUDY. (2015) (0)
- PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS (2023) (0)
- Stratification of high-risk prostate cancer with positive lymph nodes into prognostic groups to predict cancer related death: A European multi-institutional study (2020) (0)
- 1495: Stress Urinary Incontinence and Erectile Dsyfunction in a Prostate Cancer Screening Cohort (2007) (0)
- Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney sparing strategies: an international collaborative study (2021) (0)
- DOES THE INCLUSION OF NON‐INDEX LESIONS AT BIOPSY IMPROVE OUR ABILITY TO PREDICT ADVERSE PATHOLOGIC OUTCOMES AT RADICAL PROSTATECTOMY? IMPLICATIONS FOR TARGETED PLUS SYSTEMATIC BIOPSY SCHEMES: MP03‐04 (2017) (0)
- MP62-20 THE DETECTION OF A PI-RADS 4-5 LESION AT MULTIPARAMETRIC MRI BEFORE CONFIRMATORY BIOPSY IS THE STRONGEST PREDICTOR OF DISEASE PROGRESSION AMONG MEN WITH LOW-RISK PROSTATE CANCER INCLUDED IN AN ACTIVE SURVEILLANCE PROSPECTIVE PROTOCOL (2021) (0)
- MP16-18 SURVIVAL OUTCOMES AFTER RADICAL CYSTECTOMY VERSUS CONSERVATIVE MANAGEMENT FOR T1 HIGH GRADE NON-MUSCLE INVASIVE MICROPAPILLARY BLADDER CANCER: A MULTICENTER COLLABORATION BY THE EUROPEAN ASSOCIATION OF UROLOGY - YOUNG ACADEMIC UROLOGISTS (2021) (0)
- Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach (2020) (0)
- Care pathways for the management of metastatic and castration-resistant prostate cancer in the era of novel therapeutic options: Experience of the EAU guidelines office (2018) (0)
- Prostate Cancer: Localized: Surgical Therapy VIPD43-10 HYPOGONADISM INDEPENDENTLY PREDICTS PATHOLOGICAL GLEASON PATTERN 5 AT THE TIME OF RADICAL PROSTATECTOMY (2016) (0)
- MP38-20 SIMPLIFIED CLINICAL COMORBIDITY INDEX FOR PATIENTS CANDIDATE TO RADICAL CYSTECTOMY (2016) (0)
- 82 IF A PRO-ERECTILE PHARMACOLOGICAL APPROACH IS CONSIDERED AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY, THIS SHOULD BE INITIATED SOON AFTER SURGERY (2010) (0)
- The impact of a positive urine culture before ureteroscopy and laser lithotripsy in patients with ureteral/renal stones: Results from a single centre series (2020) (0)
- Reply by Authors. (2021) (0)
- Assessing the risk of early and late toxicity of post-prostatectomy radiation therapy: A long-term multi-institutional analysis (2017) (0)
- Prostate Cancer Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy (2016) (0)
- QUALITY OF LIFE IN PATIENTS SUBMITTED TO EXTERNAL BEAM RADIOTHERAPY AS ADJUVANT TREATMENT AFTER RADICAL PROSTATECTOMY. PRELIMINARY RESULTS (2006) (0)
- The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study. (2020) (0)
- Development and external validation of a novel model to indentify patients who can avoid systematic prostate biopsy in addition to mp-MRI targeted biopsies: Results from a two-center series (2018) (0)
- Is there a preferential lymph node metastasis pathway in prostate cancer according to the site of the index lesion at multiparametric MRI? A topographic mapping study (2023) (0)
- MP55-19 IMPACT OF HISTOLOGICAL VARIANTS IN NODE POSITIVE PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR BLADDER CANCER (2020) (0)
- NATURAL HISTORY OF PATIENTS TREATED WITH SALVAGE RADIATION THERAPY FOR RISING PSA AFTER RADICAL PROSTATECTOMY: A LONG‐TERM SURVIVAL ANALYSIS: PD72‐05 (2017) (0)
- MP11-09 ADDED VALUE OF RADIOLOGICAL TUMOR STAGE IN PREDICTING EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY WITHIN CLINICAL STAGE: A STAGE-BY-STAGE ANALYSIS (2021) (0)
- The implementation of a prospective standardized postoperative complication system according to the EAU guidelines is associated with a decrease in the rate of adverse postoperative outcomes over time (2020) (0)
- MP69-01 CAN WE CONSIDER PATIENTS WITH LIMITED BIOPSY GLEASON SCORE 3+4 ELIGIBLE FOR ACTIVE SURVEILLANCE? (2014) (0)
- ASSESSMENT OF ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY ACCORDING TO PREOPERATIVE AND POSTOPERATIVE CAPRA RISK SCORES: RESULTS OF A LARGE, TWO‐CENTER EXPERIENCE.: MP47‐14 (2017) (0)
- PO-0708: Reliability and ideal cut-off of PSADT in patients candidate to early salvage radiotherapy after prostatectomy (2013) (0)
- The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort (2022) (0)
- 534: The Predictive Accuracy of the Partin Tables in Men with PSA Values in Excess of 20 NG/ML May be Limited (2006) (0)
- Development of a classification system for reporting postoperative complications in prostate cancer patients treated with robot-assisted radical prostatectomy: A comprehensive analysis based on the EAU guidelines recommendations (2021) (0)
- PD13-07 EVALUATING PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR LOCALISED PROSTATE CANCER: A SYSTEMATIC REVIEW USING THE CONSENSUS-BASED STANDARD FOR THE SELECTION OF HEALTH MEASUREMENT INSTRUMENTS (COSMIN) METHODOLOGY (2021) (0)
- Value of repeated ureterorenoscopy within the first 3 months after endoscopic treatment in upper tract urothelial carcinoma (UTUC) (2018) (0)
- Editorial Comment to Relationship between androgen deprivation therapy and community‐acquired respiratory infections in patients with prostate cancer (2016) (0)
- First repeated biopsy represents the most informative predictor of progression-free survival at 3 years follow-up in patients included in an active surveillance protocol for low-risk prostate cancer (2017) (0)
- 552 LOCALLY ADVANCED (PT3-PT4) RENAL CELL CARCINOMA: COMPARISON OF DIFFERENT PT PROPOSAL OF RECLASSIFICATION (2007) (0)
- Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of MRI-targeted biopsy: A study that challenges the dogma (2022) (0)
- Focal therapy for prostate cancer: do apical lesions correlate with worse outcomes? (2020) (0)
- THE IMPACT OF NUMBER OF LYMPH NODE REMOVED IN THE DETECTION OF LYMPHNODE METASTASIS: A SENSITIVITY CURVE ANALYSIS. (2014) (0)
- 804 Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy (2016) (0)
- Oncologic surveillance for surgically-treated high risk upper tract urothelial carcinoma (2021) (0)
- 214 Prognostic significance of markers of systemic inflammatory response in patients with non-muscle invasive bladder cancer (2016) (0)
- PD39-10 THE ASSOCIATION BETWEEN PSA DENSITY AND THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER ACROSS ALL PIRADS SCORES IN MEN WITH POSITIVE MPMRI. WHEN PSA DENSITY CAN HELP AVOIDING PROSTATE BIOPSY? (2023) (0)
- MP75-18 INITIAL NEGATIVE MULTI-PARAMETRIC MRI WITH CONCOMITANT NEGATIVE BIOPSY (2020) (0)
- Do we really need detailed biopsy assessment of patients with low-risk prostate cancer candidate to active surveillance? A prospective validation of the ISUP recommendations (2019) (0)
- MP05-12 SHOULD WE ROUTINELY RECOMMEND A CENTRAL REVIEW OF MAGNETIC RESONANCE IMAGING OF THE PROSTATE IN MEN WITH POSITIVE MP-MRI? IMPLICATION FOR TARGETED BIOPSIES (2021) (0)
- 635 The impact of time to biochemical recurrence on cancer-specific mortality in patients with high-risk prostate cancer treated with radical prostatectomy: A competing-risks regression analysis (2014) (0)
- Serum Cholinesterase in patients treated with salvage radical prostatectomy for radiation recurrence (2018) (0)
- 99m-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: A phase 2 prospective, single-institution study (2022) (0)
- MP69-15 OUTCOME OF RADICAL PROSTATECTOMY FOR MISCLASSIFIED ACTIVE SURVEILLANCE CANDIDATES (2014) (0)
- DEVELOPMENT AND SPLIT SAMPLE VALIDATION OF AN UPDATED NOMOGRAM PREDICTING THE PROBABILITY OF LYMPH NODE INVASION IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION (2009) (0)
- Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer? (2023) (0)
- Can Bayesian Network empower propensity score estimation from Real World Data? (2023) (0)
- MP08-10 THE INTRODUCTION OF A SURGICAL CHECKLIST FOR THE TRANSURETHRAL RESECTION OF THE BLADDER IMPROVES RECURRENCE-FREE SURVIVAL IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS (2018) (0)
- External validation and head-to-head comparison of all the prognostic models recommended by the European Association of Urology guidelines to predict oncologic outcomes in patients with renal cell carcinoma (2021) (0)
- Five-year trend of blood and urine cultures in a tertiary-referral urology center for hospitalized patients: a real-life study (2022) (0)
- 937 Prognostic value of tumour volume on disease progression of patients treated with radical prostatectomy for node positive prostate cancer (2015) (0)
- There is no way to compensate a non-timely use of early salvage radiation therapy in men with recurrent Prostate Cancer after Radical Prostatectomy. A retrospective, multi-centre analyses on oncological and toxicity outcomes (2021) (0)
- 682 Clinico-dosimetric factors predicting long-term severe urinary incontinence after post-prostatectomy RT: Results of a longitudinal observational study (2016) (0)
- MP37-20 INDIVIDUAL SURGEON COMMITMENT TO PELVIC LYMPH NODE DISSECTION RATHER THAN SURGICAL VOLUME IS A MAJOR DETERMINANT OF THE EXTENT OF NODAL DISSECTION DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY (2014) (0)
- Renal function assessment during follow-up after surgical treatment for renal cell carcinoma (2019) (0)
- Holmium Laser Enucleation of the Prostate is associated with complications and sequelae even in the hands of an experienced surgeon. Results from a prospective series (2023) (0)
- 1016 Are continent urinary diversions feasible at the time of radical cystectomy after pelvic radiotherapy? Analysis of a large retrospective multicenter series (2016) (0)
- PROSTATE VOLUME AT INITIAL BIOPSY IS THE MOST IMPORTANT PREDICTOR OF REPEAT BIOPSY OUTCOME. VALIDATION OF A NOVEL PREDICTIVE TOOL (2006) (0)
- MP41-08 DIAGNOSTIC ACCURACY OF PREOPERATIVE LYMPH NODE STAGING OF BLADDER CANCER: A CONCORDANCE ANALYSIS OF A MULTICENTER COHORT (2021) (0)
- 834 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM TO DETERMINE THE IMPACT OF THE BIOPSY SCHEME ON CANCER DETECTION IN MEN UNDERGOING AN INITIAL PROSTATE BIOPSY (2009) (0)
- MP38-03 DOES PROSTATE CANCER FAMILY HISTORY HAVE AN IMPACT ON ACTIVE SURVEILLANCE ADHERENCE IN MEN WITH LOW- OR FAVOURABLE INTERMEDIATE RISK DISEASE? (2023) (0)
- 969 How to optimize the use of robotic assisted radical prostatectomy: The role of preoperative patient characteristics to identify ideal candidates for minimally invasive approach (2014) (0)
- 2030 HIGH-RISK PROSTATE CANCER PATIENTS WHO HAVE SPECIMEN-CONFINED DISEASE AT PATHOLOGY HAVE EXCEPTIONALLY GOOD OUTCOMES AFTER SURGERY (2010) (0)
- Is there an impact of transperineal vs. transrectal MRI-targeted biopsy on the risk of upgrading and concordance with final pathology in prostate cancer patients undergoing radical prostatectomy? An EAU-YAU study (2023) (0)
- Impact of pre-operative PSMA PET/CT for men with cN0M0 conventional imaging and pN+ prostate cancer: Results from a multicenter study (2023) (0)
- Reply from Authors re: Michael W. Kattan. Classification and Regression Trees Versus Nomograms: A Bone Scan Positivity Example. Eur Urol 2010;57:559-60 (2010) (0)
- A novel pathway to detect Muscle-Invasive Bladder Cancer (MIBC) combining clinical features and preoperative VI-RADS scoring criteria: Results from a prospective multicenter validation analysis (2023) (0)
- 947 A POPULATION-BASED STUDY OF PERIOPERATIVE MORTALITY AFTER RETROPERITONEAL LYMPHADENECTOMY FOR NON SEMINOMATOUS TESTICULAR GERM CELL TUMOURS: CLINICAL IMPLICATIONS FOR INFORMED CONSENT (2009) (0)
- TIME TO CONTINENCE RECOVERY IS AN INDEPENDENT PREDICTOR OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2008) (0)
- 158 Stratification of high-risk prostate cancer into prognostic categories; a European multi-institutional study (2012) (0)
- The effects of 18F-FDG PET/CT on the management and prognosis of patients with bladder cancer (BCa) and upper urinary tract urothelial carcinoma (UTUC) (2017) (0)
- Do we really need detailed biopsy assessment of patients with low-risk prostate cancer candidate to active surveillance? A prospective validation of the ISUP recommendation (2019) (0)
- 688 Predicting prostate cancer specific outcome after radical prostatectomy among men with (very) high-risk, locally advanced PCa with or without additional high risk factors: A multi-institutional retrospective cohort study of 1644 patients (2013) (0)
- Development and external validation of a novel risk score to predict long-term clinical recurrence after radical prostatectomy (2019) (0)
- 799 Thirty years of radical prostatectomies at a single European tertiary care referral center (2015) (0)
- MP11-08 DEVELOPMENT OF A RISK CALCULATOR OF RECURRENCE IN INGUINAL LYMPH-NODE METASTATIC (ILNM) PATIENTS WITH SURGICALLY-RESECTED PENILE SQUAMOUS-CELL CARCINOMA (PSCC) (2020) (0)
- CONDITIONAL SURVIVAL IN ONCOLOGY: A REVIEW. (2017) (0)
- THE ROLE OF NEUTROPHIL‐TO‐LYMPHOCYTE RATIO IN MEN WITH ERECTILE DYSFUNCTION – PRELIMINARY FINDINGS OF A REAL‐LIFE CROSS‐SECTIONAL STUDY: MP81‐15 (2017) (0)
- PURE BUT NOT MIXED HISTOLOGICAL VARIANTS ARE ASSOCIATED WITH POOR SURVIVAL AT RADICAL CYSTECTOMY IN BLADDER CANCER PATIENTS: MP54‐15 (2017) (0)
- 181 CFTR gene polymorphisms are associated with reduced sperm progressive motility in Caucasian-European men with idiopathic infertility: Clinical implication in genetic testing (2016) (0)
- FACTORS PREDICTING DISEASE FREE SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION IN THE PSA ERA: ROLE OF ADJUVANT RADIOTHERAPY (2008) (0)
- PD46-09 HOW TO BALANCE THE RISK OF CANCER SPECIFIC MORTALITY AND OTHER CAUSE MORTALITY IN THE DECISION BETWEEN SURGERY OR OBSERVATION FOR PATIENTS WITH T1 KIDNEY CANCER (2016) (0)
- Validation of preoperative thrombocytosis as adverse prognostic factor in advanced bladder cancer (BCA) after radical cystectomy (RC) (2017) (0)
- IMPACT OF SAMPLING DENSITY ON INITIAL 10 OR MORE (+) CORE PROSTATE BIOPSY: DEVELOPMENT AND INTERNAL VALIDATION OF A 10+ CORES BIOPSY NOMOGRAM (2006) (0)
- PD15-05 WHAT IS THE RISK OF LATE RECURRENCE AND MORTALITY AFTER SALVAGE RADIATION THERAPY FOR POST-PROSTATECTOMY PSA RISING? A LONG-TERM, MULTI-INSTITUTIONAL ANALYSIS (2019) (0)
- 913 The pattern of recurrent prostate cancer in pN+ post radical prostatectomy has independent prognostic capability (2015) (0)
- MP56-04 THE ROLE OF FDG PET IN THE STAGING OF BLADDER CANCER PATIENTS CANDIDATE FOR RADICAL CYSTECTOMY (2022) (0)
- 722: Pathological Characteristics and Stage Migration of Patients with Prostate Cancer and Lymph Node Invasion Undergoing an Extended Pelvic Lymph Node Dissection at a Single Institution Over a 15 Year Period (2007) (0)
- 251 EXCELLENT LONG-TERM OUTCOME OF PATIENTS WITH LOW VOLUME OF LYMPH NODE INVASION TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION AT THE TIME OF RADICAL PROSTATECTOMY (2007) (0)
- EP-1349: Long term results of a phase I-II study of moderate hypofractionated IGRT in prostate cancer (2016) (0)
- Can we predict the site of positive surgical margins based on the site of the index lesion at multiparametric mri? A topographic, single center study (2023) (0)
- PD15-09 PELVIC LYMPH NODE DISSECTION CAN BE SAFELY OMITTED IN MEN WITH A RISK OF NODAL METASTASES ≤5% BASED ON THE BRIGANTI NOMOGRAM: VALIDATION OF THE EAU GUIDELINS RECCOMENDATIONS FOR NODAL DISSECTION BASED ON PATIENT OUTCOME (2014) (0)
- MP75-20 THE RATE OF PIRADS 3 IS NOT A PROXY OF THE QUALITY OF MRI OF THE PROSTATE. RESULTS OF A SINGLE HIGH VOLUME RADIOLOGIST SERIES (2020) (0)
- MP50-14 THE IMPACT OF RACE/ETHNICITY ON UPSTAGING AND/OR UPGRADING RATES AMONG INTEREDIATE RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2021) (0)
- What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institutional series (2020) (0)
- Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. (2023) (0)
- 970 CRITICAL ASSESSMENT OF THE PERFORMANCE OF PSA KINETICS FOR THE PREDICTION OF [11C]CHOLINE PET/CT IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY (2011) (0)
- Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review. (2023) (0)
- in the absence of synchronous metastatic systemic dissem- ination. Accordingly, more accurate risk stratification and surgical planning before nephrectomy may increase local control at initial surgery and diminish unnecessary and potentially harmful surgical procedures during follow-up. (2015) (0)
- PD-0306: Factors influencing urinary incontinence following post-prostatectomy IMRT irradiation. A prospective study (2014) (0)
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer (2018) (0)
- First survival outcomes and additional secondary analyses from PURE-01: Pembrolizumab (Pembro) before radical cystectomy (RC) in muscle-invasive urothelial bladder carcinoma (MIBC) (2019) (0)
- 265: Effect of Autologous Blood Transfusion on Predictive Accuracy of Biochemical Recurrence after Radical Prostatectomy (2006) (0)
- Proposal of a novel procedure-specific classification system for postoperative complications in patients undergoing robot-assisted radical prostatectomy (2018) (0)
- IS SPERM CRYOPRESERVATION BEFORE SURGICAL TREATMENT OF INTEREST IN UROLOGIC CANCER PATIENTS (2008) (0)
- MP03-10 LIFE EXPECTANCY IN METASTATIC UROTHELIAL BLADDER CANCER PATIENTS ACCORDING TO RACE/ETHNICITY (2022) (0)
- RADICAL NEPHRECTOMY WITH OR WITHOUT LYMPH NODE DISSECTION FOR NON‐METASTATIC RENAL CELL CARCINOMA: A MULTI‐INSTITUTIONAL ANALYSIS: MP55‐16 (2017) (0)
- Is the ICIQ-SF questionnaire reliable in predicting QoL outcomes? Results of a prospective single-center study (2018) (0)
- Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference? (2023) (0)
- Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter. (2023) (0)
- Oncologic impact of cumulative smoking exposure in patients treated with salvage radical prostatectomy for radiation-recurrent prostate cancer (2017) (0)
- MP38-11 IS THERE AN IMPACT OF THE CENTER PERFORMING BASELINE MULTIPARAMETRIC MRI ON ACTIVE SURVEILLANCE OUTCOMES IN PROSTATE CANCER PATIENTS? (2023) (0)
- MP11-09 SECOND LINE PSMA-TARGETED SALVAGE TREATMENT IN PATIENTS WITH miN1/M1a-b OLIGORECURRENT PCa (2023) (0)
- PATTERN OF POSITIVE NODE METASTASES IN PATIENTS TREATED WITH EXTENDED AND SUPER EXTENDED PELVIC LYMPH NODE DISSECTION AND RADICAL CYSTECOTMY DUE TO BLADDER CANCER: MP58‐20 (2017) (0)
- 58 Intrafascial technique offers improved functional outcomes in patients treated with bilateral nerve sparing robotic radical prostatectomy (2011) (0)
- MP48-15 EFFECTS OF SILODOSIN ON SEXUAL FUNCTION – REALISTIC PICTURE FROM THE EVERYDAY CLINICAL PRACTICE (2014) (0)
- ACCURATE PREDICTION OF LONG-TERM RISK OF BIOCHEMICAL FAILURE AFTER SALVAGE RADIOTHERAPY INCLUDING THE IMPACT OF PELVIC NODE IRRADIATION. (2022) (0)
- 889: Predictive Accuracy, Sensitivity, and Specificity of Nuclear Matrix Protein 22 and Urine Cytology for Prediction of Recurrence of Non-Transitional Cell Carcinoma of the Bladder (2006) (0)
- Diagnostic performance of PET-CT compared to conventional CT for lymph node staging in bladder cancer patients undergoing radical cystectomy and bilateral pelvic lymph node dissection (2023) (0)
- CHANGES OVER TIME IN NODE POSITIVE PROSTATE CANCER RATES AND FEATURES AMONG MEN TREATED WITH RADICAL PROSTATECTOMY AND EXTENTED PELVIC LYMPH NODE DISSECTION AT A SINGLE REFERRAL CENTER: MP97‐12 (2017) (0)
- MP79-01 EXTERNAL VALIDATION OF THE 2019 BRIGANTI NOMOGRAM FOR THE IDENTIFICATION OF PROSTATE CANCER PATIENTS WHO SHOULD BE CONSIDERED FOR AN EXTENDED PELVIC LYMPH NODE DISSECTION (2020) (0)
- MP82-16 LONG-TERM CLINICAL RECURRENCE RATE IN PROSTATE CANCER (PCA) PATIENTS WITH ADVERSE PATHOLOGICAL CHARACTERISTICS AT ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) (2015) (0)
- 964: Validation of a Nomogram Predicting the Probability of Lymph Node Invasion (LNI) Among Patients Undergoing Radical Prostatectomy (RP) and an Extended Pelvic Lymphadenectomy (PLND) (2006) (0)
- PD60-02 CAN PELVIC LYMPH NODE DISSECTION BE OMITTED AT THE TIME OF RADICAL PROSTATECTOMY IN PATIENTS WITH A NEGATIVE PREOPERATIVE 68GA-PSMA PET/CT? THE IMPORTANCE OF PATIENT RISK STRATIFICATION ACCORDING TO INDIVIDUAL RISK OF LYMPH NODE METASTASES (2022) (0)
- PO-1354 Time Dependence of PSADT prognostic threshold in men treated with post-prostatectomy salvage RT (2021) (0)
- PD17-03 COMPARATIVE ANALYSES OF MICRO-ULTRASOUND VERSUS MRI-TARGETED BIOPSY FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER. PRELIMINARY RESULTS FROM THE PROSPECTIVE US-MIRROR TRIAL (2022) (0)
- Is focal therapy for prostate cancer an attractive option? Results of an international survey from the young academic urologists (YAU) amongst 484 physicians (2018) (0)
- Rehabilitation of sexual function following prostatectomy (2008) (0)
- PD28-07 ASSESSMENT OF THE RATE OF ADHERENCE TO INTERNATIONAL GUIDELINES OF ANDROGEN DEPRIVATION THERAPY WITH EXTERNAL BEAM RADIATION THERAPY- A POPULATION-BASED STUDY (2016) (0)
- MP2-12 PROGNOSTIC IMPACT OF TUMOR STAGE ON POSITIVE LYMPH NODE STATUS IN UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY (2015) (0)
- 1637 SEMINAL VESICLE PRESERVATION DOES NOT IMPROVE FUNCTIONAL OUTCOME OF PATIENTS TREATED WITH BILATERAL NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY (2011) (0)
- PD57-12 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION (2021) (0)
- Regional differences in total hospital costs for radical cystectomy in the United States. (2023) (0)
- Which patients with Oligometastatic Prostate Cancer should be considered for Cytoreductive Radical Prostatectomy as part of a multimodal treatment? Results from a large, multi-institutional collaboration (2021) (0)
- Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma (2019) (0)
- PROSTATE CANCER DETETCTION RATE AT TOTAL PSA- LEVELS BELOW 2.5ng/ml: THE UTILITY OF PERCENT FREE PSA, MEANINGFUL %fPSA CUTOFFS AND THE CLINICAL SIGNIFICANCE OF PROSTATE CANCERS DETECTED (2008) (0)
- MP79-20 ASSESSING THE OPTIMAL TIMING OF POSTOPERATIVE TREATMENTS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH NODE-POSITIVE PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2020) (0)
- What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 Prostate Cancer? Results form a large Multi-Institutional series (2021) (0)
- Long-term outcomes of clinically node-positive prostate cancer patients treated with radical prostatectomy as part of a multimodal treatment: patterns of recurrence and impact on competing-risk mortality (2020) (0)
- Assessing the effect of red blood cell transfusion on the risk of acute kidney injury after nephron-sparing surgery (2022) (0)
- 1116 RADICAL PROSTATECTOMY FOR VERY HIGH RISK T3B/4 PROSTATE CANCER – LONG TERM RESULTS OF A MULTIINSTITUTIONAL EXPERIENCE (2012) (0)
- 609 AGE ADJUSTED VALIDATION OF THE MOST STRINGENT CRITERIA FOR ACTIVE SURVELLIANCE: IMPLICATIONS FOR PATIENT SELECTION (2010) (0)
- Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy (2020) (0)
- MP-04 . 02 Utilizing fractional polynomials to predict post-chemotherapy retroperitoneal lymph node dissection pathology (2016) (0)
- PD61-06 IS CYSTOSCOPIC SPHINCTER EVALUATION A RELIABLE WITNESS BEFORE CONTINENCE SURGERY? A PROSPECTIVE, BLINDED, REAL LIFE, SINGLE CENTRE STUDY (2021) (0)
- MP48-12 OPTIMIZING TIMING AND INDICATIONS FOR 68GA-PSMA PET/CT IN PATIENTS WITH BIOCHEMICAL RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY (2022) (0)
- Characterization of late recurrence after radical cystectomy in a large multicenter cohort of bladder cancer patients (2016) (0)
- 1263: Competing Risks Nomogram Predicting the Probability of Bladder Cancer Recurrence after Cystectomy can Reliably Distinguish between those Destined to Recur and those who May Die of Other Causes before Recurrence (2006) (0)
- 437 Detrimental role of pre-prostatectomy neoadjuvant androgen deprivation in node-negative patients treated with adjuvant RT (2016) (0)
- MP63-20 DEVELOPMENT AND EXTERNAL VALIDATION OF A PATHOLOGICAL NODAL STAGING SCORE FOR PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA (2015) (0)
- OC-0321: Impact of urinary symptoms and incontinence on anxiety and depression 1 year after postprostatectomy radiotherapy (2015) (0)
- MP14-07 PATTERNS AND PREDICTORS OF CLINICAL RECURRENCE FOLLOWING EARLY SALVAGE RADIATION THERAPY IN PATIENTS WITH PSA RISE AFTER RADICAL PROSTATECTOMY: A LONG TERM MULTI-INSTITUTIONAL ANALYSIS (2016) (0)
- Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer (MIBC) reveals unique features that may inspire new seguential therapies in pathologically-nonresponders (2020) (0)
- MP61-12 WHICH MEN WITH CN1 PROSTATE CANCER AT PSMA PET/CT REPRESENT THE IDEAL CANDIDATE TO RADICAL PROSTATECTOMY? DEVELOPMENT OF A NOVEL RISK STRATIFICATION TOOL FOR INDIVIDUALIZED APPROACHES BASED ON A LARGE, MULTI-INSTITUTIONAL SERIES (2023) (0)
- Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362. (2022) (0)
- Which patients with clinically node positive prostate cancer should be considered as candidates for radical prostatectomy as part of a multimodal treatment? The impact of nodal burden (2019) (0)
- 675 TIME TO BIOCHEMICAL RECURRENCE IS A STRONG AND INDEPENDENT PREDICTOR OF CSS AND OS IN HIGH-RISK PROSTATE CANCER (2011) (0)
- Pathological findings at radical prostatectomy after initial active surveillance in low-risk prostate cancer patients. Did we miss the chance to cure? (2017) (0)
- Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy (2018) (0)
- 1468 INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION (2011) (0)
- 967 The impact of robotic-assisted radical prostatectomy on pelvic lymph node dissection and perioperative outcomes in patients with high-risk prostate cancer (2014) (0)
- Validation of pre-treatment risk stratification parameters according to EAU Guidelines on upper tract urothelial carcinoma (UTUC) (2018) (0)
- MP78-15 BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: WHO IS AT RISK OF DYING FROM PROSTATE CANCER? (2015) (0)
- Does the inclusion of non-index lesions at biopsy improve our ability to predict adverse pathologic outcomes at radical prostatectomy? Implications for targeted plus systematic biopsy schemes (2017) (0)
- Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis. (2017) (0)
- Adrenal Lesions: Progress on All Fronts. (2016) (0)
- GLEASON SCORE UPGRADING AT TIME OF PATHOLOGICAL GLEASON SCORE OCCURS MORE FREQUENTLY IN EXTERNAL BASED BIOPSIES THAN IN UNIVERSITY-BASED BIOPSIES (2006) (0)
- P099 Defining the real high-risk prostate cancer patient: Sub-stratification into three prognostic groups (2013) (0)
- MP51-07 THE PROGNOSTIC VALUE OF THE NUMBER OF POSITIVE TARGETED CORES IN MEN WITH POSITIVE MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE. RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2022) (0)
- CAN WE MODULATE THE EXTENT OF NODAL DISSECTION ACCORDING TO THE PREOPERATIVE RISK OF LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY?: MP97‐10 (2017) (0)
- Clinical benefit and cost-effectiveness of a biopsy-all strategy in patients diagnosed with renal mass: Simulation of a randomized controlled trial (2023) (0)
- MP40-14 PREDICTORS OF CANCER-SPECIFIC SURVIVAL AFTER DISEASE RECURRENCE IN PATIENTS WITH RENAL CELL CARCINOMA: THE EFFECT OF TIME TO RECURRENCE (2014) (0)
- The association of type and number of high‐risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy (2022) (0)
- No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: interim results from the PURE01 study (2020) (0)
- The effect of anatomical location of retroperitoneal lymph node metastases on cancer specific survival in patients with clear cell renal cell carcinoma (2017) (0)
- 474 Pathologic nodal staging scores (pNSS) for prostate cancer: A decision tool for adjuvant therapy after radical prostatectomy (2013) (0)
- 1742 OUTCOME OF PATIENTS POTENTIALLY SUITABLE FOR ACTIVE SURVEILLANCE UNDERGOING RADICAL PROSTATECTOMY AS FIRST TREATMENT CHOICE. RESULTS OF INTERMEDIATE-TERM FOLLOW-UP (2010) (0)
- MP79-02 PERFORMANCE CHARACTERISTICS OF PET/CT SCAN IN MEN TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER: A PER PATIENT ANALYSIS WITH PATHOLOGICAL CONFIRMATION ACCORDING TO EACH AREA OF DISSECTION (2020) (0)
- PREDICTING LOCAL FAILURE AFTER RADICAL CYSTECTOMY IN BLADDER CANCER PATIENTS: IMPLICATIONS FOR THE SELECTION OF CANDIDATES AT ADJUVANT RADIATION THERAPY: MP58‐09 (2017) (0)
- 185 Reliability and ideal cut-off of PSA doubling time in patients candidate to timely salvage radiotherapy for a biochemical recurrence after prostatectomy (2013) (0)
- Mp14-19 the Time Elapsed Between Radical Prostatectomy and Post-Operative Radiotherapy Has a Significant Impact on the Subsequent Erectile Function Recovery Rates (2016) (0)
- MP78-12 ASSOCIATION OF CIGARETTE SMOKING AND SMOKING CESSATION WITH BIOCHEMICAL RECURRENCE IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER (2015) (0)
- 468 Cancer volume is an independent predictor for biochemical progression and clinical failure in high-risk prostate cancer patients following radical prostatectomy : A single centre experience (2013) (0)
- PD66-09 ACCURATE PREDICTION OF PROGRESSION TO MUSCLE INVASIVE DISEASE IN PATIENTS WITH T1G3 BLADDER CANCER: A CLINICAL DECISION-MAKING TOOL (2018) (0)
- 828 CAN WE PREDICT LYMPHORRHEA AND CLINICALLY SIGNIFICANT LYMPHOCELES AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2010) (0)
- 263 Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy among patients with lymph node metastases from prostate cancer (2014) (0)
- MP37-17 CHANGING PATTERNS AND PREDICTORS OF SALVAGE RADIATION THERAPY USE OVER TIME IN PATIENTS TREATED FOR POST-PROSTATECTOMY BIOCHEMICAL RECURRENCE: A TREND ANALYSIS OVER A 20-YEAR PERIOD FROM A MULTI-INSTITUTIONAL SERIES (2020) (0)
- MP43-19 DROP-OUT RATES FROM ACTIVE SURVEILLANCE FOR DISEASE PROGRESSION REMAIN CONSISTENT AND NOT NEGLIGIBLE OVER TIME. A PLEA FOR LONG-TERM ASSESSMENT BASED ON A LARGE, PROSPECTIVELY COLLECTED ACTIVE SURVEILLANCE COHORT (2022) (0)
- MP42-13 RISK STRATIFICATION AMONG MEN UNDERGOING RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER IN U.S. COHORT: AN EMPACT STUDY (2014) (0)
- In reply to the letter to the editor 'in Reply to Gandaglia et al.' by De Bari et al. (2014) (0)
- MP50-09 IMAGING INTENSITY AFTER SURGERY FOR CLEAR CELL RENAL CELL CARCINOMA (2022) (0)
- 396 Impact of stage migration on bladder cancer: A slow but steady improvement in the long term survival rates after radical cystectomy in the last 25 years (2016) (0)
- 231 Partial urethral outflow obstruction alters spontaneous peristaltic ureter activity in vivo in rats (2012) (0)
- Re: Pawel Rajwa, Takafumi Yanagisawa, Manuel Gruber, et al. Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-review. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.013. (2022) (0)
- Association between the extent of lymph node dissection and severe toxicity in men with prostate cancer treated with post-prostatectomy radiation therapy: results from a large multi-institutional series (2020) (0)
- PD05-09 PET/CT ALLOWS FOR A RELIABLE ASSESSMENT OF THE REAL NODAL BURDEN IN CLINICALLY NODE-POSITIVE PROSTATE CANCER PATIENTS CANDIDATE FOR RADICAL PROSTATECTOMY: RESULTS FROM A MULTI-INSTITUTIONAL SERIES (2021) (0)
- WHICH PATIENTS ARE AT REAL HIGH RISK FOR DYING FROM PROSTATE CANCER? A LONG-TERM FOLLOW-UP ANALYSIS ON HIGH RISK PROSTATE CANCER PATIENTS TREATED IN THE PSA ERA (2009) (0)
- Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma. (2022) (0)
- 294 IN HIGH-RISK PROSTATE CANCER, 3 OR MORE POSITIVE NODES AT RADICAL PROSTATECTOMY REPRESENT AN INDEPENDENT PREDICTOR OF WORSE CSS, WHILE 1 OR 2 POSITIVE NODES DO NOT INFLUENCE CSS (2014) (0)
- Impact of bilateral neurovascular bundle preservation on oncological outcomes in non-organ confined prostate cancer patients (2019) (0)
- 930 AGE ADJUSTED VALIDATION OF THE MOST STRINGENT CRITERIA FOR ACTIVE SURVELLIANCE: IMPLICATIONS FOR PATIENT SELECTION (2010) (0)
- Should we target all visible areas at mp-MRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series (2020) (0)
- MP4-16 PATTERNS OF CLINICAL RECURRENCE AND IMPACT OF SITE OF METASTASIS ON MORTALITY OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION (2015) (0)
- Prostate Cancer: Localized VIModerated Poster 451552 PREDICTING FAVOURABLE PATHOLOGICAL OUTCOME IN PATIENTS WITH CLINICAL HIGH RISK PROSTATE CANCER. A NOVEL NOMOGRAM BASED ON A MULTI-INSTITUTIONAL ANALYSIS (2010) (0)
- PD57-02 WHEN IS MP-MRI RELIABLE IN PREDICTING EXTRA-PROSTATIC EXTENSION IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2020) (0)
- Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States. (2023) (0)
- More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes after salvage radiotherapy for rising PSA after surgery: A long-term, multi-institutional analysis (2017) (0)
- IDENTIFYING THE OPTIMAL CANDIDATE FOR EARLY SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A LONG‐TERM MULTI‐INSTITUTIONAL ANALYSIS: PD51‐02 (2017) (0)
- PD45-10 IMPACT OF CLINICAL TUMOR STAGE AND PREOPERATIVE PSA-VALUE ON CANCER SPECIFIC SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH GLEASON 9-10 ON PROSTATE BIOPSY. (2019) (0)
- 772 PREDICTORS OF LONG-TERM SURVIVAL OF PATIENTS WITH HIGH VOLUME OF NODAL METASTASES AT EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER. THE IMPORTANCE OF AN INTEGRATED, MULTIMODAL APPROACH (2012) (0)
- 115 THE ACCURACY OF THE PERCENTAGE OF POSITIVE CORES IN PREDICTING ADVANCED PROSTATE CANCER DOES NOT CHANGE ACCORDING TO THE EXTENT OF BIOPSY SCHEME (2010) (0)
- The role of percentage of PSA reduction after focal therapy using high intensity focused ultrasound for primary localized prostate cancer. Results from a large multinstitutional series (2020) (0)
- 623 Impact on anxiety and depression of urinary symptoms and incontinence after postprostatectomy radiotherapy in the first year after treatment (2015) (0)
- ASSESSING THE RISK OF EARLY AND LATE TOXICITY OF POST‐PROSTATECTOMY RADIATION THERAPY: A LONG‐TERM MULTI‐INSTITUTIONAL ANALYSIS: PD72‐10 (2017) (0)
- Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.012: Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion? (2021) (0)
- ASSESSING THE 20‐YEAR OUTCOMES OF RADICAL PROSTATECTOMY FOR HIGH RISK PROSTATE CANCER: RESULTS FROM A LARGE, MULTI‐INSTITUTIONAL SERIES: PD51‐08 (2017) (0)
- No impact on disease recurrence or progression of the stage at re-TUR in Ta high-grade bladder cancer patients treated with BCG: A multi-center collaboration of EAU Young Academic Urologists Urothelial Carcinoma Group (2020) (0)
- 203: Effect of Surgical Margins on Cancer Control Outcomes after Radical Prostatectomy. When do Margins Matter? (2006) (0)
- The current role of renal tumor biopsy in small renal masses: long-term results from a prospective, single-institutional database (2022) (0)
- 325: Lymph Node Invasion in Prostate Cancer patients with PSA <10 ng/ml: Which Patients Deserve a Pelvic Lymph Node Dissection? (2007) (0)
- TIME FROM PROSTATE BIOPSY TO RADICAL PROSTATECTOMY REPRESENTS AN INDEPENDENT PREDICTOR OF PROSTATE CANCER SIGNIFICANT UPGRADING (2009) (0)
- 962 TESTING THE MOST STRINGENT CRITERIA FOR ACTIVE SURVEILLANCE: AN ANALYSIS BASED ON PATHOLOGICAL FEATURES AT RADICAL PROSTATECTOMY (2009) (0)
- MP33-08 PROSTATE CANCER TREATMENT OPTIONS: A CONTEMPORARY WORLDWIDE TREND ANALYSIS (2019) (0)
- 932 THERE IS NO WAY TO IDENTIFY PATIENTS WHO WILL HARBOR PT2A PROSTATE CANCER AT RADICAL PROSTATECTOMY. IMPLICATIONS FOR FOCAL THERAPIES (2010) (0)
- Development of a composite biomarker-based calculator to predict the probability of pathologic complete response (pT0) after neoadjuvant pembrolizumab (pembro) in muscle invasive bladder cancer (MIBC). (2020) (0)
- 624 Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? (2015) (0)
- THE NUMBER OF BIOPSY CORES REPRESENTS ONE OF THE FOREMOST PREDICTOR OF CLINICALLY SIGNIFICANT GLEASON SUM UPGRADING IN LOW RISK PROSTATE CANCER PATIENTS (2009) (0)
- Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505-16. (2023) (0)
- PD60-03 THE IMPACT OF HISTOLOGICAL VARIANTS ON THE PERFORMANCE CHARACTERISTICS OF 68GA-PSMA PET/CT IN THE PRIMARY AND RECURRENT SETTING (2022) (0)
- Which positive surgical margins features impact on the risk of prostate cancer specific mortality? A disease-tailored, competing-risk, long-term analysis (2019) (0)
- Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence (2023) (0)
- PD17-08 COMPARING THE DIAGNOSTIC ACCURACY OF 68GA-PSMA AND 11C-CHOLINE PET/CTSCAN ACCORDING TO PSA LEVEL: A LARGE MULTI-INSTITUTIONAL ANALYSIS WITH HISTOLOGICAL VERIFICATION IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER (2019) (0)
- Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution Series. (2023) (0)
- PD36-04 UTILITY OF PRE- AND POST-PEMBROLIZUMAB VESICAL IMAGING – REPORTING AND DATA SYSTEM (VIRADS) TO PREDICT THE PATHOLOGICAL RESPONSE IN MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER (MIBC): AN ANALYSIS OF THE PURE-01 COHORT (2023) (0)
- PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES (2016) (0)
- 48 Development of the first model of radical prostatectomy in mouse: A feasibility study with biochemical validation (2016) (0)
- MP24-06 THE IMPACT OF INSURANCE STATUS ON TUMOR CHARACTERISTICS AND TREATMENT SELECTION IN CONTEMPORARY PROSTATE CANCER PATIENTS (2015) (0)
- MP78-05 MEDIUM TERM ONCOLOGICAL OUTCOMES IN A LARGE COHORT OF MEN TREATED WITH EITHER FOCAL- OR HEMI-ABALTION WITH HIFU FOR PRIMARY LOCALIZED PROSTATE CANCER (2019) (0)
- MORE EXTENSIVE BIOPSY SCHEMES DO NOT INCREASE THE RATE OF AGREEMENT BETWEEN BIOPSY AND FINAL PATHOLOGY (2008) (0)
- Relative contribution of androgen deprivation therapy in combination with adjuvant radiotherapy for node-positive prostate cancer (2021) (0)
- Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007. (2023) (0)
- 484: Prostate Volume at Initial Biopsy is the Most Important Predictor of Repeat Biopsy Outcome. Validation of a Novel Predictive Tool (2006) (0)
- NERVE-SPARING RADICAL PROSTATECTOMY DOES NOT UNDERMINE THE RATE OF BIOCHEMICAL RECURRENCE IN CAREFULLY SELECTED PATIENTS WITH PATHOLOGICALLY CONFIRMED EXTRACAPSULAR EXTENSION (2008) (0)
- MP55-15 SHOULD WE CONSIDER ALL AJCC STAGE IIIB BCA EQUAL? THE IMPACT OF LOCAL T STAGING IN N2 AND N3 PATIENTS AFTER RADICAL CYSTECTOMY (2020) (0)
- Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series (2020) (0)
- 926 TIME FROM PROSTATE BIOPSY TO RADICAL PROSTATECTOMY REPRESENTS AN INDEPENDENT PREDICTOR OF PROSTATE CANCER SIGNIFICANT UPGRADING (2009) (0)
- 802 A NOVEL NOMOGRAM PREDICTING A POSITIVE [11C] CHOLINE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/TC) SCAN IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
- SUN-026 THE RADICAL NEPHRECTOMY PARADOX: THE UNEXPECTED AKI RISK (2020) (0)
- MP66-17 DEVELOPMENT OF A PROCEDURE-SPECIFIC CLASSIFICATION SYSTEM FOR REPORTING POSTOPERATIVE COMPLICATIONS IN PROSTATE CANCER PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY (2019) (0)
- RESEARCH — MEN ’ S SEXUAL HEALTH Postoperative Orgasmic Function Increases over Time in Patients Undergoing Nerve-Sparing Radical (2009) (0)
- Inclusion of prostate cancer foci outside imaging detected index lesion improves the ability to predict final pathological stage: Implications for a correct patient staging (2018) (0)
- A PRE-TREATMENT NOMOMOGRAM PREDICTING DISEASE RECURRENCE AFTER HIGH-DOSE BRACHYTHERAPY (2008) (0)
- 372 THE NUMBER OF POSITIVE NODES IS THE STRONGEST PREDICTOR OF CANCER SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PATHOLOGICAL T3 PROSTATE CANCER (2013) (0)
- A competing risk analysis of survival after radical cystectomy for bladder cancer patients: The impact of age at the time of surgery (2019) (0)
- MP12-07 THE ANATOMICAL LOCATION OF LYMPHADENOPATHIES AT IMAGING PREDICTS THE RISK OF LYMPH NODE INVASION AT FINAL PATHOLOGY IN PATIENTS WITH RENAL CELL CARCINOMA (2022) (0)
- Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14. (2020) (0)
- Prognostic value of concomitant carcinoma in situ in radical cystectomy specimens on patients with bladder cancer: A meta-analysis of 24,136 patients (2018) (0)
- Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer. (2023) (0)
- Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer (2023) (0)
- Positive predictive value of mpmri in men under active surveillance: Can the biopsy history influence radiological assessment? (2021) (0)
- 469 ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN LOCALLY ADVANCED PROSTATE CANCER: A MULTI-CENTER EXPERIENCE (2011) (0)
- – Prostate Cancer New Clinical Indications for 18 F / 11 C-choline , New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging : A Systematic Review of the Literature (2016) (0)
- MP51-08 DOES A POSITIVE MULTI-PARAMETRIC MRI ALWAYS WARRANT PROSTATE BIOPSY? THE IMPORTANCE OF INTEGRATING CLINICAL AND IMAGING DATA BASED ON A LARGE, MULTI-INSTITUTIONAL SERIES (2022) (0)
- Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis. (2022) (0)
- Initial steps of an online search tool development for diagnostic and prognostic factors in prostate cancer (2020) (0)
- INCLUSION OF MPMRI INTO THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC) RISK CALCULATOR: A NEW PROPOSAL TO IMPROVE THE ACCURACY OF PROSTATE CANCER DETECTION: MP77‐15 (2017) (0)
- PD42-03 ONCOLOGIC SURVEILLANCE INTENSITY FOR VARIANT HISTOLOGY VERSUS PURE UROTHELIAL CARCINOMA OF THE BLADDER AFTER RADICAL CYSTECTOMY (2022) (0)
- Perioperative morbidity and complications after robot-assisted and open surgery partial nephrectomy: An observational prospective study (2017) (0)
- 675 A COMPARATIVE SURVIVAL ANALYSIS OF NON BILHARZIAL SQUAMOUS CELL CARCINOMA VS. TRANSITIONAL CELL CARCINOMA AFTER CYSTECTOMY (2009) (0)
- Preoperative estimation of long-term oncologic outcomes in patients treated with surgery for kidney cancer (2018) (0)
- Comparing the diagnostic accuracy of 68Ga-PSMA and 11C-Choline PET/CT scan according to PSA level: A large multi-institutional analysis with histological verification in patients treated with salvage lymph node dissection for recurrent prostate cancer (2019) (0)
- Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.04.043. (2019) (0)
- Added value of mpMRI, MRI-targeted and systematic biopsy in the prediction of adverse pathologic features in contemporary prostate cancer patients undergoing radical prostatectomy (2019) (0)
- PELVIC LYMPH NODE DISSECTION SHOULD BE OMITTED IN LOW RISK PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS (2009) (0)
- 265 Assessing the optimal extent of salvage lymph node dissection in patients with single pelvic nodal uptake at [11c]-choline pet/ct scan from recurring prostate cancer (2014) (0)
- 733 MORTALITY PREDICTIONS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA (2009) (0)
- MP41-13 TIME FROM BIOCHEMICAL TO CLINICAL RECURRENCE SHOULD BE CONSIDERED AS A PROXY OF OVERALL SURVIVAL IN PATIENTS WITH CLINICALLY-LOCALIZED PROSTATE CANCER WHO EXPERIENCE RECURRENCE AFTER RADICAL PROSTATECTOMY (2019) (0)
- 363 STRATIFICATION OF HIGH-RISK PROSTATE CANCER INTO PROGNOSTIC CATEGORIES; A EUROPEAN MULTI-INSTITUTIONAL STUDY (2012) (0)
- Can radical cystectomy be performed safely in the metastatic setting? Location of metastatic bladder cancer as a determinant of in-hospital mortality (2017) (0)
- Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review. (2022) (0)
- When can we de-intensify treatments in ISUP Grade Group 5 prostate cancer? Long-term results of a single center, high volume series (2022) (0)
- Introducing PIONEER : a project to harness big data in prostate cancer 2 research 3 4 (2019) (0)
- Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype (2022) (0)
- MP14-06 THE IMPACT OF ADJUVANT RADIOTHERAPY ON CANCER-SPECIFIC MORTALITY IN PROSTATE CANCER PATIENTS WITH SEMINAL VESICLE INVOLVEMENT: A COMPETING-RISKS REGRESSION ANALYSIS (2016) (0)
- Assessing in-hospital morbidity after urethroplasty using the EAU quality criteria for standardized reporting (2021) (0)
- Multiparametric magnetic resonance imaging in fusion with transrectal ultrasound for targeted prostate biopsy by BioJet™ System (2016) (0)
- Prevalence and trends in kidney stone among adults in the United States, 2007-2014 (2019) (0)
- Digital inflection rigidometry and penile dynamic colour doppler ultrasound: Analysis and correlations (2009) (0)
- Single nucleotide polymorphisms and risk of prostate cancer: Development and validation of a novel genetic risk score for individualized screening and diagnostic programmes (2018) (0)
- 1249: Internal Validation of a Competing-Risks Survival Nomogram for Patients Treated with Cystectomy for Bladder Cancer (2006) (0)
- 74 Three incisions or one incision: Who wins at 5 years? Comparison of outcomes of transobturator slings and single incision slings in a single-center surgical series (2015) (0)
- 2120 CIRCULATING ESTRADIOL BUT NOT TESTOSTERONE IS A SIGNIFICANT PREDICTOR OF HIGH GRADE PROSTATE CANCER IN PATIENTS UNDERGOING OPEN RADICAL PROSTATECTOMY (2010) (0)
- Evaluating Patient-Reported Outcomes Measures (PROMs) for localised prostate cancer: A systematic review using the Consensus-based Standard for the selection of health Measurement Instruments (COSMIN) methodology (2021) (0)
- Identifying the most appropriate instrument for Patient-Reported Outcome Measures (PROMs) in patients with clinically localised prostate cancer (2020) (0)
- Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma (2022) (0)
- Neutrophil to lymphocyte ratio is associated with lymph node invasion and higher nodal burden in contemporary high risk patients treated with radical prostatectomy and extended pelvic lymph node dissection (2018) (0)
- In reply to the letter to the editor ‘ in Reply to Gandaglia et al . (2014) (0)
- Performance characteristics of PET/CT scan in men treated with salvage lymph node dissection for recurrent prostate cancer: a per patient analysis with pathological confirmation according to each area of dissection (2020) (0)
- THE EFFECT OF COMPETING MORTALITY ON THE RISK OF BLADDER-CANCER RECURRENCE AND BLADDER CANCER SPECIFIC SURVIVAL (2006) (0)
- Corrigendum re "Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study" [Eur Urol 2012;62:797-802]. (2019) (0)
- PD61-09 FINAL RESULTS OF A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL ASSESSING THE IMPACT OF EARLY DORSAL VENOUS COMPLEX (eDVC) LIGATION ON URINARY CONTINENCE RECOVERY AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY (2021) (0)
- 1068 Impact of surgical volume on the rates of pelvic lymph node dissection in patients with prostate cancer treated with robot-assisted radical prostatectomy: Results from a tertiary referral centre (2014) (0)
- THE EFFECT OF ANATOMICAL LOCATION OF RETROPERITONEAL LYMPH NODE METASTASES ON CANCER SPECIFIC SURVIVAL IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA: PD04‐04 (2017) (0)
- MP67-03 IDENTIFYING THE OPTIMAL CANDIDATES FOR A SUPER-EXTENDED STAGING PELVIC LYMPH-NODE DISSECTION IN PROSTATE CANCER PATIENTS TREATED IN THE PET-PSMA ERA. RESULTS FROM A MULTI-INSTITUTIONAL SERIES (2023) (0)
- 2017 FACTORS PREDICTING POSITIVE [11C]CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY (2010) (0)
- Multiparametric magnetic resonance imaging in fusion with transrectal ultrasound fusion biopsy with the BioJet™ System for the detection of clinically significant prostate cancer. Technical details and initial results (2017) (0)
- Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? (2023) (0)
- Pre-operative risk calculator for the probability of completing surgery for kidney cancer: The key role of tumour complexity and surgical experience (2023) (0)
- How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study (2020) (0)
- IS THE ICIQ‐SF QUESTIONNAIRE RELIABLE IN A REAL‐LIFE SETTING? RESULTS OF A PROSPECTIVE SINGLE‐CENTER STUDY: MP46‐01 (2017) (0)
- How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study (2020) (0)
- MULTIPARAMETRIC MRI CANNOT PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER OUTSIDE THE INDEX LESION: IMPLICATIONS FOR EXTENDED BIOPSY TEMPLATES: MP03‐13 (2017) (0)
- 1475 INTRAFASCIAL TECHNIQUE OFFERS IMPROVED FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH BILATERAL NERVE SPARING ROBOTIC RADICAL PROSTATECTOMY (2011) (0)
- 514 Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for non-metastatic bladder cancer: Results from a single high-volume institution (2016) (0)
- Lymph node dissection in urological cancers: one topic, many controversies (2017) (0)
- Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. (2021) (0)
- The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer (2023) (0)
- The number of positive mpMRI-targeted cores is linearly associated with the risk of multifocal clinically significant prostate cancer: Implications for correct patient staging and counselling (2018) (0)
- PD42-03 ASSOCIATION OF PATHOLOGIC RESPONSE TO NEOADJUVANT PEMBROLIZUMAB WITH TUMOR SUBTYPE FROM THE PURE01 STUDY (2020) (0)
- REPLY (2012) (0)
- MP32-06 IMPACT OF NEOADJUVANT PEMBROLIZUMAB ON INTRA AND PERI-OPERATIVE COMPLICATIONS AFTER RADICAL CYSTECTOMY: A COMPARISON WITH BOTH STANDARD CHEMOTHERAPY AND NO ADJUVANT TREATMENT (2019) (0)
- 899 DOES BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY AND ADJUVANT RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER INVARIABLY IMPACT CANCER-SPECIFIC MORTALITY? (2011) (0)
- BODY MASS INDEX AND COMORBIDITIES DO NOT AFFECT ERECTILE FUNCTION OR URINARY CONTINENCE RECOVERY AFTER BILATERAL NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY (2008) (0)
- Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. (2009) (0)
- 788 NERVE-SPARING TECHNIQUE DURING RADICAL PROSTATECTOMY IS STRONGLY ASSOCIATED WITH THE RATE OF URINARY CONTINENCE RECOVERY. LONG TERM FOLLOW UP OF A SINGLE TERTIARY CARE CENTER (2011) (0)
- 740 Neoadjuvant cisplatinum-based chemotherapy does not impact perioperative morbidity in patients underwent radical cystectomy for bladder cancer (2015) (0)
- Predictors of undetectable disease after radical cystectomy: Results from a single, large single-institution series (2019) (0)
- The role of a digital psychological support for prostate cancer patients managed by a multidisciplinary disease unit: Initial experience from a referral center (2021) (0)
- MP48-13 THE KEY ROLE OF CONCOMITANT ANDROGEN-DEPRIVATION THERAPY ON THE EFFICACY OF IMAGING GUIDED TREATMENTS IN MEN WITH BIOCHEMICAL RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND POSITIVE 68GA-PSMA PET/CT SCAN (2022) (0)
- 530 The effect of time elapsed from surgery on the subsequent risk of cancer specific mortality in renal cell carcinoma patients (2016) (0)
- In reply to Yu. (2012) (0)
- 430 Patterns of clinical recurrence and predictors of systemic progression of prostate cancer patients with PSA persistence after radical prostatectomy (2016) (0)
- NATURAL HISTORY OF SURGICALLY TREATED LOCAL RECURRENCE AFTER NEPHRECTOMY: MP16‐15 (2017) (0)
- 454 Impact of pre-treatment PSA level on cancer control after early salvage radiation therapy post-radical prostatectomy: Need for patient stratification according to prostate cancer features (2015) (0)
- MP56-02 HEAD TO HEAD COMPARISON OF CONDITIONAL ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER (2015) (0)
- 678 External beam radiotherapy with or without androgen deprivation therapy in very elderly patients with high metastatic risk prostate cancer (2016) (0)
- MP48-09 TOXICITY PROFILE OF IMMEDIATE POST-PROSTATECTOMY RADIATION THERAPY: RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2022) (0)
- Multiparametric MRI increases clinically significant prostate cancer detection relative to standard clinical predictors: Results of a risk adapted analysis in a non-screened population (2018) (0)
- PD15-08 WHEN TO DE-INTENSIFY ONCOLOGIC SURVEILLANCE SCHEME FOR NON-CLEAR CELL RENAL CELL CARCINOMA (2022) (0)
- MP24-09 BALANCING EFFICACY AND TOXICITY OF DOCETAXEL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. RESULTS FROM A POOLED ANALYSIS OF THREE PROSPECTIVE RANDOMIZED TRIALS (2021) (0)
- UROSEPSIS FOLLOWING URETERORENOSCOPY FOR THE TREATMENT OF UROLITHIASIS OR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA: A FOCUS ON UNDERESTIMATED AND HARMFUL POSTOPERATIVE COMPLICATION: MP68‐03 (2017) (0)
- 760 FEMINIZING GENITOPLASTY: PARENTAL PERSPECTIVES AND GENITAL SENSATION IN ADULT LIFE (2007) (0)
- The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma (2022) (0)
- Rebuttal from Author re: George N. Thalmann. Positive Lymph Nodes at Lymphadenectomy for Prostate Cancer: Where Do We Set the Tiller? Eur Urol 2009;55:271-2 (2009) (0)
- 404 MORTALITY AT 120 DAYS AFTER PROSTATIC BIOPSY: A POPULATION-BASED STUDY OF 22175 MEN (2007) (0)
- HP-03-005 Development of a risk stratification tool to predict the presence of hypogonadism in men with sexual dysfunction (2017) (0)
- 998 HIGH-RISK PROSTATE CANCER PRESENTING WITH BIOPSY GLEASON SCORE 8, 9 OR 10: DOWNGRADING AND CANCER-SPECIFIC SURVIVAL (2012) (0)
- PD39-04 MPMRI OF THE PROSTATE IN PATIENTS CARRYING A HIGH CLINICAL RISK OF PROSTATE CANCER DIAGNOSIS: IS THIS IMAGING TEST NECESSARY FOR DIAGNOSTIC PURPOSES IN THIS SUBSET OF PATIENTS? (2023) (0)
- MP36-13 THERE IS NO WAY TO AVOID CONCOMITANT SYSTEMATIC PROSTATE BIOPSIES IN ADDITION TO MP-MRI TARGETED SAMPLING IN MEN WITH POSITIVE IMAGING (2019) (0)
- Ileal Conduit Versus Orthotopic Neobladder Urinary Diversion in Robot-assisted Radical Cystectomy: Results from a Multi-institutional Series. (2023) (0)
- 133 IMPACT OF ADJUVANT RADIOTHERAPY ON CANCER SPECIFIC SURVIVAL OF PATIENTS WITH SEMINAL VESICLE INVASION AND NODE POSITIVE DISEASE: RESULTS OF A MATCHED-ANALYSIS (2010) (0)
- MP63-04 CLINICAL AND PATHOLOGICAL LYMPH NODE PROGRESSION IN PATIENTS WITH A CT1-T2 N0 M0 RENAL MASS: SHALL WE FOREVER DISCARD THE USE OF LYMPH NODE DISSECTION IN LOW RISK PATIENTS? (2015) (0)
- MP36-16 DEVELOPMENT AND EXTERNAL VALIDATION OF A NOVEL MODEL TO IDENTIFY PATIENTS WITH EQUIVOCAL LESION AT MULTIPARAMETRIC MRI WHO CAN AVOID PROSTATE BIOPSY (2019) (0)
- MP50-01 SURVIVAL ANALYSIS OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY COMPARING OBSERVATION VS. ADJUVANT ANDROGEN DEPRIVATION THERAPY ALONE VS. ADJUVANT ANDROGEN DEPRIVATION PLUS EXTERNAL BEAM RADIATION THERAPY. (2016) (0)
- Regression tree analysis to identify the best candidates for neoadjuvant chemotherapy (NAC) in patients with clinically lymph node-positive penile squamous cell carcinoma (PSCC). (2020) (0)
- PD33-02 VARIANT HISTOLOGIC DIFFERENTIATION IN BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: INCIDENCE AND LONG TERM SURVIVAL IN A SINGLE INSTITUTION STUDY. (2016) (0)
- SAT-092 THE DUEL OF DAVID AND GOLIATH: HOW SHOULD MGFR BEAT THE ESTIMATED GFR? (2020) (0)
- Imaging intensity after surgery for clear cell renal cell carcinoma (2022) (0)
- Time from biochemical to clinical recurrence should be considered as a proxy of overall survival in patients with clinically-localized prostate cancer who experience recurrence after radical prostatectomy (2019) (0)
- 1975 LONG-TERM ERECTILE FUNCTION OUTCOMES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) (2013) (0)
- Stage-migration and survival of lymph node positive prostate cancer patients: A comprehensive trend analyses of surgically treated men over the last two decades (2018) (0)
- 1038: Erectile Function Following Nerve Sparing Radical Prostatectomy Correlates Well with Post -Operative Penile Length in Flaccidity and at Maximum Erection. Surgical Technique Counts (2007) (0)
- Unfavourable cancer specific survival after neoadjuvant chemotherapy and radical cystectomy in bladder cancer patients with squamous-cell variant: A multi-institutional study (2021) (0)
- Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients? (2023) (0)
- Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients (2022) (0)
- MP56-18 NON-SURGICALLY RELATED CAUSES OF ERECTILE DYSFUNCTION AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: RESULTS FROM A SINGLE INSTITUTION SERIES (2015) (0)
- PD60-10 A MORE EXTENDED PELVIC LYMPH NODE DISSECTION DECREASES RECURRENCE RATES IN SELECTED PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2022) (0)
- Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data (2020) (0)
- 1017 Systematic assessment of positive surgical margins features in open vs. robot-assisted radical prostatectomy: Is there a difference? (2015) (0)
- Assessing the impact of salvage radiation therapy field after radical prostatectomy: a long-term analysis from a large multi-institutional series (2020) (0)
- 10 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY AT A SINGLE EUROPEAN INSTITUTION (2009) (0)
- IMPACT OF PROSTATE INVOLVEMENT ON OUTCOMES IN PATIENTS TREATED WITH RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER: MP54‐19 (2017) (0)
- Chronic kidney disease at the time of surgery for renal cancer: How and when is it possible to improve from the baseline renal function? Results from a single tertiary care referral centre (2020) (0)
- PD59-07 NEGLECTED LYMPH NODAL METASTASES IN PATIENTS WITH RENAL CANCER: WHEN TO EXTEND THE ANATOMICAL TEMPLATE OF LYMPH NODE DISSECTION DURING NEPHRECTOMY (2022) (0)
- 509 Simplified Charlson Comorbidity Index for assessment of perioperative mortality after radical cystectomy (2016) (0)
- PD60-07 DO PERFORMANCE CHARACTERISTICS OF MULTI-PARAMETRIC MRI OF THE PROSTATE CHANGE ACCORDING TO PATIENT AGE? CLINICAL IMPLICATIONS FOR AGE-TAILORED BIOPSY APPROACHES (2019) (0)
- OP3-06 IMPACT OF TIME TO BIOCHEMICAL RECURRENCE ON CANCER-SPECIFIC MORTALITY IN PATIENTS WITH HIGH-RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: A COMPETING-RISKS REGRESSION ANALYSIS (2014) (0)
- MP56-06 SHOULD WE TARGET ALL VISIBLE AREAS AT MPMRI SUSPICIOUS FOR CLINICALLY SIGNIFICANT PROSTATE CANCER IN ADDITION TO THE INDEX LESION? RESULTS FROM A TWO-INSTITUTION SERIES (2020) (0)
- 927: Feminizing Genitoplasty: Genital Sensation in Adult Life (2007) (0)
- Saturation of the mpMRI lesion is not necessary to minimize the risk of missing clinically significant prostate cancer at targeted biopsy. Analysis of a large, multi-institutional series (2021) (0)
- Definition and predictors of upgrading at final pathology in prostate cancer patients undergoing mri-targeted and systematic biopsies: Results from a large, multi-institutional series (2022) (0)
- 695 Impact of stage migration on node positive prostate cancer rate and features: A 20-year, single institution analysis in men treated with extended pelvic lymph node dissection (2013) (0)
- Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy. (2023) (0)
- Oncologic surveillance intensity for variant histology versus pure urothelial carcinoma of the bladder after radical cystectomy (2022) (0)
- 264 PERCENTAGE OF POSITIVE BIOPSY CORES IS AN ACCURATE PREDICTOR OF LYMPH NODE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION (2007) (0)
- An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma (2022) (0)
- Assessing the association between the template of pelvic salvage lymph node dissection for node-only recurrent prostate cancer and oncological outcomes. Results of a multi-institutional series (2021) (0)
- 891 Is [11C]choline PET/CT recommended for restaging prostate cancer patients after radical prostatectomy when PSA is lower than 1 ng/ml? (2012) (0)
- 191 Cancer-control outcomes in patients with clinically high-risk prostate cancer (PCa) treated with robotic-assisted laparoscopic radical prostatectomy (RALP): A multi-institutional database analysis (2015) (0)
- Pure histological variants are associated with poor survival at radical cystectomy in patients with bladder cancer (2017) (0)
- The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training (2023) (0)
- Development of novel criteria for active surveillance based on multiparametric MRI alone in men with Gleason 3 + 4 prostate cancer: Use of imaging to safely expand the eligibility for active surveillance (2019) (0)
- Final results of a prospective, randomized controlled trial assessing the impact of early Dorsal Venous Complex (eDVC) ligation on urinary continence recovery after robot-assisted radical prostatectomy (2021) (0)
- Towards the noninvasive identification of pathologic responders to neoadjuvant pembrolizumab in muscle-invasive urothelial bladder cancer (MIBC). (2019) (0)
- Preoperative anemia is a predictor of disease recurrence, cancer-specific survival and overall survival in bladder cancer patients: A retrospective study on 4335 radical cystectomies (2016) (0)
- Re: Kathia De Man, Nick Van Laeken, Vanessa Schelfhout, et al. 18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial. Eur Urol. In press. https://doi.org/10.10 (2022) (0)
- 1206 PRE-OPERATIVE URINARY AND ERECTILE FUNCTION REPRESENT SIGNIFICANT PREDICTORS OF POST-OPERATIVE URINARY CONTINENCE RECOVERY IN PATIENTS TREATED WITH NERVE SPARING RADICAL PROSTATECTOMY (2010) (0)
- Where do we miss extracapsular extension at multiparametric magnetic resonance imaging of the prostate? A site-per-site analysis in a single center, radical prostatectomy series (2018) (0)
- MP13-15 HOLMIUM LASER ENUCLEATION OF THE PROSTATE IS ASSOCIATED WITH COMPLICATIONS AND SEQUELAE EVEN IN THE HANDS OF AN EXPERIENCED SURGEON (2023) (0)
- 226 Surgical management of benign prostatic obstruction: Current practice patterns and attitudes in Europe (2014) (0)
- Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients. (2021) (0)
- 223 Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy (2018) (0)
- 727 Inverse stage migration: Contemporary results of 140.253 North American prostate cancer patients treated with radical prostatectomy from 2004 to 2012 (2016) (0)
- SP044 ROLE OF CELL DEATH IN NEPHROCALCINOSIS: AN IN VITRO STUDY OF HK-2 CELLS (2018) (0)
- The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study (2022) (0)
- MP14-05 ADJUVANT VEGF-TKI INHIBITORS AFTER SURGERY IMPROVES PROGRESSION FREE SURVIVAL (BUT NOT SURVIVAL) IN HIGH-RISK RCC PATIENTS (2021) (0)
- 1126 THE EFFECT OF PREOPERATIVE CANCER AGGRESSIVENESS ON LEARNING CURVE AMONG HIGH VOLUME SURGEONS PERFORMING RADICAL RETROPUBIC PROSTATECTOMY (2012) (0)
- Re: Kerrington Powell, Michael C. Burns, Vinay Prasad. Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint. Eur Urol. 2023;83:101-2. (2023) (0)
- 620 Complication rates after radical cystectomy following any previous abdominal-pelvic-perineal radiotherapy: An international, multicenter retrospective study on 609 cases (2016) (0)
- MP77-05 ASSOCIATION OF PERIOPERATIVE BLOOD TRANSFUSION WITH ONCOLOGIC OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2014) (0)
- PD10-07 CAN WE RELY ON AVAILABLE MODELS TO IDENTIFY CANDIDATES FOR EXTENDED PELVIC LYMPH NODE DISSECTION (EPLND) IN MEN STAGED WITH PSMA-PET? EXTERNAL VALIDATION OF THE BRIGANTI NOMOGRAMS AND DEVELOPMENT OF A NOVEL TOOL TO IDENTIFY OPTIMAL CANDIDATES FOR EPLND (2023) (0)
- MP63-01 A PROPOSAL FOR A NOVEL PERI-OPERATIVE MORTALITY RISK ASSESSMENT TOOL IN CONTEMPORARY PATIENTS TREATED WITH RADICAL CYSTECTOMY (2016) (0)
- MP45-02 EXTERNAL VALIDATION AND HEAD-TO-HEAD COMPARISON OF ALL THE PROGNOSTIC MODELS RECOMMENDED BY THE EUROPEAN ASSOCIATION OF UROLOGY GUIDELINES TO PREDICT ONCOLOGIC OUTCOMES IN PATIENTS WITH RENAL CELL CARCINOMA (2021) (0)
- Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma (2023) (0)
- 125 RADICAL RETROPUBIC PROSTATECTOMY IN PATIENTS PREVIOUSLY SUBMITTED TO HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR BENIGN PROSTATIC ENLARGEMENT: A FEASIBILITY STUDY (2007) (0)
- Clinical outcomes of patients with renal cell carcinoma and imperative indication to become anephric: Implications for multidisciplinary board evaluation (2022) (0)
- Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin. Letter. (2021) (0)
- PD17-11 ADDED VALUE OF CONCOMITANT SYSTEMATIC BIOPSIES IN PREDICTING UPGRADING IN PATIENTS WITH LOCALIZED PROSTATE CANCER DIAGNOSED BY MRI-TARGETED BIOPSY: IMPLICATIONS FOR TREATMENT SELECTION (2019) (0)
- PD15-12 HYPOGONADISM IS AN INDEPENDENT PREDICTOR OF NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION (2014) (0)
- Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients. (2023) (0)
- MP37-02 IMPACT OF SURGICAL VOLUME ON SURGICAL MARGIN STATUS IN PATIENTS TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY (2014) (0)
- Natural history of patients affected by nodal recurrence from prostate cancer treated with salvage lymph node dissection without additional treatments (2018) (0)
- Neoadjuvant pembrolizumab may result in long-term outcome improvement in biomarker-unselected patients with Muscle-Invasive Bladder Cancer (MIBC): Updated results from PURE-01 (2022) (0)
- PD17-04 PROSTATE CANCERS DETECTED AT MULTI-PARAMETRIC MRI TARGETED VERSUS SYSTEMATIC BIOPSIES: ARE THEY EQUAL? RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2022) (0)
- Long-term impact of adjuvant versus early salvage radiation therapy on clinical recurrence in PT3N0 prostate cancer patients treated with radical prostatectomy: results of amulti-institutional series (2016) (0)
- Re: Deepika Reddy, Max Peters, Taimur T. Shah, et al. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol 2022;81:407-13. (2022) (0)
- An open-label, phase 2 study of personalized approach with perioperative immunotherapy for bladder preservation in muscle-invasive urothelial bladder carcinoma (MIBC). (2022) (0)
- Renal tumor heterogeneity analysis in Von Hippel-Lindau disease using single-cell RNA sequencing (2023) (0)
- MP57-20 PATTERNS OF CLINICAL RECURRENCE AND PREDICTORS OF SYSTEMIC PROGRESSION OF PROSTATE CANCER PATIENTS WITH PSA PERSISTENCE AFTER RADICAL PROSTATECTOMY (2016) (0)
- Changing patterns and predictors of salvage radiation therapy use over time in patients treated for post-prostatectomy biochemical recurrence: a trend analysis over a 20-year period from a multi institutional series (2020) (0)
- 1557 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS (2010) (0)
- 907 OUTCOME OF PATIENTS POTENTIALLY SUITABLE FOR ACTIVE SURVEILLANCE UNDERGOING RADICAL PROSTATECTOMY AS FIRST TREATMENT CHOICE. RESULTS OF INTERMEDIATE-TERM FOLLOW-UP (2010) (0)
- Re: Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience. J Urol. 2020;203(6):1122-7. (2020) (0)
- MP11-11 TAILORING THE OPTIMAL USE OF ANDROGEN-DEPRIVATION THERAPY CONCOMITANT TO POST-OPERATIVE RADIOTHERAPY AMONG MEN WITH PN1 PROSTATE CANCER. LONG-TERM RESULTS OF A LARGE, SINGLE INSTITUTION SERIES (2023) (0)
- PD-0459: Whole-pelvis RT improves bRFS of node-negative patients treated with post-prostatectomy high-dose salvage RT (2013) (0)
- 865 PATHOLOGICAL GLEASON SCORE DICTATES SURVIVAL IN PATIENTS WITH PT3B PCA TREATED WITH RP AND ADJUVANT RT. RESULTS FROM TWO-INSTITUTION SERIES ANALYSIS (2010) (0)
- MP55-09 ASSOCIATION OF AN IMMUNE-GENE SIGNATURE WITH PATHOLOGIC RESPONSE AND OUTCOME AFTER NEOADJUVANT PEMBROLIZUMAB (PEMBRO), COMPARED TO NEOADJUVANT CHEMOTHERAPY (NAC), IN MUSCLE-INVASIVE BLADDER CANCER (MIBC) (2020) (0)
- 865PAdjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: A joint study of the EAU-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration (2017) (0)
- SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2009) (0)
- MP11-06 THE PROGNOSTIC ROLE OF 68Ga-PSMA PET/CT AND THE IMPACT OF METASTASIS-DIRECTED THERAPY ON CANCER PROGRESSION IN MEN WITH BIOCHEMICAL RECURRENCE FROM PROSTATE CANCER. RESULTS FROM A LARGE, SINGLE INSTITUTION SERIES (2023) (0)
- ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY: MP29‐17 (2018) (0)
- HP-03-003 The impact of renal cancer diagnosis and planned treatment (radical vs partial nephrectomy) over sexual and mental health (2016) (0)
- PD57-09 SYSTEMATIC REVIEW AND META-ANALYSIS OF ADJUVANT THERAPY AFTER NEPHRECTOMY FOR HIGH-RISK, NON-METASTATIC RENAL CELL CARCINOMA (2018) (0)
- 1491 IF A PRO-ERECTILE PHARMACOLOGICAL APPROACH IS CONSIDERED AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY, THIS SHOULD BE INITIATED SOON AFTER SURGERY (2010) (0)
- 247 SPATIAL DISTRIBUTION OF POSITIVE CORES DECREASES MISCLASSIFICATION RATES OF PATIENTS WITH LOW RISK PROSTATE CANCER CANDIDATE FOR ACTIVE SURVEILLANCE (2013) (0)
- The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot‐assisted radical prostatectomy: A multi‐institutional study (2021) (0)
- Mapping EAU guideline practice variations across Europe: An audit of ADT before surgery in locally advanced and high-risk prostate cancer in 6315 cases across 31 European countries (2022) (0)
- 422 Predictors of early failure after timely administered salvage radiotherapy for biochemical recurrence after radical prostatectomy (2014) (0)
- Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence. (2022) (0)
- MP46-05 IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2014) (0)
- 116 THE PRESENCE OF NERVE FIBERS ON NERVE SPARING RADICAL PROSTATECTOMY SPECIMEN DOES NOT CORRELATE WITH POSTOPERATIVE ERECTILE FUNCTION (2007) (0)
- Treatment of erectile dysfunction: defyning the optimal response (2008) (0)
- Update on Genitourinary Pathology: From the Latest Morphological Novelties to Molecular Pathology and Genomics (2017) (0)
- 262 Assessing the optimal postoperative management of node positive prostate cancer patients: Results from a large, multi-institutional series (2014) (0)
- Should we routinely recommend a central review of magnetic resonance imaging of the prostate in men with positive mp-MRI? Implication for targeted biopsies (2021) (0)
- Re: Kathrin Meisterhofer, Sereina Herzog, Karin A. Strini, Luca Sebastianelli, Ricarda Bauer, Orietta Dalpiaz. Male Slings for Postprostatectomy Incontinence: A Systematic Review and Meta-analysis. Eur Urol Focus 2020;6:575-92. (2020) (0)
- 971: Clinical Complications of Extended Lymphadenectomy (PLND) in Patients Affected by Localized Prostate Cancer Undergoing Radical Retropubic Prostatectomy at a Single Institution (2006) (0)
- FP092 NOVEL ROLE OF IL-20 CYTOKINE SUBFAMILY IN THE PATHOGENESIS OF CHRONIC KIDNEY DISEASES (2018) (0)
- Development and split-sample validation of the first nomogram to identify the candidates for extended pelvic lymph node dissection among men staged with multi-parametric MRI for clinically localized prostate cancer (2018) (0)
- 13 IMMEDIATELY-PREOPERATIVE SERUM TOTAL TESTOSTERONE IS NOT AN INDEPENDENT PREDICTOR OF EITHER LOCALLY ADVANCED OR HIGH GLEASON GRADES DISEASE IN PATIENTS UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY (2009) (0)
- 446 Salvage lymph node dissection for clinically recurrent prostate cancer: Which patients do benefit from this approach? (2015) (0)
- 1561 NO RESIDUAL TUMOR (PT0) AT RADICAL PROSTATECTOMY IN CLINICAL T1A-B PROSTATE CANCER. DEVELOPMENT OF A NOVEL AND USER-FRIENDLY PREDICTING TOOL (2010) (0)
- 735 What is the prognostic impact of nodal tumour burden in patients with a single positive node at final pathology (2016) (0)
- Predictors of early cancer specific and other cause mortality in high risk prostate cancer patients after radical prostatectomy: Results from a large, multi-institutional analysis (2017) (0)
- Back to the future: Is the use of fasciocutaneous penile flap increasing in contemporary years for reconstructing the anterior urethra? (2022) (0)
- Dissection of primary prostate cancer to determine the clonal origin of synchronous lymph node metastasis. (2020) (0)
- Impact of histological variants in node positive patients treated with radical cystectomy for bladder cancer (2020) (0)
- MP51-14 IMPACT OF 68GA-PSMA PET/CT AND METASTASIS-DIRECTED THERAPY ON CLINICAL RECURRENCE IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. RESULTS FROM A SINGLE CENTER SERIES (2022) (0)
- MP74-02 LONG-TERM OUTCOMES OF CLINICALLY NODE-POSITIVE PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT: PATTERNS OF RECURRENCE AND IMPACT ON COMPETING-RISK MORTALITY (2020) (0)
- Frailty Index in predicting surgical outcomes after partial nephrectomy in patients with renal cell carcinoma (2023) (0)
- Impact of early dorsal venous complex ligation on early urinary continence recovery after robot-assisted radical prostatectomy: Results of a pre-specified interim analysis of a randomized clinical trial (2019) (0)
- Effect of the level of node metastases in patients treated with radical cystectomy and extended pelvic lymph node dissection (2018) (0)
- Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis (2019) (0)
- 907 THE NUMBER OF POSITIVE SECTION MARGINS IN HIGH-RISK PROSTATE CANCER IS A POWERFUL AND INDEPENDENT PREDICTOR OF CANCER-SPECIFIC AND OVERALL SURVIVAL IN HIGH-RISK LOCALIZED PROSTATE CANCER (2011) (0)
- 903 CHARLSON COMORBIDITY INDEX IS NOT AN INDEPENDENT PREDICTOR OF OVERALL SURVIVAL IN PATIENTS WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY (2011) (0)
- 102 Population-based assessment of treatment modalities in the elderly with localized renal cell carcinoma: The 2000–2009 update (2015) (0)
- 516 IF YOU PLAN A PELVIC LYMPH NODE DISSECTION AT RADICAL PROSTATECTOMY, THIS MUST BE EXTENDED: RESULTS OF A SENSITIVITY ANALYSIS (2009) (0)
- ASSOCIATION BETWEEN EARLY URINARY CONTINENCE AND ERECTILE FUNCTION RECOVERY AFTER ROBOT‐ASSISTED RADICAL PROSTATECTOMY: DEVELOPMENT OF A NOVEL POSTOPERATIVE RISK SCORE TO OPTIMIZE PATIENT COUNSELING AND FOLLOW‐UP: PD15‐08 (2017) (0)
- PO-1423 PSA dynamics forecasts identify tumor recurrence after external radiotherapy for prostate cancer (2022) (0)
- Identifying the optimal candidate for salvage lymph node dissection for nodal recurrence of prostate cancer: Results from a large, multi-institutional analysis (2017) (0)
- PD57-05 COMPARISON OF PERI-OPERATIVE COMPLICATIONS ACCORDING TO SURGICAL APPROACH AND URINARY DIVERSION IN PATIENTS TREATED WITH NEOADJUVANT PEMBROLIZUMAB (PURE-01) AND RADICAL CYSTECTOMY FOR MIBC (2019) (0)
- The most common location for stricture after transurethral prostate surgery (TPS) is the bulbomembranous urethra: False! (2022) (0)
- 2066 MISCLASSIFICATION OF MICRO-FOCUS PROSTATE CANCER DECREASES WITH THE EXTENT OF BIOPSY SAMPLING. IMPORTANCE OF ACCURATE DETECTION (2012) (0)
- Relapse-free survival (RFS) of clinical T2-4N0 urothelial bladder carcinoma (UBC) after radical cystectomy (RC), with or without perioperative chemotherapy (POC): Endpoints for clinical trial design. (2018) (0)
- 801 DETECTION OF LYMPH-NODE METASTASES WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL RETROPUBIC PROSTATECTOMY: VALIDATION BY OPEN PELVIC-RETROPERITONEAL LYMPHADENECTOMY (2009) (0)
- MP63-19 ADEQUATE VS INADEQUATE BCG INTRAVESICAL THERAPY IN INTERMEDIATE AND HIGH RISK NMIBC: TOTAL NUMBER OF INSTILLATIONS IS WHAT REALLY MATTERS (2023) (0)
- MP51-19 ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2020) (0)
- 186 THE 2011 NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES RECOMMENDATIONS FOR PELVIC LYMPH NODE DISSECTION IN PROSTATE CANCER PATIENTS ARE NOT ACCURATE. A PLEA FOR RENEWAL (2012) (0)
- 1713: Accuracy of Percent Free Psato Predict Prostate Cancer at Biopsy in PSA Ranges Lower than 2.5ng/ml (2007) (0)
- MP76-05 LENGTH OF INFERTILITY AFFECTS SEMINAL PARAMETERS - FINDINGS OF A CROSS-SECTIONAL SURVEY IN WHITE-EUROPEAN MEN PRESENTING FOR PRIMARY COUPLE'S INFERTILITY (2015) (0)
- MP56-03 NUMBER OF LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY FOR NODE NEGATIVE PROSTATE CANCER: A POTENTIAL MARKER OF DISEASE PERSISTENCE IN PATIENTS WITH EARLY BIOCHEMICAL FAILURE (2015) (0)
- Re: Roselyne Choinière, Philippe D. Violette, Mélanie Morin, et al. Evaluation of Benefits and Harms of Surgical Treatments for Post-radical Prostatectomy Urinary Incontinence: A Systematic Review and Meta-analysis. Eur Urol Focus 2022;8:1042-52. (2023) (0)
- Non-absorbable clip migration after robot-assisted partial nephrectomy: A rare but challenging complication (2023) (0)
- MP61-01 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT IMPACT ON CANCER SPECIFIC SURVIVAL FOR PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER (2014) (0)
- The impact of the EAU guidelines panel recommendations on reporting and grading complications on perioperative outcomes after robot-assisted radical cystectomy with intracorporeal diversion (2019) (0)
- 762P Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer (MIBC) reveals unique features that may inspire new sequential therapies in pathologically-nonresponders (2020) (0)
- Metastatic hormone-sensitive prostate cancer: local treatment strategies (2021) (0)
- The impact of surgical experience on the risk of surgical margins and biochemical recurrence after robot-assisted radical prostatectomy: A learning-curve study (2019) (0)
- Does centralized revision of prostate biopsy impact on active surveillance outcomes? Results from a single, high-volume institution series (2022) (0)
- Oncologic outcomes of robot assisted radical prostatectomy at single tertiary European centre with more than 10 years follow up (2017) (0)
- Balancing efficacy and toxicity of docetaxel in patients with metastatic castration-resistant prostate cancer. Results from a pooled analysis of three prospective randomized trials (2021) (0)
- NATURAL PROGRESSION IN MEN TREATED WITH HORMONAL THERAPY AFTER RADICAL PROSTATECTOMY FAILURE (2006) (0)
- MP41-14 THE LEARNING CURVE OF RADICAL NEPHRECTOMY FOR KIDNEY CANCER: IMPLICATIONS FOR SURGICAL TRAINING (2021) (0)
- Changing patterns of robot-assisted radical cystectomy with intracorporeal diversion at a single high-volume center: The effect of learning curve on clinical outcomes (2019) (0)
- MP48-05 NEOADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS WITH UPPER TRACT UROTHELIAL CANCER: ONCOLOGIC OUTCOMES FROM A MULTICENTER STUDY (2021) (0)
- North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy (2018) (0)
- PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment (2023) (0)
- P1 PROSTATE CANCER: STAGINGWednesday, 18 March, 12.45-14.15, Room A315 PATIENTS WITH ORGAN CONFINED PROSTATE CANCER AND POSITIVE SURGICAL MARGINS HAVE SIMILAR RECURRENCE RATES COMPARED TO PATIENTS WITH EXTRA-CAPSULAR EXTENSION AND NEGATIVE SURGICAL MARGINS. A PLEA FOR STAGE RE-CLASSIFICATION (2009) (0)
- 178 A SINGLE SPOT AT [(11)C]CHOLINE-PET/CT SCAN IS NOT PREDICTIVE OF A SINGLE, ISOLATED NODAL METASTASIS AT FINAL PATHOLOGY. IMPLICATIONS FOR SALVAGE TREATMENTS (2012) (0)
- IS TRANSURETHRAL RESECTION ALONE ENOUGH FOR DIAGNOSIS HISTOLOGICAL VARIANTS? A SINGLE CENTER STUDY: MP58‐13 (2017) (0)
- MP11-04 THE IMPORTANCE OF THE SIZE OF NODAL METASTASES IN PREDICTING RECURRENCE OF NODE POSITIVE PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: IMPLICATIONS FOR POST-OPERATIVE TREATMENT TAILORING (2018) (0)
- Effect of positive surgical margins at radical prostatectomy on cancer‐specific mortality in high/very high‐risk prostate cancer patients with Gleason Grade Group 4–5 (2022) (0)
- PD10-08 THE PROGNOSTIC IMPACT OF PREOPERATIVE PSMA-PET ON EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A MULTI-CENTER ANALYSIS (2023) (0)
- 1041 Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for selection of active surveillance candidates (2015) (0)
- SHOULD SEPTA- AND OCTOGENARIAN PATIENTS WITH PROSTATE CANCER BE TREATED WITH RADICAL PROSTATECTOMY? (2009) (0)
- 908 An initial serum PSA level less than 5 ng/ml at diagnosis does not correlate with tumor volume in low risk prostate cancer patients. Implications for conservative treatments (2012) (0)
- MP22-06 IMAGING TARGETED TREATMENTS VERSUS EXTENDED SALVAGE LYMPH NODE DISSECTION FOR PATIENTS WITH A SINGLE NODAL RECURRENCE OF PROSTATE CANCER: A COMPARATIVE ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2019) (0)
- Secondary treatment for men with localized prostate cancer: A pooled analysis of PRIAS and ERSPC-Rotterdam datasets within the PIONEER data platform (2021) (0)
- Techniques to Improve Sexual Function Following Robot-Assisted Radical Prostatectomy (2018) (0)
- 1514: Impact of Holmium Laser Enucleation (Holep) Versus Trans-Urethral Resection (Turp) of the Prostate On Sexual Function : Results of a Prospective Multicentric Randomized Trial (2004) (0)
- 784 Why the outcomes of initial cases of open and robotic surgeons cannot be compared? Importance of patients selection (2012) (0)
- DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC). (2022) (0)
- When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma (2022) (0)
- 431 External validation of a model predicting survival of men with recurrent prostate cancer after radical prostatectomy (2016) (0)
- 61 Prophylactic irradiation of pelvic lymph-nodal area after prostatectomy does not increase the risk of second neoplasms: A single institution analysis of 1109 patients with 10 years follow-up (2016) (0)
- 144: Surgical Margin Status in European Versus North American Patients at Radical Prostatectomy (2006) (0)
- 746 PATIENTS WITH PT2 PROSTATE CANCER AND POSITIVE SURGICAL MARGINS DO NOT BENEFIT FROM ADJUVANT RADIATION THERAPY (2009) (0)
- MP56-02 NEOADJUVANT PEMBROLIZUMAB MAY RESULT IN LONG-TERM OUTCOME IMPROVEMENT IN BIOMARKER-UNSELECTED PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER (MIBC): UPDATED RESULTS FROM PURE-01 (2022) (0)
- The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy (2023) (0)
- P030 Effect of neoadjuvant hormonal treatments on cancer specific survival of high-risk prostate cancer patients (2014) (0)
- MP68-03 PREVALENCE OF AND IMPACT OF HEALTH-SIGNIFICANT COMORBIDITIES IN CAUCASIAN-EUROPEAN MEN PRESENTING FOR PRIMARY COUPLE’S INFERTILITY – RESULTS OF A CROSS-SECTIONAL SURVEY (2014) (0)
- Reply to Manish Garg, Apul Goel and Jai Prakash's letter to the editor re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary (2013) (0)
- The relationship between percentage PSA reduction and rate of failure after focal therapy for prostate cancer (2020) (0)
- Is there an age limit for the indication of extended pelvic lymph node dissection during radical prostatectomy in patients with clinically localized prostate cancer? (2018) (0)
- MP53-17 WHERE DO WE MISS EXTRACAPSULAR EXTENSION AT MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE? (2018) (0)
- PD42-05 FECAL MICROBIOTA PROFILING OF PATIENTS TREATED WITH NEOADJUVANT PEMBROLIZUMAB FOR MUSCLE INVASIVE UROTHELIAL CARCINOMA (2021) (0)
- Local treatment of metastasis improves oncological outcome in men with prostate cancer undergoing cytoreductive radical prostatectomy (cRP) for metastatic prostate cancer (mPCA) (2018) (0)
- The effect of pathologic T-stage and Gleason score on cancer-specific survival in patients with positive surgical margins after surgery for high-risk prostate cancer. (2014) (0)
- Abstract A33: Intratissutal and urinary microbiome in therapy-naive bladder cancer patients: Definition of a gender-specific common microbiome (2020) (0)
- Five-Year Outcomes and Late Toxicity in Prostate Cancer Patients Treated With Moderate Hypofractionated Helical Tomotherapy and Simultaneous Integrated Boost in a Phase 1-2 Study (2015) (0)
- MP38-18 INCORPORATING THE PRECISE RECOMMENDATIONS TO EVALUATE PROGRESSION IN MEN ON ACTIVE SURVEILLANCE FOR LOW-GRADE PROSTATE CANCER: WHICH PATIENTS WITH LOW PRECISE SCORE NEED A CONFIRMATORY BIOPSY? (2023) (0)
- 1215: Leydig Cell Tumour of the Testis: Presentation, Therapy and Impact of Surgery on Symptomatic Features (2007) (0)
- 421 Identifying patients at real risk of dying from prostate cancer. A novel risk score for the selection of patients candidate for adjuvant radiation therapy (2012) (0)
- 99m-Technetium-PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing with radical prostatectomy and extended pelvic lymph node dissection (2022) (0)
- Re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80. (2023) (0)
- The detection of a PI-RADS 4-5 lesion at multiparametric MRI before confirmatory biopsy. Is the strongest predictor of disease progression among men with low-risk prostate cancer included in an active surveillance prospective protocol (2021) (0)
- Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series (2022) (0)
- 990 Prediction of bladder outlet obstruction: Development of a clinical nomogram (2013) (0)
- 638 Combination of postoperative prognostic features to predict cancer specific survival in high-risk prostate cancer: A multi institutional competing risk analysis (2014) (0)
- MP37-11 ASSOCIATION BETWEEN THE EXTENT OF LYMPH NODE DISSECTION AND SEVERE TOXICITY IN MEN WITH PROSTATE CANCER TREATED WITH POST-PROSTATECTOMY RADIATION THERAPY: RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2020) (0)
- Surgery or Frailty: Who is the master in eGFR decline after renal surgery in living donor and renal cancer patients? (2023) (0)
- P-06 Erectile Dysfunction following Radical Prostatectomy (2007) (0)
- Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsies (2021) (0)
- MP23-11 PERIOPERATIVE COMPLICATIONS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: AN INTERNATIONAL MULTICENTER COLLABORATION (2022) (0)
- Re: Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. (2020) (0)
- MP83-08 THIRTY YEARS OF RADICAL PROSTATECTOMIES AT A SINGLE TERTIARY CARE REFERRAL CENTER (2015) (0)
- The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to preoperative staging. A comparison between 68Ga-PSMA-PET versus conventional imaging in a large, multi-institutional study (2022) (0)
- MP82-06 NEW CLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMA TO ENHANCE RISK STRATIFICATION OF PATIENTS ELIGIBLE TO ENDOSCOPIC MANAGEMENT: AN INTERNATIONAL COLLABORATIVE STUDY (2020) (0)
- PD11-12 DEVELOPMENT AND VALIDATION OF A NOVEL EPS-METABOLOMIC SIGNATURE FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER. (2019) (0)
- Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537–44 (2021) (0)
- Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance: Results from a single institution series (2020) (0)
- Risk of death from prostate cancer in patients with biopsy Gleason score 6 and additional clinical high-risk features: A European multi-institutional study (2020) (0)
- 911 Oncological outcome and prognostic factors for locally advanced prostate cancer treated with radical prostatectomy: An EMPaCT study (2013) (0)
- Contemporary conditional cancer-specific survival rates in stage III non-seminoma testis cancer patients: A population-based analysis (2023) (0)
- Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform (2022) (0)
- Validation of the novel risk-class for non-muscle invasive bladder cancer: Comparison of oncological outcomes between very-high risk and high risk patients (2023) (0)
- 960 Can Educational Level Affect the Compliance With the Treatment of Patients With Erectile Dysfunction (Ed)? Results of a Single Major Tertiary Academic Centre (2007) (0)
- 773 IS THERE A ROLE FOR SALVAGE EXTENDED LYMPH NODE DISSECTION FOR PATIENTS WITH NODAL RECURRENCE OF PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY? RESULTS BASED ON A MULTI-INSTITUTIONAL ANALYSIS (2013) (0)
- The more you see, the more you miss: Association between PI-RADS score of the index lesion and multifocal, clinically significant prostate cancer (2018) (0)
- The role of histologic subtypes in follow-up scheme of postsurgical kidney cancer patients (2018) (0)
- PS-07-010 The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction - preliminary findings of a real-life cross-sectional study (2017) (0)
- MP48-10 THE ROLE OF PRIOR BLADDER CANCER ON ANY RECURRENCE AND DISTANT METASTASIS IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY (2021) (0)
- Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11] (2022) (0)
- 632 Robot-assisted radical prostatectomy is associated with faster and greater recovery from orgasm associated incontinence (2015) (0)
- CAN 24 CORES TRANS-RECTAL SATURATION BIOPSY IDENTIFY UNILATERAL PROSTATE CANCER POTENTIALLY AMENABLE TO FOCAL TREATMENT? (2009) (0)
- Case Presentation: Intermediate-risk Prostate Cancer in a Fit 66-year-old Man. (2015) (0)
- The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study (2018) (0)
- Conditional survival after radical cystectomy for non-metastatic muscle-invasive adenocarcinoma of the urinary bladder: A population-based analysis (2023) (0)
- Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial. (2022) (0)
- MP51-18 ONE OUT OF TEN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY COMPLAINS OF POSTOPERATIVE PAINFUL ORGASM (2015) (0)
- Incidence and impact of histological variants on survival in candidates for radical cystectomy: Results from a multicenter collaboration (2019) (0)
- MP51-16 THE RISK OF RECURRENCE IN CN1 PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY VARIES ACCORDING TO THE TYPE PREOPERATIVE STAGING. A COMPARISON BETWEEN 68GA-PSMA-PET VERSUS CONVENTIONAL IMAGING IN A LARGE, MULTI-INSTITUTIONAL STUDY (2022) (0)
- MP63-03 END STAGE RENAL DISEASE AFTER SURGERY IN PATIENTS WITH NORMAL PREOPERATIVE KIDNEY FUNCTION: THE EFFECT OF NEPHRON-SPARING SURGERY IN DELAYING THE ONSET OF THE DISEASE (2015) (0)
- 1838: Prospective Randomized Trial Evaluating Residual Prostatic Tissue and Functional Outcome of Different Surgical Approaches for the Treatment of Bladder Outlet Obstruction due to BPH (2007) (0)
- PD15-04 THERE IS NO WAY TO COMPENSATE FOR A NON-TIMELY USE OF SALVAGE RADIATION THERAPY IN MEN WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY (2019) (0)
- Interim results of PEANUT: pembrolizumab and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC). (2020) (0)
- Immuno- versus chemo-therapy as first line treatment for advanced urothelial cancer: A systematic review and meta-analysis (2022) (0)
- PD16-07 PREDICTING TOXICITY-RELATED DOCETAXEL DISCONTINUATION AND SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER USING OPEN PHASE 3 TRIAL DATA (2020) (0)
- 691 PSA DENSITY DOES NOT IMPROVE THE ABILITY TO PREDICT NON-ORGAN CONFINED AND HIGH GRADE PROSTATE CANCER COMPARED TO PSA IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2009) (0)
- The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with oligometastatic prostate cancer: an external validation study (2020) (0)
- The black box of intraoperative adverse incident reporting during radical cystectomy: Not only post-operative complications matter (2023) (0)
- MP58-15 LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE IDENTIFIES PATIENTS AT HIGH-RISK OF ADVERSE OUTCOMES AFTER KIDNEY SURGERY FOR RENAL CANCER: A PROSPECTIVE CLINICAL STUDY (2023) (0)
- PD27-07 IMPACT OF SURGICAL TECHNIQUE ON THE RISK OF BIOCHEMICAL RECURRENCE IN PATIENTS WITH INTERMEDIATE AND HIGH-RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY (2014) (0)
- PD35-01 WHICH PATIENTS WITH CN1 DISEASE AT PET/CT ARE AFFECTED BY SYSTEMIC DISEASE? IMPLICATIONS FOR TAILORED TREATMENT APPROACHES BASED ON A LARGE MULTI-INSTITUTIONAL SERIES (2021) (0)
- 18 IMPACT OF STAGE MIGRATION ON THE PREVALENCE OF PELVIC LYMPH NODE METASTASES IN PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: A 23-YEAR SINGLE INSTITUTION EXPERIENCE (2009) (0)
- Survival outcomes after radical cystectomy versus conservative management for clinical T1 high grade non-muscle invasive micropapillary bladder cancer: A multicenter collaboration by the European Association of Urology–Young Academic Urologists (2021) (0)
- Oncological and functional outcomes of cytoreductive radical prostatectomy (cRP) in men with metastatic hormone-naive prostate cancer (mhnPCA) (2020) (0)
- 520 PELVIC LYMPH NODE DISSECTION SHOULD BE OMITTED IN LOW RISK PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS (2009) (0)
- Rehabilitation of sexual function following definitive treatment of local prostate cancer (2008) (0)
- 620 PERCENTAGE OF POSITIVE CORES STRONGLY INFLUENCES THE RATE OF GLEASON SUM AGREEMENT BETWEEN PROSTATE BIOPSY AND RADICAL PROSTATECTOMY (2009) (0)
- MP51-20 THE ASSOCIATION OF TYPE AND NUMBER OF D’AMICO HIGH-RISK CRITERIA WITH RATES OF PATHOLOGICALLY NON ORGAN CONFINED PROSTATE CANCER (2022) (0)
- 84 DOES ORGASM ASSOCIATED INCONTINENCE (CLIMACTURIA) IMPACT ON ORGASMIC FUNCTION IN MEN SUBMITTED TO BILATERAL NERVE SPARING OPEN RADICAL PROSTATECTOMY (2010) (0)
- 1928 ASSOCIATION BETWEEN THE NUMBER OF CORES TAKEN AT INITIAL PROSTATE BIOPSY AND INSIGNIFICANT PROSTATE CANCER AT RADICAL PROSTATECTOMY IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE. NEED FOR ACCURATE BIOPSY SAMPLING (2013) (0)
- 546 Patterns of recurrence and long-term cancer-specific mortality of prostate cancer patients treated with salvage radical prostatectomy for radio-recurrent prostate cancer (2016) (0)
- Molecular characterization of residual bladder cancer after pembrolizumab (2021) (0)
- MP50-18 PREDICTION OF POST-OPERATIVE OUTCOMES BY ANALYSES OF VIDEO-RECORDED SURGERY IN PATIENTS SUBMITTED TO ROBOTIC-ASSISTED RADICAL PROSTATECTOMY (2021) (0)
- MP48-08 METASTASIS WITHIN THREE YEARS FROM RADICAL NEPHROURETERECTOMY AS A BRIDGE TO OVERALL SURVIVAL: IMPLICATIONS FOR PATIENT COUNSELING, CURRENT, AND FUTURE STUDIES (2021) (0)
- Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment? (2023) (0)
- ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2009) (0)
- MP69-18 HOW TO EXPAND INDICATIONS FOR ACTIVE SURVEILLANCE WITHOUT COMPROMISING CANCER CONTROL: A SYSTEMATIC ASSESSMENT OF THE CURRENTLY USED CRITERIA FOR PROSTATE CANCER PATIENTS (2014) (0)
- 473 Pathological nodal staging score for prostate cancer: A tool to address adequate nodal dissection in men treated with radical prostatectomy (2013) (0)
- 898 EFFECTIVENESS OF SHORT-TERM TRANEXAMIC ACID IN REDUCING BLEEDING AND TRANSFUSION RATE IN PATIENTS UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY: RESULTS OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND CONTROLLED TRIAL (2011) (0)
- PD14-10 CURRENT TRENDS IN MANAGEMENT OF HIGH-RISK PROSTATE CANCER IN EUROPE: RESULTS OF A WEB-BASED SURVEY BY THE PROSTATE CANCER WORKING GROUP OF THE YOUNG ACADEMIC UROLOGISTS WORKING PARTY OF THE EUROPEAN ASSOCIATION OF UROLOGY (2014) (0)
- Which urological patients harbor urinary tract infections before surgery? Results from a large prospective series of patients elected for urologic surgery (2018) (0)
- PD11-03 ASSESSMENT OF OTHER-CAUSE MORTALITY IN T1AN0M0 RENAL CELL CARCINOMA PATIENTS WITH 15 YEARS OF FOLLOW-UP: A SEER-BASED ANALYSIS (2020) (0)
- Neutrophil–lymphocyte ratio predicts pathological features and biochemical recurrence after radical prostatectomy (2016) (0)
- 447 Late recovery of erectile function in men treated with robotic-assisted laparoscopic radical prostatectomy (RALP): A novel nomogram development and validation (2016) (0)
- Impact of intraoperative bleeding on the risk of chronic kidney disease after elective nephron sparing surgery in patients with T1b kidney cancer (2019) (0)
- How to deal with steroids use in the management of metastatic prostate cancer during pandemic (2020) (0)
- MP80-20 LONG-TERM FUNCTIONAL OUTCOMES OF PROSTATE CANCER PATIENTS TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY (2016) (0)
- A positive PSMA PET/CT Predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy (2020) (0)
- 686 Association between time to biochemical recurrence and cancer specific and other cause mortality in men with high risk prostate cancer treated with radical prostatectomy without adjuvant treatments. A multi-institutional analysis (2013) (0)
- 357 High risk prostate with pT3-tumor and positive surgical margin – relevance for clinical failure and prostate cancer mortality: Results of a prospective single institution series (2012) (0)
- Diagnostic and prognostic factors in patients with prostate cancer (2021) (0)
- Endoscopic evaluation of late rectal toxicity after radiotherapy in 597 prostate cancer patients (2016) (0)
- PD42-10 INDEPENDENT PREDICTORS AND PATTERNS OF EARLY AND LATE RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: A MULTICENTER COLLABORATION (2022) (0)
- 909 Impact of the extent of lymph node dissection on survival of patients with locally advanced prostate cancer treated with radical prostatectomy (2015) (0)
- The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm. (2023) (0)
- A BS TR AC T MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (2018) (0)
- 827 IS THE REGION OF PELVIC LYMPH NODE DISSECTION ASSOCIATED WITH LYMPHORRHEA AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2010) (0)
- Erratum: Age‐adjusted validation of the most stringent criteria for active surveillance in low‐risk prostate cancer patients (2012) (0)
- 387 Identification of population-specific genetic risk profiles in young individuals with or without family history of prostate cancer (2016) (0)
- IMPACT OF PREVIOUS EXPERIENCE WITH OPEN SURGERY AND INITIAL ANNUAL ROBOTIC CASELOAD ON POSITIVE SURGICAL MARGIN RATES AFTER ROBOT‐ASSISTED RADICAL PROSTATECTOMY: MP97‐11 (2017) (0)
- 1646: PSA Represents a Highly Accurate Predictor of Pathologic Stage and Surgical Outcomes (2006) (0)
- Prevalence and prognostic impact of prostate cancer histological variants at radical prostatectomy: A long-term, single center analysis (2018) (0)
- Prediction of progression to MIBC for pT1 bladder cancer: Development of a clinical decision-making tool (2017) (0)
- CAN RADICAL CYSTECTOMY BE PERFORMED SAFELY IN THE METASTATIC SETTING? LOCATION OF METASTATIC BLADDER CANCER AS A DETERMINANT OF IN‐HOSPITAL MORTALITY: MP34‐20 (2017) (0)
- Do all patients equally benefit from the Enhanced Recovery After Surgery (ERAS) protocol after radical cystectomy? (2023) (0)
- Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions. (2023) (0)
- MP45-11 WHICH CLINICAL CHARACTERISTICS SHOULD PROMPT MULTIDISCIPLINARY TEAM EVALUATION AFTER DIAGNOSING NON-METASTATIC RENAL CELL CARCINOMA: IMPLICATIONS FOR PATIENT REFERRAL, PRE-SURGICAL TRIALS AND HEALTH CARE POLICIES (2021) (0)
- MP64-11 PROGNOSTIC IMPACT OF GLEASON GRADE AT THE MARGIN IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2021) (0)
- Radical prostatectomy for stage T1a-T1b prostate cancer: Analysis of predictors for residual disease and biochemical recurrence (2008) (0)
- CAN WE PREDICT PROLONGED LYMPHORRHEA IN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY AND PELVIC LYMPHADENECTOMY (2008) (0)
- Prognostic differences and survival outcomes in patients with papillary renal cell carcinoma subtypes – a comparison between type I VS. type II (2020) (0)
- The Surgical Learning Curve for Cancer Control after Robot-Assisted Radical Prostatectomy (2022) (0)
- PREDICTION OF EXTREME UPGRADE FROM BIOPSY GRADE 1 TO GRADE 4 OR 5 AT RADICAL PROSTATECTOMY: THE IMPORTANCE OF THE EXTENT OF BIOPSY SAMPLING: MP97‐08 (2017) (0)
- The role of prior bladder cancer on any recurrence and distant metastasis in patients treated with radical nephroureterectomy (2021) (0)
- MP63-11 PREOPERATIVE PLATELET TO LYMPHOCYTE RATIO AS A PREDICTOR OF SURVIVAL AFTER RADICAL CYSTECTOMY DUE TO BLADDER CANCER (2016) (0)
- Papillary renal cell carcinoma type I and II: Two distinct diseases with different clinical and therapeutical implications (2021) (0)
- MP21-09 WHO DIES FROM PROSTATE CANCER? A COMPREHENSIVE ANALYSIS OF A LARGE SERIES OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY WITH LONG-TERM FOLLOW-UP (2018) (0)
- Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma. (2022) (0)
- What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study (2018) (0)
- MP16-18 VALIDATION OF STAMPEDE CRITERIA FOR NON-METASTATIC PROSTATE CANCER - AN EMPACT STUDY (2018) (0)
- In reply to the letter to the editor 'in Reply to Gandaglia et al.' by De Bari et al. (2014) (0)
- MP21-15 WHEN CAN BIOCHEMICAL RECURRENCE BE CONSIDERED A SURROGATE FOR HARDER CLINICAL ENDPOINTS IN HIGH RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL, LONG-TERM ANALYSES (2018) (0)
- PD57-08 INDIVIDUALIZED RISK STRATICATION OF PATIENTS CANDIDATE TO RADICAL PROSTATECTOMY BASED ON CLINICAL AND MULTI-PARAMETRIC MRI PARAMETERS: BEYOND THE CONVENTIONAL CLINICAL RISK MODELS (2021) (0)
- MP41-12 RADICAL CYSTECTOMY IN PATHOLOGICAL T4A AND T4B PATIENTS: IS THERE ANY SPACE FOR SUB STRATIFICATION? (2018) (0)
- 936 THE IMPACT OF AGE AND COMORBIDITIES ON SURVIVAL AFTER RADICAL PROSTATECTOMY IN HIGH-RISK PROSTATE CANCER PATIENTS: A COMPETING-RISKS ANALYSIS (2012) (0)
- MP47-09 THE ADDED VALUE OF HISTOLOGICAL SUBTYPE IN THE PREDICTION OF ONCOLOGIC OUTCOMES IN PATIENTS WITH NON-METASTATIC PAPILLARY RENAL CELL CARCINOMA (2022) (0)
- POD-07.02 Positive Surgical Margin at Bladder Neck Is an Independant Predictor of Local Failure and Prostate Cancer Mortality in pT3-Prostate Cancer. Results of a Prospective Single Institution Series (2011) (0)
- 679 Proposal of a new rehabilitation protocal based on the use of intracavernous injections and Tadalafil: preliminary results from a pilot study (2018) (0)
- PD56-02 THE DETRIMENTAL EFFECT OF FRAILTY STATUS ON RENAL FUNCTION RECOVERY AFTER PARTIAL NEPHRECTOMY – LONG-TERM RESULTS FROM A PROSPECTIVE SURGICAL COHORT (2022) (0)
- First-line treatment in advanced renal cell carcinoma: A quasi-individual patient data meta-analysis (2022) (0)
- 640 Head-to-head comparison of conditional oncological outcomes after radical prostatectomy in patients with intermediate and high risk prostate cancer (2015) (0)
- Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities (2020) (0)
- Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy (2022) (0)
- 172 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM TO ASSESS THE MOST ACCURATE BIOPSY SCHEME TO BE PERFORMED IN PATIENTS UNDERGOING REPEAT BIOPSY. RESULTS DERIVED FROM SATURATION BIOPSY DATA (2010) (0)
- MP23-09 ACUTE KIDNEY INJURY AND ITS DURATION IN PATIENTS TREATED WITH RADICAL CYSTECTOMY IN THE ENHANCED RECOVERY AFTER SURGERY ERA: OPTIMIZING THE SELECTION OF PATIENTS FOR RESTRICTIVE FLUID THERAPY (2022) (0)
- Identifying the most informative cut-off of psa to define biochemical recurrence after radical prostatectomy: A stage-by-stage analysis (2021) (0)
- Assessing the need for systematic biopsies in addition to targeted biopsies according to the volume of the index lesion diagnosed at mpmri. Results from a large multi-institutional database (2021) (0)
- A timely administration of metastasis-directed therapy can reduce the risk of disease progression in men with positive 68Ga-PSMA PET/CT for biochemical recurrence after radical prostatectomy (2022) (0)
- 977 Nephron sparing surgery decreases other-causes mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma (2016) (0)
- MP05-16 WHAT IS THE DEFINITION OF MISCLASSIFICATION IN PATIENTS WITH GRADE GROUP 2 PROSTATE CANCER ELIGIBLE FOR ACTIVE SURVEILLANCE AND DIAGNOSED WITH MRI TARGETED BIOPSY? A MULTI-INSTITUTIONAL ANALYSIS WITH PATHOLOGICAL CONFIRMATION (2021) (0)
- MP56-16 THE IMPACT OF RE-TUR ON CLINICAL OUTCOMES IN A LARGE COHORT OF T1G3 PATIENTS TREATED WITH BCG. (2014) (0)
- MP15-03 PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN PATIENTS TREATED WITH SALVAGE RADICAL PROSTATECTOMY FOR RADIATION-RECURRENT PROSTATE CANCER (2022) (0)
- SP267RENAL HISTOLOGY VERSUS ESTIMATED GLOMERULAR FILTRATION RATE: BEYOND THE LOOKING GLASS (2019) (0)
- 770 DEVOLEPMENT AND INTERNAL VALIDATION OF THE FIRST TOOL TO PREDICT LONG TERM SURVIVAL OF NODE POSITIVE PROSTATE CANCER PATIENTS TREATED IN THE PSA ERA (2013) (0)
- Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and morphological imaging in recurrent urothelial carcinomas: A retrospective, multi-center study (2017) (0)
- MP56-05 INTERREADER AGREEMENT IN MULTIPARAMETRIC MRI REPORTING USING PROSTATE IMAGING REPORTING AND DATA SYSTEM VERSION 2.1 (2020) (0)
- 737Holmium laser enucleation of the prostate is more cost effective than open prostatectomy: Results of a randomized prospective study (2005) (0)
- Trends of lymphadenectomy in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: The impact of surgical technique (2017) (0)
- MP56-16 VERY LONG TERM OUTCOMES OF RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER. RESULTS FROM A SINGLE INSTITUTION SERIES (2015) (0)
- PD46-06 UROLOGICAL FOLLOW-UP AND MUTATIONAL PATTERNS IN LYNCH SYNDROME PATIENTS: A SINGLE CENTER EXPERIENCE (2023) (0)
- PS-08-001 Subjective penile morphometric alterations after radical prostatectomy - Findings of a cross-sectional real-life study (2017) (0)
- MP53-20 ADDED VALUE OF MPMRI IN THE STRATIFICATION OF PATIENTS WITH HIGH-RISK PATIENTS PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: IMPLICATIONS FOR TAILORED MULTI-MODAL STRATEGIES (2022) (0)
- Oncological outcomes in patients with recurrent prostate cancer staged with PSMA PET/CT: Results from 3 European tertiary centers (2022) (0)
- 148 Pretreatment tables for the prediction of pathological outcomes of patients with locally advanced prostate cancer (2012) (0)
- 776 ASSOCIATION BETWEEN TIME TO BIOCHEMICAL RECURRENCE AND CANCER SPECIFIC AND OTHER CAUSE MORTALITY IN MEN WITH HIGH RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY WITHOUT ADJUVANT TREATMENTS. A MULTI-INSTITUTIONAL ANALYSIS (2013) (0)
- Molecular characterization to delineate the clonal evolution of primary prostate cancer with synchronous lymph node metastasis. (2022) (0)
- MP55-06 OUTCOME OF NON-RESPONDERS TO NEOADJUVANT IMMUNOTHERAPY COMPARED TO CISPLATIN-BASED CHEMOTHERAPY BEFORE RADICAL CYSTECTOMY IN MUSCLE-INVASIVE BLADDER CANCER (2020) (0)
- Penile Rehabilitation After Robotic Radical Prostatectomy: The Best Strategy (2011) (0)
- MP22-01 TREND OF USE OF ADJUVANT AND SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY AND IMPACT ON LONG-TERM OUTCOMES: RESULTS FROM THREE HIGH VOLUME CENTERS OVER THE LAST TWO DECADES (2018) (0)
- Incremental utility of mp-MRI performed before confirmatory biopsy in reducing the risk of progression during active surveillance for men with low risk prostate cancer: Is imaging always useful? (2019) (0)
- 798 PROGNOSTIC ROLE OF MICRORNA 221 IN HIGH RISK PROSTATE CANCER (2013) (0)
- 466: Age is an Independent Predictor of Bone Metastasis at Prostate Cancer Diagnosis (2007) (0)
- 780 Models assessing the need for pelvic lymph node dissection cannot be reliably used in men with prostate cancer previously treated with surgery for benign prostatic enlargement (2012) (0)
- Factors affecting self-reported, long-term (1-2 yrs) urinary incontinence from postprostatectomy RT (2018) (0)
- Molecular characterization to delineate the clonal evolution of primary prostate cancer with synchronous lymph node metastasis (2022) (0)
- PD26-09 PRIMARY TA HIGH GRADE BLADDER TUMORS: DETERMINATION OF THE RISK OF PROGRESSION (2022) (0)
- 1013 PREDICTING FAVOURABLE PATHOLOGICAL OUTCOME IN PATIENTS WITH CLINICAL HIGH RISK PROSTATE CANCER. A NOVEL NOMOGRAM BASED ON A MULTI-INSTITUTIONAL ANALYSIS (2010) (0)
- Validating the comprehensive complication index for assessing cumulative morbidity after robot-assisted radical cystectomy: results from a high-volume institution (2022) (0)
- PD16-02 ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IN MEN WITH METASTATIC HORMONE-NAIVE PROSTATE CANCER (MHNPCA) (2020) (0)
- PD51-01 INTERIM RESULTS OF PEANUT (2020) (0)
- 1125 A NOVEL TOOL FOR THE PREDICTION OF URINARY INCONTINENCE AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2012) (0)
- MP77-03 GLEASON SCORE UPGRADING TO 8-10 PREDICTS BIOCHEMICAL RECURRENCE IN MEN UNDERGOING RADICAL PROSTATECTOMY: ANALYSIS ON 7310 HIGH-RISK PATIENTS FROM THE EMPACT DATABASE. (2015) (0)
- The role of cytoreductive radical prostatectomy (cRP) in men with hormone-sensitive, metastatic prostate cancer (mPCA). (2017) (0)
- MP15-07 ANALYSIS OF PERIOPERATIVE COMPLICATIONS IN PATIENTS WITH PROSTATE CANCER BASED ON EXTENSION OF PELVIC LYMPH NODE DISSECTION (2021) (0)
- Are we improving functional outcomes of prostate cancer patients treated with robot-assisted radical prostatectomy? A 10-year analysis in men treated at two high volume, tertiary referral centers (2019) (0)
- Comparison of robot-assisted and open surgery partial nephrectomy: an observational prospective study on functional and oncologic outcomes (2017) (0)
- The Detection of Prostate Cancer with Magnetic Resonance Imaging-targeted Prostate Biopsies is Superior With the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Reply. (2023) (0)
- INCOMPLETENESS OF THE TRANSURETHRAL RESECTION AS A PREDICTOR OF ADVERSE PATHOLOGICAL FEATURES AT THE TIME OF RADICAL CYSTECTOMY: IMPLICATIONS FOR NEOADJUVANT CHEMOTHERAPY SELECTION: MP58‐01 (2017) (0)
- ERECTILE DYSFUNCTION Is Erectile Dysfunction a Reliable Proxy of General Male Health Status ? The Case for the International Index of Erectile Function — Erectile (2010) (0)
- 1063 TIME TO BIOCHEMICAL RECURRENCE IS A STRONG AND INDEPENDENT PREDICTOR OF CSS AND OS IN HIGH-RISK PROSTATE CANCER (2011) (0)
- Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma (2021) (0)
- Which are the long-term outcomes of prostate cancer patients undergoing non-interventional management (i.e., watchful waiting) and what is the impact of comorbidities and life expectancy? – PIONEER Research Question #2 (2021) (0)
- Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery. Eur Urol. In press. https://doi.org/10.1016/j (2022) (0)
- P-01-038 Preoperative hypogonadism does not impact on erectile function recovery after radical prostatectomy (2017) (0)
- Iron induces ferroptosis and synergizes with anti-androgen therapy in prostate cancer pre-clinical models (2019) (0)
- Assessing the need for and the optimal duration of hormonal therapy in association with post-prostatectomy radiation therapy: Results from a multi-institutional study (2018) (0)
- SURVIVAL AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PSA PERSISTENCE: THE IMPACT OF COMPETING CAUSES OF MORTALITY: PD51‐10 (2017) (0)
- Patients adhering to standardized protocols for functional outcome assessment after radical prostatectomy show higher rates of return to preoperative status: Implications for possible selection biases (2018) (0)
- Concordance of pathologic outcomes in patients with synchronous bilateral renal masses elected for surgical treatment: Implications for preoperative renal biopsy (2020) (0)
- MP51-15 THE ROLE OF 68GA-PSMA- AND 68GA-DOTA-RM2 PET/MRI IN THE PRIMARY STAGING OF HIGH-RISK PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY. PRELIMINARY RESULTS OF A PROSPECTIVE, SINGLE CENTER STUDY (2022) (0)
- MP32-16 INCIDENCE AND IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN CANDIDATES FOR RADICAL CYSTECTOMY: RESULTS FROM A MULTICENTER COLLABORATION (2019) (0)
- MP55-04 NO-RESPONSE AT MPMRI AFTER NEOADJUVANT PEMBROLIZUMAB IS A PROXY OF ADVERSE PATHOLOGICAL AND ONCOLOGICAL OUTCOMES IN PATIENTS TREATED WITH RADICAL CYSTECTOMY (2020) (0)
- MP80-02 LATE RECOVERY OF ERECTILE FUNCTION IN MEN TREATED WITH ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: A NOVEL NOMOGRAM DEVELOPMENT AND VALIDATION (2016) (0)
- MP09-17 A POTENTIALLY NOVEL IMMUNOTHERAPY TARGET IN PROSTATE CANCER (2020) (0)
- Validation and survival of biopsy Gleason Grade Group V patients treated with radical prostatectomy or external beam radiation therapy: 4+5 vs. 5+4 vs. 5+5 (2021) (0)
- Are men with low risk prostate cancer but high pirads score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series (2020) (0)
- MP69-14 RADICAL CYSTECTOMY AS INITIAL PART OF MULTIMODALITY TREATMENT IN CT4 VERY HIGH-RISK PROSTATE CANCER – RESULTS OF A MULTI-INSTITUTIONAL STUDY OF 62 PATIENTS (2016) (0)
- MP82-03 SALVAGE LYMPH NODE DISSECTION FOR CLINICALLY RECURRENT PROSTATE CANCER: WHICH PATIENTS DO BENEFIT FROM THIS APPROACH? (2015) (0)
- Re: Dries Develtere, Giuseppe Rosiello, Pietro Piazza, et al. Early Catheter Removal on Postoperative Day 2 After Robot-assisted Radical Prostatectomy: Updated Real-life Experience with the Aalst Technique. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.003. (2022) (0)
- MP34-14 WHICH PATIENTS WITH CLINICALLY NODE POSITIVE PROSTATE CANCER BENEFIT FROM RADICAL PROSTATECTOMY? THE IMPACT OF THE SIZE AND SITE OF NODAL INVOLVEMENT (2018) (0)
- Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy (2022) (0)
- INCIDENCE RATES AND CANCER CONTROL OUTCOMES OF CONTEMPORARY PRIMARY NEUROENDOCRINE PROSTATE CANCER: ANALYSIS OF SEER DATABASE: PD47‐12 (2017) (0)
- Identifying the optimal candidates for concomitant androgen-deprivation therapy among patients receiving metastasis-directed therapy for positive 68Ga-PSMA PET/CT for biochemical recurrent prostate cancer after radical prostatectomy (2023) (0)
- THE ASSOCIATION BETWEEN LYMPH NODE DENSITY AND BIOCHEMICAL RECURRENCE IN PATIENTS WITH PROSTATE CANCER AND NODAL METASTASES IS RELATED TO THE EXTENT OF PELVIC LYMPH NODE DISSECTION (2008) (0)
- Re: A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. (2023) (0)
- 1591 AGE, COMORBIDITIES, AND RACE ARE PREDICTORS TO UNDERGO RADICAL CYSTECTOMY AT LOW VOLUME INSTITUTIONS (2012) (0)
- Understanding the Role of Ureteral Access Sheath in Preventing Post-Operative Infectious Complications in Stone Patients Treated with Ureteroscopy and Ho:YAG Laser Lithotripsy: Results from a Tertiary Care Referral Center (2023) (0)
- MP51-11 HAS THE INTRODUCTION OF MPMRI IN THE DIAGNOSTIC PATHWAY OF PROSTATE CANCER LED TO IMPROVED ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY? RESULT FROM A LARGE SINGLE-INSTITUTIONAL SERIES (2022) (0)
- PD15-08 A MORE EXTENSIVE PELVIC LYMPH NODE DISSECTION IS ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER (2014) (0)
- 1035 FACTORS PREDICTING PATHOLOGICAL STAGE IN PATIENTS SUBMITTED TO RADICAL RETROPUBIC PROSTATECTOMY DUE TO INCIDENTAL (T1A-T1B) PROSTATE CANCER (2007) (0)
- PD-0416 Derivation and external validation of a RAPID Risk score for predicting significant prostate cancer (2022) (0)
- 822 What should be the optimal definition of misclassification in patients managed with active surveillance for very low risk prostate cancer (2015) (0)
- Challenging the dogma: Should unilateral pelvic lymph node dissection be envisioned in the multiparametric prostate MRI era? (2022) (0)
- Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series (2020) (0)
- PATHOLOGICAL FINDINGS AT RADICAL PROSTATECTOMY AFTER INITIAL ACTIVE SURVEILLANCE IN LOW‐RISK PROSTATE CANCER PATIENTS. DID WE MISS THE CHANCE TO CURE?: PD51‐11 (2017) (0)
- 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM (2013) (0)
- 1578: BMI and its Ability to Improve Prediction of Biochemical Recurrence (BCR) after Radical Prostatectomy (RP): Does a Statistically Significant Marker Always Improve Predictive Accuracy in Multivariate Models? (2006) (0)
- Poster: Clinical track: ProstatePO-0730: The independent benefit deriving from high doses and WPRT in salvage post-prostatectomy radiotherapy (2017) (0)
- WHEN TO PERFORM PREOPERATIVE BONE SCINTIGRAPHY FOR KIDNEY CANCER STAGING: PD52‐05 (2017) (0)
- MP60-09 EFFECT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON ONCOLOGIC OUTCOMES IN D’AMICO INTERMEDIATE- AND HIGH-RISK RADICAL PROSTATECTOMY PATIENTS (2018) (0)
- PD51-02 PLANNED SECONDARY ANALYSIS OF PURE-01 (2020) (0)
- PD49-08 HYPERTENSION AND CARDIOVASCULAR MORBIDITY FOLLOWING RADICAL NEPHRECTOMY ARE ONLY SUSTAINED BY RENAL PARENCHYMA LOSS AND CARDIOVASCULAR MORBIDITY (2020) (0)
- IMPORTANCE OF TUMOR SIZE AS RISK STRATIFICATION PARAMETER IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC): MP78‐14 (2017) (0)
- Prognostic value of Gleason score at positive surgical margin in prostate cancer. A systematic review and meta-analysis (2020) (0)
- Impact of variant histologic differentiation in bladder cancer patients on recurrence pattern after radical cystectomy: Implications for follow up schemes (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alberto Briganti?
Alberto Briganti is affiliated with the following schools:
